gene_symbol,gene_hgnc_id,disease_label,disease_mondo_id,classification,go_id,go_label,mapping_type,confidence,evidence_category
AARS1,HGNC:20,Charcot-Marie-Tooth disease axonal type 2N,MONDO:0013212,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AARS2,HGNC:21022,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AARS2,HGNC:21022,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
AARS2,HGNC:21022,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
AARS2,HGNC:21022,mitochondrial disease,MONDO:0044970,Definitive,GO:0006412,translation,keyword,high,keyword
AARS2,HGNC:21022,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
ABCA3,HGNC:33,interstitial lung disease due to ABCA3 deficiency,MONDO:0012582,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ABCA3,HGNC:33,interstitial lung disease due to ABCA3 deficiency,MONDO:0012582,Definitive,GO:0006810,transport,keyword,medium,keyword
ABCA3,HGNC:33,interstitial lung disease due to ABCA3 deficiency,MONDO:0012582,Definitive,GO:0016020,membrane,keyword,medium,keyword
ABCA3,HGNC:33,interstitial lung disease due to ABCA3 deficiency,MONDO:0012582,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ABCA3,HGNC:33,interstitial lung disease due to ABCA3 deficiency,MONDO:0012582,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ABCA3,HGNC:33,interstitial lung disease due to ABCA3 deficiency,MONDO:0012582,Definitive,GO:0005488,binding,keyword,medium,keyword
ABCA3,HGNC:33,interstitial lung disease due to ABCA3 deficiency,MONDO:0012582,Definitive,GO:0005215,transporter activity,keyword,high,keyword
ABCA3,HGNC:33,interstitial lung disease due to ABCA3 deficiency,MONDO:0012582,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
ABCA3,HGNC:33,interstitial lung disease due to ABCA3 deficiency,MONDO:0012582,Definitive,GO:0010467,gene expression,direct,high,Expression
ABCA3,HGNC:33,interstitial lung disease due to ABCA3 deficiency,MONDO:0012582,Definitive,GO:0006412,translation,inferred,medium,Expression
ABCA4,HGNC:34,ABCA4-related retinopathy,MONDO:0800406,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ABCA4,HGNC:34,ABCA4-related retinopathy,MONDO:0800406,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
ABCA4,HGNC:34,ABCA4-related retinopathy,MONDO:0800406,Definitive,GO:0010467,gene expression,direct,high,Expression
ABCA4,HGNC:34,ABCA4-related retinopathy,MONDO:0800406,Definitive,GO:0006412,translation,inferred,medium,Expression
ABCA4,HGNC:34,ABCA4-related retinopathy,MONDO:0800406,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ABCA4,HGNC:34,ABCA4-related retinopathy,MONDO:0800406,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ABCA4,HGNC:34,ABCA4-related retinopathy,MONDO:0800406,Definitive,GO:0006810,transport,keyword,medium,keyword
ABCA4,HGNC:34,ABCA4-related retinopathy,MONDO:0800406,Definitive,GO:0005215,transporter activity,keyword,high,keyword
ABCA4,HGNC:34,ABCA4-related retinopathy,MONDO:0800406,Definitive,GO:0016020,membrane,keyword,medium,keyword
ABCB4,HGNC:45,progressive familial intrahepatic cholestasis type 3,MONDO:0011214,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ABCB4,HGNC:45,progressive familial intrahepatic cholestasis type 3,MONDO:0011214,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ABCB4,HGNC:45,progressive familial intrahepatic cholestasis type 3,MONDO:0011214,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ABCB4,HGNC:45,progressive familial intrahepatic cholestasis type 3,MONDO:0011214,Definitive,GO:0010467,gene expression,direct,high,Expression
ABCB4,HGNC:45,progressive familial intrahepatic cholestasis type 3,MONDO:0011214,Definitive,GO:0006412,translation,inferred,medium,Expression
ABCD1,HGNC:61,adrenoleukodystrophy,MONDO:0018544,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ABCD1,HGNC:61,adrenoleukodystrophy,MONDO:0018544,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ABCD1,HGNC:61,adrenoleukodystrophy,MONDO:0018544,Definitive,GO:0010467,gene expression,direct,high,Expression
ABCD1,HGNC:61,adrenoleukodystrophy,MONDO:0018544,Definitive,GO:0006412,translation,inferred,medium,Expression
ABCG5,HGNC:13886,sitosterolemia,MONDO:0008863,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ABCG5,HGNC:13886,sitosterolemia,MONDO:0008863,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ABCG5,HGNC:13886,sitosterolemia,MONDO:0008863,Definitive,GO:0005794,Golgi apparatus,keyword,high,keyword
ABCG5,HGNC:13886,sitosterolemia,MONDO:0008863,Definitive,GO:0010467,gene expression,direct,high,Expression
ABCG5,HGNC:13886,sitosterolemia,MONDO:0008863,Definitive,GO:0006412,translation,inferred,medium,Expression
ABCG5,HGNC:13886,sitosterolemia,MONDO:0008863,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ABCG8,HGNC:13887,sitosterolemia,MONDO:0008863,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ABCG8,HGNC:13887,sitosterolemia,MONDO:0008863,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ABCG8,HGNC:13887,sitosterolemia,MONDO:0008863,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ABCG8,HGNC:13887,sitosterolemia,MONDO:0008863,Definitive,GO:0010467,gene expression,direct,high,Expression
ABCG8,HGNC:13887,sitosterolemia,MONDO:0008863,Definitive,GO:0006412,translation,inferred,medium,Expression
ABHD12,HGNC:15868,PHARC syndrome,MONDO:0012984,Definitive,GO:0010467,gene expression,direct,high,Expression
ABHD12,HGNC:15868,PHARC syndrome,MONDO:0012984,Definitive,GO:0006412,translation,inferred,medium,Expression
ABHD12,HGNC:15868,PHARC syndrome,MONDO:0012984,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ABHD12,HGNC:15868,PHARC syndrome,MONDO:0012984,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ABHD5,HGNC:21396,Dorfman-Chanarin disease,MONDO:0010155,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ABHD5,HGNC:21396,Dorfman-Chanarin disease,MONDO:0010155,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
ABHD5,HGNC:21396,Dorfman-Chanarin disease,MONDO:0010155,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ABHD5,HGNC:21396,Dorfman-Chanarin disease,MONDO:0010155,Definitive,GO:0005488,binding,keyword,medium,keyword
ABHD5,HGNC:21396,Dorfman-Chanarin disease,MONDO:0010155,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ACAD8,HGNC:87,isobutyryl-CoA dehydrogenase deficiency,MONDO:0012648,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACAD8,HGNC:87,isobutyryl-CoA dehydrogenase deficiency,MONDO:0012648,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ACAD8,HGNC:87,isobutyryl-CoA dehydrogenase deficiency,MONDO:0012648,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ACAD9,HGNC:21497,acyl-CoA dehydrogenase 9 deficiency,MONDO:0012624,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACAD9,HGNC:21497,acyl-CoA dehydrogenase 9 deficiency,MONDO:0012624,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ACAD9,HGNC:21497,acyl-CoA dehydrogenase 9 deficiency,MONDO:0012624,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ACAD9,HGNC:21497,acyl-CoA dehydrogenase 9 deficiency,MONDO:0012624,Definitive,GO:0010467,gene expression,direct,high,Expression
ACAD9,HGNC:21497,acyl-CoA dehydrogenase 9 deficiency,MONDO:0012624,Definitive,GO:0006412,translation,inferred,medium,Expression
ACAD9,HGNC:21497,acyl-CoA dehydrogenase 9 deficiency,MONDO:0012624,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
ACAD9,HGNC:21497,acyl-CoA dehydrogenase 9 deficiency,MONDO:0012624,Definitive,GO:0016020,membrane,keyword,medium,keyword
ACADM,HGNC:89,medium chain acyl-CoA dehydrogenase deficiency,MONDO:0008721,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACADM,HGNC:89,medium chain acyl-CoA dehydrogenase deficiency,MONDO:0008721,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ACADM,HGNC:89,medium chain acyl-CoA dehydrogenase deficiency,MONDO:0008721,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
ACADM,HGNC:89,medium chain acyl-CoA dehydrogenase deficiency,MONDO:0008721,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ACADS,HGNC:90,short chain acyl-CoA dehydrogenase deficiency,MONDO:0008722,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACADS,HGNC:90,short chain acyl-CoA dehydrogenase deficiency,MONDO:0008722,Definitive,GO:0010467,gene expression,direct,high,Expression
ACADS,HGNC:90,short chain acyl-CoA dehydrogenase deficiency,MONDO:0008722,Definitive,GO:0006412,translation,inferred,medium,Expression
ACADVL,HGNC:92,very long chain acyl-CoA dehydrogenase deficiency,MONDO:0008723,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACADVL,HGNC:92,very long chain acyl-CoA dehydrogenase deficiency,MONDO:0008723,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ACADVL,HGNC:92,very long chain acyl-CoA dehydrogenase deficiency,MONDO:0008723,Definitive,GO:0010467,gene expression,direct,high,Expression
ACADVL,HGNC:92,very long chain acyl-CoA dehydrogenase deficiency,MONDO:0008723,Definitive,GO:0006412,translation,inferred,medium,Expression
ACADVL,HGNC:92,very long chain acyl-CoA dehydrogenase deficiency,MONDO:0008723,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ACAT1,HGNC:93,beta-ketothiolase deficiency,MONDO:0008760,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ACAT1,HGNC:93,beta-ketothiolase deficiency,MONDO:0008760,Definitive,GO:0010467,gene expression,direct,high,Expression
ACAT1,HGNC:93,beta-ketothiolase deficiency,MONDO:0008760,Definitive,GO:0006412,translation,inferred,medium,Expression
ACAT1,HGNC:93,beta-ketothiolase deficiency,MONDO:0008760,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
ACAT1,HGNC:93,beta-ketothiolase deficiency,MONDO:0008760,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ACAT1,HGNC:93,beta-ketothiolase deficiency,MONDO:0008760,Definitive,GO:0009056,catabolic process,keyword,medium,keyword
ACAT1,HGNC:93,beta-ketothiolase deficiency,MONDO:0008760,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
ACD,HGNC:25070,ACD-related short telomere syndrome,MONDO:0100569,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACD,HGNC:25070,ACD-related short telomere syndrome,MONDO:0100569,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ACD,HGNC:25070,ACD-related short telomere syndrome,MONDO:0100569,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ACD,HGNC:25070,ACD-related short telomere syndrome,MONDO:0100569,Definitive,GO:0010467,gene expression,direct,high,Expression
ACD,HGNC:25070,ACD-related short telomere syndrome,MONDO:0100569,Definitive,GO:0006412,translation,inferred,medium,Expression
ACO2,HGNC:118,mitochondrial disease,MONDO:0044970,Strong,GO:0003674,molecular_function,inferred,low,Functional Alteration
ACO2,HGNC:118,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACO2,HGNC:118,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ACO2,HGNC:118,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
ACO2,HGNC:118,mitochondrial disease,MONDO:0044970,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
ACOX1,HGNC:119,peroxisomal acyl-CoA oxidase deficiency,MONDO:0009919,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACOX1,HGNC:119,peroxisomal acyl-CoA oxidase deficiency,MONDO:0009919,Definitive,GO:0010467,gene expression,direct,high,Expression
ACOX1,HGNC:119,peroxisomal acyl-CoA oxidase deficiency,MONDO:0009919,Definitive,GO:0006412,translation,inferred,medium,Expression
ACOX1,HGNC:119,peroxisomal acyl-CoA oxidase deficiency,MONDO:0009919,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ACSF3,HGNC:27288,combined malonic and methylmalonic acidemia,MONDO:0013661,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACSF3,HGNC:27288,combined malonic and methylmalonic acidemia,MONDO:0013661,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ACSF3,HGNC:27288,combined malonic and methylmalonic acidemia,MONDO:0013661,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ACSL4,HGNC:3571,non-syndromic X-linked intellectual disability,MONDO:0019181,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACSL4,HGNC:3571,non-syndromic X-linked intellectual disability,MONDO:0019181,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ACSL4,HGNC:3571,non-syndromic X-linked intellectual disability,MONDO:0019181,Definitive,GO:0010467,gene expression,direct,high,Expression
ACSL4,HGNC:3571,non-syndromic X-linked intellectual disability,MONDO:0019181,Definitive,GO:0006412,translation,inferred,medium,Expression
ACTA1,HGNC:129,alpha-actinopathy,MONDO:0100084,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACTA1,HGNC:129,alpha-actinopathy,MONDO:0100084,Definitive,GO:0010467,gene expression,direct,high,Expression
ACTA1,HGNC:129,alpha-actinopathy,MONDO:0100084,Definitive,GO:0006412,translation,inferred,medium,Expression
ACTA1,HGNC:129,alpha-actinopathy,MONDO:0100084,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ACTA1,HGNC:129,alpha-actinopathy,MONDO:0100084,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ACTA1,HGNC:129,alpha-actinopathy,MONDO:0100084,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACTA1,HGNC:129,alpha-actinopathy,MONDO:0100084,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ACTA1,HGNC:129,alpha-actinopathy,MONDO:0100084,Definitive,GO:0005488,binding,keyword,medium,keyword
ACTA1,HGNC:129,alpha-actinopathy,MONDO:0100084,Definitive,GO:0010467,gene expression,direct,high,Expression
ACTA1,HGNC:129,alpha-actinopathy,MONDO:0100084,Definitive,GO:0006412,translation,inferred,medium,Expression
ACTA1,HGNC:129,alpha-actinopathy,MONDO:0100084,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ACTB,HGNC:132,Baraitser-Winter cerebrofrontofacial syndrome,MONDO:0017579,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ACTC1,HGNC:143,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACTC1,HGNC:143,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ACTC1,HGNC:143,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0010467,gene expression,direct,high,Expression
ACTC1,HGNC:143,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0006412,translation,inferred,medium,Expression
ACTG1,HGNC:144,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACTN1,HGNC:163,platelet-type bleeding disorder 15,MONDO:0014078,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ACVR1,HGNC:171,fibrodysplasia ossificans progressiva,MONDO:0007606,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ACVR1,HGNC:171,fibrodysplasia ossificans progressiva,MONDO:0007606,Definitive,GO:0023052,signaling,keyword,medium,keyword
ACVR1,HGNC:171,fibrodysplasia ossificans progressiva,MONDO:0007606,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
ACVR1,HGNC:171,fibrodysplasia ossificans progressiva,MONDO:0007606,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ACVR1,HGNC:171,fibrodysplasia ossificans progressiva,MONDO:0007606,Definitive,GO:0010467,gene expression,direct,high,Expression
ACVR1,HGNC:171,fibrodysplasia ossificans progressiva,MONDO:0007606,Definitive,GO:0006412,translation,inferred,medium,Expression
ACY1,HGNC:177,aminoacylase 1 deficiency,MONDO:0012368,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ACY1,HGNC:177,aminoacylase 1 deficiency,MONDO:0012368,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ADA,HGNC:186,"severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",MONDO:0007064,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ADA,HGNC:186,"severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",MONDO:0007064,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ADA,HGNC:186,"severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",MONDO:0007064,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ADA,HGNC:186,"severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",MONDO:0007064,Definitive,GO:0005764,lysosome,keyword,high,keyword
ADA2,HGNC:1839,deficiency of adenosine deaminase 2,MONDO:0100317,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ADA2,HGNC:1839,deficiency of adenosine deaminase 2,MONDO:0100317,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ADA2,HGNC:1839,deficiency of adenosine deaminase 2,MONDO:0100317,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ADA2,HGNC:1839,deficiency of adenosine deaminase 2,MONDO:0100317,Definitive,GO:0005488,binding,keyword,medium,keyword
ADA2,HGNC:1839,deficiency of adenosine deaminase 2,MONDO:0100317,Definitive,GO:0010467,gene expression,direct,high,Expression
ADA2,HGNC:1839,deficiency of adenosine deaminase 2,MONDO:0100317,Definitive,GO:0006412,translation,inferred,medium,Expression
ADAM9,HGNC:216,ADAM9-related retinopathy,MONDO:0800398,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ADAM9,HGNC:216,ADAM9-related retinopathy,MONDO:0800398,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
ADAM9,HGNC:216,ADAM9-related retinopathy,MONDO:0800398,Definitive,GO:0010467,gene expression,direct,high,Expression
ADAM9,HGNC:216,ADAM9-related retinopathy,MONDO:0800398,Definitive,GO:0006412,translation,inferred,medium,Expression
ADAM9,HGNC:216,ADAM9-related retinopathy,MONDO:0800398,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ADAM9,HGNC:216,ADAM9-related retinopathy,MONDO:0800398,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ADAMTS13,HGNC:1366,congenital thrombotic thrombocytopenic purpura,MONDO:0010122,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ADAMTS13,HGNC:1366,congenital thrombotic thrombocytopenic purpura,MONDO:0010122,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ADAMTS13,HGNC:1366,congenital thrombotic thrombocytopenic purpura,MONDO:0010122,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ADGRV1,HGNC:17416,Usher syndrome type 2,MONDO:0016484,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ADGRV1,HGNC:17416,Usher syndrome type 2,MONDO:0016484,Definitive,GO:0010467,gene expression,direct,high,Expression
ADGRV1,HGNC:17416,Usher syndrome type 2,MONDO:0016484,Definitive,GO:0006412,translation,inferred,medium,Expression
ADK,HGNC:257,adenosine kinase deficiency,MONDO:0100255,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ADK,HGNC:257,adenosine kinase deficiency,MONDO:0100255,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ADK,HGNC:257,adenosine kinase deficiency,MONDO:0100255,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ADK,HGNC:257,adenosine kinase deficiency,MONDO:0100255,Definitive,GO:0010467,gene expression,direct,high,Expression
ADK,HGNC:257,adenosine kinase deficiency,MONDO:0100255,Definitive,GO:0006412,translation,inferred,medium,Expression
AFG2A,HGNC:18119,syndromic complex neurodevelopmental disorder,MONDO:0800439,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
AFG2A,HGNC:18119,syndromic complex neurodevelopmental disorder,MONDO:0800439,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
AFG2A,HGNC:18119,syndromic complex neurodevelopmental disorder,MONDO:0800439,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
AGA,HGNC:318,aspartylglucosaminuria,MONDO:0008830,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AGA,HGNC:318,aspartylglucosaminuria,MONDO:0008830,Definitive,GO:0005764,lysosome,keyword,high,keyword
AGA,HGNC:318,aspartylglucosaminuria,MONDO:0008830,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
AGA,HGNC:318,aspartylglucosaminuria,MONDO:0008830,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
AGK,HGNC:21869,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
AGK,HGNC:21869,mitochondrial disease,MONDO:0044970,Definitive,GO:0016301,kinase activity,keyword,high,keyword
AGK,HGNC:21869,mitochondrial disease,MONDO:0044970,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
AGK,HGNC:21869,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
AGK,HGNC:21869,mitochondrial disease,MONDO:0044970,Definitive,GO:0016020,membrane,keyword,medium,keyword
AGK,HGNC:21869,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
AGL,HGNC:321,glycogen storage disease III,MONDO:0009291,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
AGL,HGNC:321,glycogen storage disease III,MONDO:0009291,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
AGL,HGNC:321,glycogen storage disease III,MONDO:0009291,Definitive,GO:0016740,transferase activity,keyword,high,keyword
AGL,HGNC:321,glycogen storage disease III,MONDO:0009291,Definitive,GO:0010467,gene expression,direct,high,Expression
AGL,HGNC:321,glycogen storage disease III,MONDO:0009291,Definitive,GO:0006412,translation,inferred,medium,Expression
AGL,HGNC:321,glycogen storage disease III,MONDO:0009291,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AGO2,HGNC:3263,Lessel-Kreienkamp syndrome,MONDO:0030897,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
AGO2,HGNC:3263,Lessel-Kreienkamp syndrome,MONDO:0030897,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
AGO2,HGNC:3263,Lessel-Kreienkamp syndrome,MONDO:0030897,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AGPAT2,HGNC:325,lipodystrophy,MONDO:0006573,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AGPAT2,HGNC:325,lipodystrophy,MONDO:0006573,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
AGPAT2,HGNC:325,lipodystrophy,MONDO:0006573,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
AGPAT2,HGNC:325,lipodystrophy,MONDO:0006573,Definitive,GO:0016020,membrane,keyword,medium,keyword
AGPAT2,HGNC:325,lipodystrophy,MONDO:0006573,Definitive,GO:0005886,plasma membrane,keyword,high,keyword
AGPAT2,HGNC:325,lipodystrophy,MONDO:0006573,Definitive,GO:0010467,gene expression,direct,high,Expression
AGPAT2,HGNC:325,lipodystrophy,MONDO:0006573,Definitive,GO:0006412,translation,inferred,medium,Expression
AHI1,HGNC:21575,Joubert syndrome 3,MONDO:0012078,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
AHI1,HGNC:21575,Joubert syndrome 3,MONDO:0012078,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
AHI1,HGNC:21575,Joubert syndrome 3,MONDO:0012078,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AHI1,HGNC:21575,Joubert syndrome 3,MONDO:0012078,Definitive,GO:0023052,signaling,keyword,medium,keyword
AIRE,HGNC:360,autoimmune polyendocrine syndrome type 1,MONDO:0009411,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AIRE,HGNC:360,autoimmune polyendocrine syndrome type 1,MONDO:0009411,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
AIRE,HGNC:360,autoimmune polyendocrine syndrome type 1,MONDO:0009411,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
AIRE,HGNC:360,autoimmune polyendocrine syndrome type 1,MONDO:0009411,Definitive,GO:0010467,gene expression,direct,high,Expression
AIRE,HGNC:360,autoimmune polyendocrine syndrome type 1,MONDO:0009411,Definitive,GO:0006412,translation,inferred,medium,Expression
AK2,HGNC:362,reticular dysgenesis,MONDO:0009973,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AK2,HGNC:362,reticular dysgenesis,MONDO:0009973,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
AK2,HGNC:362,reticular dysgenesis,MONDO:0009973,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
AK2,HGNC:362,reticular dysgenesis,MONDO:0009973,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
AK2,HGNC:362,reticular dysgenesis,MONDO:0009973,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
AK2,HGNC:362,reticular dysgenesis,MONDO:0009973,Definitive,GO:0010467,gene expression,direct,high,Expression
AK2,HGNC:362,reticular dysgenesis,MONDO:0009973,Definitive,GO:0006412,translation,inferred,medium,Expression
AK2,HGNC:362,reticular dysgenesis,MONDO:0009973,Definitive,GO:0023052,signaling,keyword,medium,keyword
AK2,HGNC:362,reticular dysgenesis,MONDO:0009973,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
AKR1D1,HGNC:388,congenital bile acid synthesis defect 2,MONDO:0009339,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AKR1D1,HGNC:388,congenital bile acid synthesis defect 2,MONDO:0009339,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
AKR1D1,HGNC:388,congenital bile acid synthesis defect 2,MONDO:0009339,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
AKR1D1,HGNC:388,congenital bile acid synthesis defect 2,MONDO:0009339,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
AKT3,HGNC:393,overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes,MONDO:0100283,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ALAS2,HGNC:397,X-linked erythropoietic protoporphyria,MONDO:0010420,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ALAS2,HGNC:397,X-linked erythropoietic protoporphyria,MONDO:0010420,Definitive,GO:0010467,gene expression,direct,high,Expression
ALAS2,HGNC:397,X-linked erythropoietic protoporphyria,MONDO:0010420,Definitive,GO:0006412,translation,inferred,medium,Expression
ALAS2,HGNC:397,X-linked erythropoietic protoporphyria,MONDO:0010420,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ALAS2,HGNC:397,X-linked erythropoietic protoporphyria,MONDO:0010420,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ALAS2,HGNC:397,X-linked erythropoietic protoporphyria,MONDO:0010420,Definitive,GO:0009058,biosynthetic process,keyword,medium,keyword
ALDH18A1,HGNC:9722,P5CS deficiency,MONDO:0100126,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ALDH18A1,HGNC:9722,P5CS deficiency,MONDO:0100126,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ALDH18A1,HGNC:9722,P5CS deficiency,MONDO:0100126,Definitive,GO:0009058,biosynthetic process,keyword,medium,keyword
ALDH5A1,HGNC:408,succinic semialdehyde dehydrogenase deficiency,MONDO:0010083,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ALDH5A1,HGNC:408,succinic semialdehyde dehydrogenase deficiency,MONDO:0010083,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ALG1,HGNC:18294,ALG1-congenital disorder of glycosylation,MONDO:0012052,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ALG1,HGNC:18294,ALG1-congenital disorder of glycosylation,MONDO:0012052,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ALG1,HGNC:18294,ALG1-congenital disorder of glycosylation,MONDO:0012052,Definitive,GO:0009058,biosynthetic process,keyword,medium,keyword
ALG1,HGNC:18294,ALG1-congenital disorder of glycosylation,MONDO:0012052,Definitive,GO:0016740,transferase activity,keyword,high,keyword
ALG1,HGNC:18294,ALG1-congenital disorder of glycosylation,MONDO:0012052,Definitive,GO:0006486,protein glycosylation,keyword,high,keyword
ALG12,HGNC:19358,ALG12-congenital disorder of glycosylation,MONDO:0011783,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ALG12,HGNC:19358,ALG12-congenital disorder of glycosylation,MONDO:0011783,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ALG12,HGNC:19358,ALG12-congenital disorder of glycosylation,MONDO:0011783,Definitive,GO:0006486,protein glycosylation,keyword,high,keyword
ALG2,HGNC:23159,ALG2-congenital disorder of glycosylation,MONDO:0011933,Strong,GO:0003674,molecular_function,direct,high,Biochemical Function
ALG2,HGNC:23159,ALG2-congenital disorder of glycosylation,MONDO:0011933,Strong,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ALG2,HGNC:23159,ALG2-congenital disorder of glycosylation,MONDO:0011933,Strong,GO:0006486,protein glycosylation,keyword,high,keyword
ALPK3,HGNC:17574,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0010467,gene expression,direct,high,Expression
ALPK3,HGNC:17574,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0006412,translation,inferred,medium,Expression
ALPK3,HGNC:17574,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0005634,nucleus,keyword,high,keyword
ALPK3,HGNC:17574,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ALPK3,HGNC:17574,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ALPK3,HGNC:17574,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0005488,binding,keyword,medium,keyword
ALPK3,HGNC:17574,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ALPK3,HGNC:17574,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
ALS2,HGNC:443,ALS2-related motor neuron disease,MONDO:0100227,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ALS2,HGNC:443,ALS2-related motor neuron disease,MONDO:0100227,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ALS2,HGNC:443,ALS2-related motor neuron disease,MONDO:0100227,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ALS2,HGNC:443,ALS2-related motor neuron disease,MONDO:0100227,Definitive,GO:0023052,signaling,keyword,medium,keyword
ALX1,HGNC:1494,frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome,MONDO:0013271,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ALX3,HGNC:449,frontorhiny,MONDO:0007636,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ALX3,HGNC:449,frontorhiny,MONDO:0007636,Definitive,GO:0010467,gene expression,direct,high,Expression
ALX3,HGNC:449,frontorhiny,MONDO:0007636,Definitive,GO:0006412,translation,inferred,medium,Expression
AMER1,HGNC:26837,osteopathia striata with cranial sclerosis,MONDO:0010310,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AMER1,HGNC:26837,osteopathia striata with cranial sclerosis,MONDO:0010310,Definitive,GO:0010467,gene expression,direct,high,Expression
AMER1,HGNC:26837,osteopathia striata with cranial sclerosis,MONDO:0010310,Definitive,GO:0006412,translation,inferred,medium,Expression
ANGPTL3,HGNC:491,familial hypobetalipoproteinemia 2,MONDO:0011505,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ANGPTL3,HGNC:491,familial hypobetalipoproteinemia 2,MONDO:0011505,Definitive,GO:0006810,transport,keyword,medium,keyword
ANGPTL3,HGNC:491,familial hypobetalipoproteinemia 2,MONDO:0011505,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ANGPTL3,HGNC:491,familial hypobetalipoproteinemia 2,MONDO:0011505,Definitive,GO:0010467,gene expression,direct,high,Expression
ANGPTL3,HGNC:491,familial hypobetalipoproteinemia 2,MONDO:0011505,Definitive,GO:0006412,translation,inferred,medium,Expression
ANK1,HGNC:492,hereditary spherocytosis,MONDO:0019350,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ANK1,HGNC:492,hereditary spherocytosis,MONDO:0019350,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ANK1,HGNC:492,hereditary spherocytosis,MONDO:0019350,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ANK1,HGNC:492,hereditary spherocytosis,MONDO:0019350,Definitive,GO:0016020,membrane,keyword,medium,keyword
ANK1,HGNC:492,hereditary spherocytosis,MONDO:0019350,Definitive,GO:0010467,gene expression,direct,high,Expression
ANK1,HGNC:492,hereditary spherocytosis,MONDO:0019350,Definitive,GO:0006412,translation,inferred,medium,Expression
ANKRD11,HGNC:21316,KBG syndrome,MONDO:0007846,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ANKRD11,HGNC:21316,KBG syndrome,MONDO:0007846,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ANKRD11,HGNC:21316,KBG syndrome,MONDO:0007846,Definitive,GO:0010467,gene expression,direct,high,Expression
ANKRD11,HGNC:21316,KBG syndrome,MONDO:0007846,Definitive,GO:0006412,translation,inferred,medium,Expression
ANKRD26,HGNC:29186,thrombocytopenia 2,MONDO:0008555,Definitive,GO:0023052,signaling,keyword,medium,keyword
ANKRD26,HGNC:29186,thrombocytopenia 2,MONDO:0008555,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
ANKRD26,HGNC:29186,thrombocytopenia 2,MONDO:0008555,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ANKRD26,HGNC:29186,thrombocytopenia 2,MONDO:0008555,Definitive,GO:0016020,membrane,keyword,medium,keyword
ANKRD26,HGNC:29186,thrombocytopenia 2,MONDO:0008555,Definitive,GO:0010467,gene expression,direct,high,Expression
ANKRD26,HGNC:29186,thrombocytopenia 2,MONDO:0008555,Definitive,GO:0006412,translation,inferred,medium,Expression
ANKRD26,HGNC:29186,thrombocytopenia 2,MONDO:0008555,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
ANKS6,HGNC:26724,nephronophthisis 16,MONDO:0014158,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ANKS6,HGNC:26724,nephronophthisis 16,MONDO:0014158,Definitive,GO:0023052,signaling,keyword,medium,keyword
ANKS6,HGNC:26724,nephronophthisis 16,MONDO:0014158,Definitive,GO:0010467,gene expression,direct,high,Expression
ANKS6,HGNC:26724,nephronophthisis 16,MONDO:0014158,Definitive,GO:0006412,translation,inferred,medium,Expression
ANO10,HGNC:25519,autosomal recessive spinocerebellar ataxia 10,MONDO:0013392,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ANO10,HGNC:25519,autosomal recessive spinocerebellar ataxia 10,MONDO:0013392,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ANO10,HGNC:25519,autosomal recessive spinocerebellar ataxia 10,MONDO:0013392,Definitive,GO:0023052,signaling,keyword,medium,keyword
ANO10,HGNC:25519,autosomal recessive spinocerebellar ataxia 10,MONDO:0013392,Definitive,GO:0006810,transport,keyword,medium,keyword
ANO10,HGNC:25519,autosomal recessive spinocerebellar ataxia 10,MONDO:0013392,Definitive,GO:0010467,gene expression,direct,high,Expression
ANO10,HGNC:25519,autosomal recessive spinocerebellar ataxia 10,MONDO:0013392,Definitive,GO:0006412,translation,inferred,medium,Expression
ANOS1,HGNC:6211,hypogonadotropic hypogonadism 1 with or without anosmia,MONDO:0010635,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ANOS1,HGNC:6211,hypogonadotropic hypogonadism 1 with or without anosmia,MONDO:0010635,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ANOS1,HGNC:6211,hypogonadotropic hypogonadism 1 with or without anosmia,MONDO:0010635,Definitive,GO:0010467,gene expression,direct,high,Expression
ANOS1,HGNC:6211,hypogonadotropic hypogonadism 1 with or without anosmia,MONDO:0010635,Definitive,GO:0006412,translation,inferred,medium,Expression
ANOS1,HGNC:6211,hypogonadotropic hypogonadism 1 with or without anosmia,MONDO:0010635,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ANTXR2,HGNC:21732,hyaline fibromatosis syndrome,MONDO:0009229,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ANTXR2,HGNC:21732,hyaline fibromatosis syndrome,MONDO:0009229,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ANXA11,HGNC:535,amyotrophic lateral sclerosis type 23,MONDO:0027694,Definitive,GO:0010467,gene expression,direct,high,Expression
ANXA11,HGNC:535,amyotrophic lateral sclerosis type 23,MONDO:0027694,Definitive,GO:0006412,translation,inferred,medium,Expression
ANXA11,HGNC:535,amyotrophic lateral sclerosis type 23,MONDO:0027694,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
ANXA11,HGNC:535,amyotrophic lateral sclerosis type 23,MONDO:0027694,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ANXA11,HGNC:535,amyotrophic lateral sclerosis type 23,MONDO:0027694,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ANXA11,HGNC:535,amyotrophic lateral sclerosis type 23,MONDO:0027694,Definitive,GO:0005488,binding,keyword,medium,keyword
ANXA11,HGNC:535,amyotrophic lateral sclerosis type 23,MONDO:0027694,Definitive,GO:0016020,membrane,keyword,medium,keyword
AP1B1,HGNC:554,"ichthyosiform erythroderma, corneal involvement, and hearing loss",MONDO:0009440,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AP1B1,HGNC:554,"ichthyosiform erythroderma, corneal involvement, and hearing loss",MONDO:0009440,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
AP1G1,HGNC:555,complex neurodevelopmental disorder,MONDO:0100038,Strong,GO:0003674,molecular_function,direct,high,Biochemical Function
AP1G1,HGNC:555,complex neurodevelopmental disorder,MONDO:0100038,Strong,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
AP1G1,HGNC:555,complex neurodevelopmental disorder,MONDO:0100038,Strong,GO:0006810,transport,keyword,medium,keyword
AP1G1,HGNC:555,complex neurodevelopmental disorder,MONDO:0100038,Strong,GO:0005215,transporter activity,keyword,high,keyword
AP1G1,HGNC:555,complex neurodevelopmental disorder,MONDO:0100038,Strong,GO:0038023,signaling receptor activity,keyword,medium,keyword
AP1G1,HGNC:555,complex neurodevelopmental disorder,MONDO:0100038,Strong,GO:0016020,membrane,keyword,medium,keyword
AP1G1,HGNC:555,complex neurodevelopmental disorder,MONDO:0100038,Strong,GO:0005794,Golgi apparatus,keyword,high,keyword
AP1S1,HGNC:559,MEDNIK syndrome,MONDO:0012251,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AP1S1,HGNC:559,MEDNIK syndrome,MONDO:0012251,Definitive,GO:0016020,membrane,keyword,medium,keyword
AP1S1,HGNC:559,MEDNIK syndrome,MONDO:0012251,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
AP1S1,HGNC:559,MEDNIK syndrome,MONDO:0012251,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
AP1S1,HGNC:559,MEDNIK syndrome,MONDO:0012251,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
AP4S1,HGNC:575,AP-4 deficiency syndrome,MONDO:0100176,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AP4S1,HGNC:575,AP-4 deficiency syndrome,MONDO:0100176,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
AP4S1,HGNC:575,AP-4 deficiency syndrome,MONDO:0100176,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
AP5Z1,HGNC:22197,hereditary spastic paraplegia,MONDO:0019064,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
APC,HGNC:583,gastric adenocarcinoma and proximal polyposis of the stomach,MONDO:0017790,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
APC,HGNC:583,gastric adenocarcinoma and proximal polyposis of the stomach,MONDO:0017790,Definitive,GO:0005488,binding,keyword,medium,keyword
APC,HGNC:583,classic or attenuated familial adenomatous polyposis,MONDO:0021057,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
APC,HGNC:583,classic or attenuated familial adenomatous polyposis,MONDO:0021057,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
APC,HGNC:583,classic or attenuated familial adenomatous polyposis,MONDO:0021057,Definitive,GO:0007049,cell cycle,keyword,high,keyword
APC2,HGNC:24036,lissencephaly spectrum disorders,MONDO:0018838,Strong,GO:0008150,biological_process,inferred,low,Model Systems
APC2,HGNC:24036,lissencephaly spectrum disorders,MONDO:0018838,Strong,GO:0003674,molecular_function,direct,high,Biochemical Function
APC2,HGNC:24036,lissencephaly spectrum disorders,MONDO:0018838,Strong,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
APOB,HGNC:603,familial hypobetalipoproteinemia 1,MONDO:0014252,Definitive,GO:0010467,gene expression,direct,high,Expression
APOB,HGNC:603,familial hypobetalipoproteinemia 1,MONDO:0014252,Definitive,GO:0006412,translation,inferred,medium,Expression
APOB,HGNC:603,familial hypobetalipoproteinemia 1,MONDO:0014252,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
APOB,HGNC:603,familial hypobetalipoproteinemia 1,MONDO:0014252,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
APOB,HGNC:603,familial hypobetalipoproteinemia 1,MONDO:0014252,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
APOL1,HGNC:618,"focal segmental glomerulosclerosis 4, susceptibility to",MONDO:0012931,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
APOL1,HGNC:618,"focal segmental glomerulosclerosis 4, susceptibility to",MONDO:0012931,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
APOL1,HGNC:618,"focal segmental glomerulosclerosis 4, susceptibility to",MONDO:0012931,Definitive,GO:0016020,membrane,keyword,medium,keyword
APOL1,HGNC:618,"focal segmental glomerulosclerosis 4, susceptibility to",MONDO:0012931,Definitive,GO:0005764,lysosome,keyword,high,keyword
APOL1,HGNC:618,"focal segmental glomerulosclerosis 4, susceptibility to",MONDO:0012931,Definitive,GO:0016301,kinase activity,keyword,high,keyword
APOL1,HGNC:618,"focal segmental glomerulosclerosis 4, susceptibility to",MONDO:0012931,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
APOL1,HGNC:618,"focal segmental glomerulosclerosis 4, susceptibility to",MONDO:0012931,Definitive,GO:0010467,gene expression,direct,high,Expression
APOL1,HGNC:618,"focal segmental glomerulosclerosis 4, susceptibility to",MONDO:0012931,Definitive,GO:0006412,translation,inferred,medium,Expression
AR,HGNC:644,Kennedy disease,MONDO:0010735,Definitive,GO:0010467,gene expression,direct,high,Expression
AR,HGNC:644,Kennedy disease,MONDO:0010735,Definitive,GO:0006412,translation,inferred,medium,Expression
AR,HGNC:644,Kennedy disease,MONDO:0010735,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AR,HGNC:644,Kennedy disease,MONDO:0010735,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
AR,HGNC:644,Kennedy disease,MONDO:0010735,Definitive,GO:0016567,protein ubiquitination,keyword,high,keyword
ARF1,HGNC:652,periventricular nodular heterotopia,MONDO:0020341,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ARF1,HGNC:652,periventricular nodular heterotopia,MONDO:0020341,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ARF1,HGNC:652,periventricular nodular heterotopia,MONDO:0020341,Definitive,GO:0016301,kinase activity,keyword,high,keyword
ARF1,HGNC:652,periventricular nodular heterotopia,MONDO:0020341,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
ARID1A,HGNC:11110,Coffin-Siris syndrome,MONDO:0015452,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ARID1B,HGNC:18040,Coffin-Siris syndrome,MONDO:0015452,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ARID1B,HGNC:18040,Coffin-Siris syndrome,MONDO:0015452,Definitive,GO:0023052,signaling,keyword,medium,keyword
ARL13B,HGNC:25419,Joubert syndrome,MONDO:0018772,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ARL13B,HGNC:25419,Joubert syndrome,MONDO:0018772,Definitive,GO:0010467,gene expression,direct,high,Expression
ARL13B,HGNC:25419,Joubert syndrome,MONDO:0018772,Definitive,GO:0006412,translation,inferred,medium,Expression
ARL6IP1,HGNC:697,hereditary spastic paraplegia,MONDO:0019064,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ARMC2,HGNC:23045,spermatogenic failure 38,MONDO:0032748,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ARMC2,HGNC:23045,spermatogenic failure 38,MONDO:0032748,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ARMC2,HGNC:23045,spermatogenic failure 38,MONDO:0032748,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ARMC2,HGNC:23045,spermatogenic failure 38,MONDO:0032748,Definitive,GO:0010467,gene expression,direct,high,Expression
ARMC2,HGNC:23045,spermatogenic failure 38,MONDO:0032748,Definitive,GO:0006412,translation,inferred,medium,Expression
ARMC9,HGNC:20730,Joubert syndrome 30,MONDO:0033308,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ARMC9,HGNC:20730,Joubert syndrome 30,MONDO:0033308,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
ARMC9,HGNC:20730,Joubert syndrome 30,MONDO:0033308,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ARMC9,HGNC:20730,Joubert syndrome 30,MONDO:0033308,Definitive,GO:0010467,gene expression,direct,high,Expression
ARMC9,HGNC:20730,Joubert syndrome 30,MONDO:0033308,Definitive,GO:0006412,translation,inferred,medium,Expression
ARPC1B,HGNC:704,platelet abnormalities with eosinophilia and immune-mediated inflammatory disease,MONDO:0060583,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ARPC1B,HGNC:704,platelet abnormalities with eosinophilia and immune-mediated inflammatory disease,MONDO:0060583,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ARPC1B,HGNC:704,platelet abnormalities with eosinophilia and immune-mediated inflammatory disease,MONDO:0060583,Definitive,GO:0010467,gene expression,direct,high,Expression
ARPC1B,HGNC:704,platelet abnormalities with eosinophilia and immune-mediated inflammatory disease,MONDO:0060583,Definitive,GO:0006412,translation,inferred,medium,Expression
ARSA,HGNC:713,metachromatic leukodystrophy,MONDO:0018868,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ARSA,HGNC:713,metachromatic leukodystrophy,MONDO:0018868,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ARSA,HGNC:713,metachromatic leukodystrophy,MONDO:0018868,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ARSA,HGNC:713,metachromatic leukodystrophy,MONDO:0018868,Definitive,GO:0005764,lysosome,keyword,high,keyword
ARSB,HGNC:714,mucopolysaccharidosis type 6,MONDO:0009661,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ARSB,HGNC:714,mucopolysaccharidosis type 6,MONDO:0009661,Definitive,GO:0005764,lysosome,keyword,high,keyword
ARSB,HGNC:714,mucopolysaccharidosis type 6,MONDO:0009661,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ARSB,HGNC:714,mucopolysaccharidosis type 6,MONDO:0009661,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ARX,HGNC:18060,X-linked complex neurodevelopmental disorder,MONDO:0100148,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ARX,HGNC:18060,X-linked complex neurodevelopmental disorder,MONDO:0100148,Definitive,GO:0010467,gene expression,direct,high,Expression
ARX,HGNC:18060,X-linked complex neurodevelopmental disorder,MONDO:0100148,Definitive,GO:0006412,translation,inferred,medium,Expression
ARX,HGNC:18060,X-linked complex neurodevelopmental disorder,MONDO:0100148,Definitive,GO:0005634,nucleus,keyword,high,keyword
ASAH1,HGNC:735,ASAH1-related sphingolipidosis,MONDO:0100524,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ASAH1,HGNC:735,ASAH1-related sphingolipidosis,MONDO:0100524,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ASAH1,HGNC:735,ASAH1-related sphingolipidosis,MONDO:0100524,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ASH1L,HGNC:19088,syndromic complex neurodevelopmental disorder,MONDO:0800439,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ASPA,HGNC:756,Canavan disease,MONDO:0010079,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ASPA,HGNC:756,Canavan disease,MONDO:0010079,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ASPA,HGNC:756,Canavan disease,MONDO:0010079,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ASXL1,HGNC:18318,Bohring-Opitz syndrome,MONDO:0011510,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ASXL1,HGNC:18318,Bohring-Opitz syndrome,MONDO:0011510,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ASXL2,HGNC:23805,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ASXL2,HGNC:23805,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ASXL3,HGNC:29357,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ASXL3,HGNC:29357,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ASXL3,HGNC:29357,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ASXL3,HGNC:29357,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
ATF6,HGNC:791,ATF6-related retinopathy,MONDO:0100447,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ATF6,HGNC:791,ATF6-related retinopathy,MONDO:0100447,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
ATF6,HGNC:791,ATF6-related retinopathy,MONDO:0100447,Definitive,GO:0005634,nucleus,keyword,high,keyword
ATF6,HGNC:791,ATF6-related retinopathy,MONDO:0100447,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
ATF6,HGNC:791,ATF6-related retinopathy,MONDO:0100447,Definitive,GO:0006486,protein glycosylation,keyword,high,keyword
ATF6,HGNC:791,ATF6-related retinopathy,MONDO:0100447,Definitive,GO:0005794,Golgi apparatus,keyword,high,keyword
ATF6,HGNC:791,ATF6-related retinopathy,MONDO:0100447,Definitive,GO:0010467,gene expression,direct,high,Expression
ATF6,HGNC:791,ATF6-related retinopathy,MONDO:0100447,Definitive,GO:0006412,translation,inferred,medium,Expression
ATF6,HGNC:791,ATF6-related retinopathy,MONDO:0100447,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
ATF6,HGNC:791,ATF6-related retinopathy,MONDO:0100447,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ATG7,HGNC:16935,"spinocerebellar ataxia, autosomal recessive 31",MONDO:0030323,Strong,GO:0008150,biological_process,inferred,low,Model Systems
ATG7,HGNC:16935,"spinocerebellar ataxia, autosomal recessive 31",MONDO:0030323,Strong,GO:0006914,autophagy,keyword,high,keyword
ATG7,HGNC:16935,"spinocerebellar ataxia, autosomal recessive 31",MONDO:0030323,Strong,GO:0016567,protein ubiquitination,keyword,high,keyword
ATG7,HGNC:16935,"spinocerebellar ataxia, autosomal recessive 31",MONDO:0030323,Strong,GO:0003674,molecular_function,direct,high,Biochemical Function
ATG7,HGNC:16935,"spinocerebellar ataxia, autosomal recessive 31",MONDO:0030323,Strong,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ATL1,HGNC:11231,"neuropathy, hereditary sensory, type 1D",MONDO:0013381,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ATL1,HGNC:11231,"neuropathy, hereditary sensory, type 1D",MONDO:0013381,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ATL1,HGNC:11231,"neuropathy, hereditary sensory, type 1D",MONDO:0013381,Definitive,GO:0005488,binding,keyword,medium,keyword
ATL1,HGNC:11231,"neuropathy, hereditary sensory, type 1D",MONDO:0013381,Definitive,GO:0010467,gene expression,direct,high,Expression
ATL1,HGNC:11231,"neuropathy, hereditary sensory, type 1D",MONDO:0013381,Definitive,GO:0006412,translation,inferred,medium,Expression
ATM,HGNC:795,ataxia telangiectasia,MONDO:0008840,Definitive,GO:0010467,gene expression,direct,high,Expression
ATM,HGNC:795,ataxia telangiectasia,MONDO:0008840,Definitive,GO:0006412,translation,inferred,medium,Expression
ATM,HGNC:795,ataxia telangiectasia,MONDO:0008840,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ATP13A2,HGNC:30213,Kufor-Rakeb syndrome,MONDO:0011706,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ATP13A2,HGNC:30213,Kufor-Rakeb syndrome,MONDO:0011706,Definitive,GO:0005764,lysosome,keyword,high,keyword
ATP13A2,HGNC:30213,Kufor-Rakeb syndrome,MONDO:0011706,Definitive,GO:0010467,gene expression,direct,high,Expression
ATP13A2,HGNC:30213,Kufor-Rakeb syndrome,MONDO:0011706,Definitive,GO:0006412,translation,inferred,medium,Expression
ATP13A2,HGNC:30213,Kufor-Rakeb syndrome,MONDO:0011706,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ATP13A3,HGNC:24113,pulmonary arterial hypertension,MONDO:0015924,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ATP13A3,HGNC:24113,pulmonary arterial hypertension,MONDO:0015924,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
ATP13A3,HGNC:24113,pulmonary arterial hypertension,MONDO:0015924,Definitive,GO:0010467,gene expression,direct,high,Expression
ATP13A3,HGNC:24113,pulmonary arterial hypertension,MONDO:0015924,Definitive,GO:0006412,translation,inferred,medium,Expression
ATP1A3,HGNC:801,ATP1A3-associated neurological disorder,MONDO:0700002,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ATP1A3,HGNC:801,ATP1A3-associated neurological disorder,MONDO:0700002,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ATP1A3,HGNC:801,ATP1A3-associated neurological disorder,MONDO:0700002,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
ATP1A3,HGNC:801,ATP1A3-associated neurological disorder,MONDO:0700002,Definitive,GO:0016020,membrane,keyword,medium,keyword
ATP1A3,HGNC:801,ATP1A3-associated neurological disorder,MONDO:0700002,Definitive,GO:0005886,plasma membrane,keyword,high,keyword
ATP1A3,HGNC:801,ATP1A3-associated neurological disorder,MONDO:0700002,Definitive,GO:0010467,gene expression,direct,high,Expression
ATP1A3,HGNC:801,ATP1A3-associated neurological disorder,MONDO:0700002,Definitive,GO:0006412,translation,inferred,medium,Expression
ATP6AP2,HGNC:18305,ATP6AP2-related disorder,MONDO:0100146,Definitive,GO:0005764,lysosome,keyword,high,keyword
ATP6AP2,HGNC:18305,ATP6AP2-related disorder,MONDO:0100146,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ATP6AP2,HGNC:18305,ATP6AP2-related disorder,MONDO:0100146,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ATP6V0A2,HGNC:18481,autosomal recessive cutis laxa type 2A,MONDO:0018163,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ATP6V0A2,HGNC:18481,autosomal recessive cutis laxa type 2A,MONDO:0018163,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
ATP6V0A2,HGNC:18481,autosomal recessive cutis laxa type 2A,MONDO:0018163,Definitive,GO:0005794,Golgi apparatus,keyword,high,keyword
ATP6V0A2,HGNC:18481,autosomal recessive cutis laxa type 2A,MONDO:0018163,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ATP6V0A2,HGNC:18481,autosomal recessive cutis laxa type 2A,MONDO:0018163,Definitive,GO:0016740,transferase activity,keyword,high,keyword
ATP6V0A2,HGNC:18481,autosomal recessive cutis laxa type 2A,MONDO:0018163,Definitive,GO:0016020,membrane,keyword,medium,keyword
ATP6V0A2,HGNC:18481,autosomal recessive cutis laxa type 2A,MONDO:0018163,Definitive,GO:0006486,protein glycosylation,keyword,high,keyword
ATP6V1B1,HGNC:853,"renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss",MONDO:0009968,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ATP7B,HGNC:870,Wilson disease,MONDO:0010200,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ATP7B,HGNC:870,Wilson disease,MONDO:0010200,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ATP7B,HGNC:870,Wilson disease,MONDO:0010200,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ATP7B,HGNC:870,Wilson disease,MONDO:0010200,Definitive,GO:0006810,transport,keyword,medium,keyword
ATP7B,HGNC:870,Wilson disease,MONDO:0010200,Definitive,GO:0005215,transporter activity,keyword,high,keyword
ATP7B,HGNC:870,Wilson disease,MONDO:0010200,Definitive,GO:0005794,Golgi apparatus,keyword,high,keyword
ATP7B,HGNC:870,Wilson disease,MONDO:0010200,Definitive,GO:0010467,gene expression,direct,high,Expression
ATP7B,HGNC:870,Wilson disease,MONDO:0010200,Definitive,GO:0006412,translation,inferred,medium,Expression
ATXN2,HGNC:10555,spinocerebellar ataxia type 2,MONDO:0008458,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ATXN2,HGNC:10555,spinocerebellar ataxia type 2,MONDO:0008458,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
ATXN2,HGNC:10555,spinocerebellar ataxia type 2,MONDO:0008458,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ATXN2,HGNC:10555,spinocerebellar ataxia type 2,MONDO:0008458,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
AUTS2,HGNC:14262,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
AUTS2,HGNC:14262,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
AXIN2,HGNC:904,oligodontia-cancer predisposition syndrome,MONDO:0012075,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
AXIN2,HGNC:904,oligodontia-cancer predisposition syndrome,MONDO:0012075,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
AXIN2,HGNC:904,oligodontia-cancer predisposition syndrome,MONDO:0012075,Definitive,GO:0023052,signaling,keyword,medium,keyword
AXIN2,HGNC:904,oligodontia-cancer predisposition syndrome,MONDO:0012075,Definitive,GO:0010467,gene expression,direct,high,Expression
AXIN2,HGNC:904,oligodontia-cancer predisposition syndrome,MONDO:0012075,Definitive,GO:0006412,translation,inferred,medium,Expression
AXIN2,HGNC:904,oligodontia-cancer predisposition syndrome,MONDO:0012075,Definitive,GO:0032259,methylation,keyword,medium,keyword
AXIN2,HGNC:904,oligodontia-cancer predisposition syndrome,MONDO:0012075,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
B9D1,HGNC:24123,ciliopathy,MONDO:0005308,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
B9D1,HGNC:24123,ciliopathy,MONDO:0005308,Definitive,GO:0016020,membrane,keyword,medium,keyword
B9D1,HGNC:24123,ciliopathy,MONDO:0005308,Definitive,GO:0007165,signal transduction,keyword,high,keyword
B9D1,HGNC:24123,ciliopathy,MONDO:0005308,Definitive,GO:0010467,gene expression,direct,high,Expression
B9D1,HGNC:24123,ciliopathy,MONDO:0005308,Definitive,GO:0006412,translation,inferred,medium,Expression
B9D1,HGNC:24123,ciliopathy,MONDO:0005308,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
B9D1,HGNC:24123,ciliopathy,MONDO:0005308,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BAP1,HGNC:950,BAP1-related tumor predisposition syndrome,MONDO:0013692,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BAP1,HGNC:950,BAP1-related tumor predisposition syndrome,MONDO:0013692,Definitive,GO:0010467,gene expression,direct,high,Expression
BAP1,HGNC:950,BAP1-related tumor predisposition syndrome,MONDO:0013692,Definitive,GO:0006412,translation,inferred,medium,Expression
BARD1,HGNC:952,BARD1-related cancer predisposition,MONDO:0700267,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BARD1,HGNC:952,BARD1-related cancer predisposition,MONDO:0700267,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BBS10,HGNC:26291,BBS10-related ciliopathy,MONDO:0700237,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BBS10,HGNC:26291,BBS10-related ciliopathy,MONDO:0700237,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BBS9,HGNC:30000,BBS9-related ciliopathy,MONDO:0700236,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BBS9,HGNC:30000,BBS9-related ciliopathy,MONDO:0700236,Definitive,GO:0006810,transport,keyword,medium,keyword
BBS9,HGNC:30000,BBS9-related ciliopathy,MONDO:0700236,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
BBS9,HGNC:30000,BBS9-related ciliopathy,MONDO:0700236,Definitive,GO:0016020,membrane,keyword,medium,keyword
BBS9,HGNC:30000,BBS9-related ciliopathy,MONDO:0700236,Definitive,GO:0010467,gene expression,direct,high,Expression
BBS9,HGNC:30000,BBS9-related ciliopathy,MONDO:0700236,Definitive,GO:0006412,translation,inferred,medium,Expression
BCAP31,HGNC:16695,severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome,MONDO:0010334,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BCAP31,HGNC:16695,severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome,MONDO:0010334,Definitive,GO:0005794,Golgi apparatus,keyword,high,keyword
BCAP31,HGNC:16695,severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome,MONDO:0010334,Definitive,GO:0010467,gene expression,direct,high,Expression
BCAP31,HGNC:16695,severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome,MONDO:0010334,Definitive,GO:0006412,translation,inferred,medium,Expression
BCAT2,HGNC:977,hypervalinemia and hyperleucine-isoleucinemia,MONDO:0100058,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BCAT2,HGNC:977,hypervalinemia and hyperleucine-isoleucinemia,MONDO:0100058,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
BCAT2,HGNC:977,hypervalinemia and hyperleucine-isoleucinemia,MONDO:0100058,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BCAT2,HGNC:977,hypervalinemia and hyperleucine-isoleucinemia,MONDO:0100058,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BCAT2,HGNC:977,hypervalinemia and hyperleucine-isoleucinemia,MONDO:0100058,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
BCKDHA,HGNC:986,maple syrup urine disease type 1A,MONDO:0023691,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BCKDHA,HGNC:986,maple syrup urine disease type 1A,MONDO:0023691,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
BCKDHA,HGNC:986,maple syrup urine disease type 1A,MONDO:0023691,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BCKDHB,HGNC:987,maple syrup urine disease type 1B,MONDO:0023692,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BCKDHB,HGNC:987,maple syrup urine disease type 1B,MONDO:0023692,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BCKDHB,HGNC:987,maple syrup urine disease type 1B,MONDO:0023692,Definitive,GO:0009056,catabolic process,keyword,medium,keyword
BCL10,HGNC:989,immunodeficiency 37,MONDO:0014491,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BCL10,HGNC:989,immunodeficiency 37,MONDO:0014491,Definitive,GO:0005634,nucleus,keyword,high,keyword
BCL10,HGNC:989,immunodeficiency 37,MONDO:0014491,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BCL10,HGNC:989,immunodeficiency 37,MONDO:0014491,Definitive,GO:0023052,signaling,keyword,medium,keyword
BCL10,HGNC:989,immunodeficiency 37,MONDO:0014491,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BCL11A,HGNC:13221,Dias-Logan syndrome,MONDO:0014914,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BCOR,HGNC:20893,"microphthalmia, syndromic 2",MONDO:0010261,Definitive,GO:0010467,gene expression,direct,high,Expression
BCOR,HGNC:20893,"microphthalmia, syndromic 2",MONDO:0010261,Definitive,GO:0006412,translation,inferred,medium,Expression
BCOR,HGNC:20893,"microphthalmia, syndromic 2",MONDO:0010261,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BCS1L,HGNC:1020,Bjornstad syndrome,MONDO:0009872,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BCS1L,HGNC:1020,Bjornstad syndrome,MONDO:0009872,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BCS1L,HGNC:1020,Bjornstad syndrome,MONDO:0009872,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
BCS1L,HGNC:1020,Bjornstad syndrome,MONDO:0009872,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BCS1L,HGNC:1020,Bjornstad syndrome,MONDO:0009872,Definitive,GO:0010467,gene expression,direct,high,Expression
BCS1L,HGNC:1020,Bjornstad syndrome,MONDO:0009872,Definitive,GO:0006412,translation,inferred,medium,Expression
BEST1,HGNC:12703,BEST1-related dominant retinopathy,MONDO:0700238,Definitive,GO:0010467,gene expression,direct,high,Expression
BEST1,HGNC:12703,BEST1-related dominant retinopathy,MONDO:0700238,Definitive,GO:0006412,translation,inferred,medium,Expression
BEST1,HGNC:12703,BEST1-related dominant retinopathy,MONDO:0700238,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BEST1,HGNC:12703,BEST1-related dominant retinopathy,MONDO:0700238,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BEST1,HGNC:12703,BEST1-related dominant retinopathy,MONDO:0700238,Definitive,GO:0016020,membrane,keyword,medium,keyword
BEST1,HGNC:12703,BEST1-related dominant retinopathy,MONDO:0700238,Definitive,GO:0005886,plasma membrane,keyword,high,keyword
BEST1,HGNC:12703,BEST1-related dominant retinopathy,MONDO:0700238,Definitive,GO:0005783,endoplasmic reticulum,keyword,high,keyword
BEST1,HGNC:12703,BEST1-related dominant retinopathy,MONDO:0700238,Definitive,GO:0005794,Golgi apparatus,keyword,high,keyword
BLM,HGNC:1058,Bloom syndrome,MONDO:0008876,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
BLM,HGNC:1058,Bloom syndrome,MONDO:0008876,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BLM,HGNC:1058,Bloom syndrome,MONDO:0008876,Definitive,GO:0010467,gene expression,direct,high,Expression
BLM,HGNC:1058,Bloom syndrome,MONDO:0008876,Definitive,GO:0006412,translation,inferred,medium,Expression
BLM,HGNC:1058,Bloom syndrome,MONDO:0008876,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BLNK,HGNC:14211,"agammaglobulinemia 4, autosomal recessive",MONDO:0013289,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
BLNK,HGNC:14211,"agammaglobulinemia 4, autosomal recessive",MONDO:0013289,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BLNK,HGNC:14211,"agammaglobulinemia 4, autosomal recessive",MONDO:0013289,Definitive,GO:0010467,gene expression,direct,high,Expression
BLNK,HGNC:14211,"agammaglobulinemia 4, autosomal recessive",MONDO:0013289,Definitive,GO:0006412,translation,inferred,medium,Expression
BLNK,HGNC:14211,"agammaglobulinemia 4, autosomal recessive",MONDO:0013289,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BLOC1S5,HGNC:18561,Hermansky-Pudlak syndrome 11,MONDO:0030903,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BLOC1S6,HGNC:8549,Hermansky-Pudlak syndrome 9,MONDO:0013606,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BMPR1A,HGNC:1076,juvenile polyposis syndrome,MONDO:0017380,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BMPR1A,HGNC:1076,juvenile polyposis syndrome,MONDO:0017380,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BMPR2,HGNC:1078,pulmonary arterial hypertension,MONDO:0015924,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BMPR2,HGNC:1078,pulmonary arterial hypertension,MONDO:0015924,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
BMPR2,HGNC:1078,pulmonary arterial hypertension,MONDO:0015924,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BMPR2,HGNC:1078,pulmonary arterial hypertension,MONDO:0015924,Definitive,GO:0023052,signaling,keyword,medium,keyword
BMPR2,HGNC:1078,pulmonary arterial hypertension,MONDO:0015924,Definitive,GO:0010467,gene expression,direct,high,Expression
BMPR2,HGNC:1078,pulmonary arterial hypertension,MONDO:0015924,Definitive,GO:0006412,translation,inferred,medium,Expression
BMPR2,HGNC:1078,pulmonary arterial hypertension,MONDO:0015924,Definitive,GO:0005488,binding,keyword,medium,keyword
BMPR2,HGNC:1078,pulmonary arterial hypertension,MONDO:0015924,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
BOLA3,HGNC:24415,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
BOLA3,HGNC:24415,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BPTF,HGNC:3581,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BRAT1,HGNC:21701,neonatal-onset encephalopathy with rigidity and seizures,MONDO:0013784,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BRAT1,HGNC:21701,neurodevelopmental disorder with cerebellar atrophy and with or without seizures,MONDO:0020841,Definitive,GO:0010467,gene expression,direct,high,Expression
BRAT1,HGNC:21701,neurodevelopmental disorder with cerebellar atrophy and with or without seizures,MONDO:0020841,Definitive,GO:0006412,translation,inferred,medium,Expression
BRAT1,HGNC:21701,neurodevelopmental disorder with cerebellar atrophy and with or without seizures,MONDO:0020841,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BRAT1,HGNC:21701,neurodevelopmental disorder with cerebellar atrophy and with or without seizures,MONDO:0020841,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
BRCA1,HGNC:1100,BRCA1-related cancer predisposition,MONDO:0700268,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BRCA1,HGNC:1100,BRCA1-related cancer predisposition,MONDO:0700268,Definitive,GO:0007049,cell cycle,keyword,high,keyword
BRCA1,HGNC:1100,BRCA1-related cancer predisposition,MONDO:0700268,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BRCA1,HGNC:1100,BRCA1-related cancer predisposition,MONDO:0700268,Definitive,GO:0010467,gene expression,direct,high,Expression
BRCA1,HGNC:1100,BRCA1-related cancer predisposition,MONDO:0700268,Definitive,GO:0006412,translation,inferred,medium,Expression
BRCA2,HGNC:1101,Fanconi anemia complementation group D1,MONDO:0011584,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BRCA2,HGNC:1101,Fanconi anemia complementation group D1,MONDO:0011584,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
BRCA2,HGNC:1101,Fanconi anemia complementation group D1,MONDO:0011584,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BRCA2,HGNC:1101,BRCA2-related cancer predisposition,MONDO:0700269,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BRCA2,HGNC:1101,BRCA2-related cancer predisposition,MONDO:0700269,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
BRCA2,HGNC:1101,BRCA2-related cancer predisposition,MONDO:0700269,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BRCA2,HGNC:1101,BRCA2-related cancer predisposition,MONDO:0700269,Definitive,GO:0006281,DNA repair,keyword,high,keyword
BRD4,HGNC:13575,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BRIP1,HGNC:20473,Fanconi anemia complementation group J,MONDO:0012187,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
BRIP1,HGNC:20473,Fanconi anemia complementation group J,MONDO:0012187,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BRIP1,HGNC:20473,Fanconi anemia complementation group J,MONDO:0012187,Definitive,GO:0010467,gene expression,direct,high,Expression
BRIP1,HGNC:20473,Fanconi anemia complementation group J,MONDO:0012187,Definitive,GO:0006412,translation,inferred,medium,Expression
BRIP1,HGNC:20473,Fanconi anemia complementation group J,MONDO:0012187,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BRIP1,HGNC:20473,Fanconi anemia complementation group J,MONDO:0012187,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
BRIP1,HGNC:20473,Fanconi anemia complementation group J,MONDO:0012187,Definitive,GO:0005488,binding,keyword,medium,keyword
BRIP1,HGNC:20473,familial ovarian cancer,MONDO:0016248,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BRSK2,HGNC:11405,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BRSK2,HGNC:11405,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0010467,gene expression,direct,high,Expression
BRSK2,HGNC:11405,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0006412,translation,inferred,medium,Expression
BSCL2,HGNC:15832,distal hereditary motor neuropathy,MONDO:0018894,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BSCL2,HGNC:15832,distal hereditary motor neuropathy,MONDO:0018894,Definitive,GO:0010467,gene expression,direct,high,Expression
BSCL2,HGNC:15832,distal hereditary motor neuropathy,MONDO:0018894,Definitive,GO:0006412,translation,inferred,medium,Expression
BSCL2,HGNC:15832,distal hereditary motor neuropathy,MONDO:0018894,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BSCL2,HGNC:15832,distal hereditary motor neuropathy,MONDO:0018894,Definitive,GO:0006914,autophagy,keyword,high,keyword
BSCL2,HGNC:15832,distal hereditary motor neuropathy,MONDO:0018894,Definitive,GO:0005794,Golgi apparatus,keyword,high,keyword
BSCL2,HGNC:15832,lipodystrophy,MONDO:0006573,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BSCL2,HGNC:15832,lipodystrophy,MONDO:0006573,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BSCL2,HGNC:15832,lipodystrophy,MONDO:0006573,Definitive,GO:0010467,gene expression,direct,high,Expression
BSCL2,HGNC:15832,lipodystrophy,MONDO:0006573,Definitive,GO:0006412,translation,inferred,medium,Expression
BSND,HGNC:16512,Bartter disease type 4A,MONDO:0011242,Definitive,GO:0010467,gene expression,direct,high,Expression
BSND,HGNC:16512,Bartter disease type 4A,MONDO:0011242,Definitive,GO:0006412,translation,inferred,medium,Expression
BSND,HGNC:16512,Bartter disease type 4A,MONDO:0011242,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
BSND,HGNC:16512,Bartter disease type 4A,MONDO:0011242,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BSND,HGNC:16512,Bartter disease type 4A,MONDO:0011242,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BTK,HGNC:1133,Bruton-type agammaglobulinemia,MONDO:0010421,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BTK,HGNC:1133,Bruton-type agammaglobulinemia,MONDO:0010421,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BTK,HGNC:1133,Bruton-type agammaglobulinemia,MONDO:0010421,Definitive,GO:0016301,kinase activity,keyword,high,keyword
BTK,HGNC:1133,Bruton-type agammaglobulinemia,MONDO:0010421,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
BTK,HGNC:1133,Bruton-type agammaglobulinemia,MONDO:0010421,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
BTK,HGNC:1133,Bruton-type agammaglobulinemia,MONDO:0010421,Definitive,GO:0023052,signaling,keyword,medium,keyword
BTK,HGNC:1133,Bruton-type agammaglobulinemia,MONDO:0010421,Definitive,GO:0010467,gene expression,direct,high,Expression
BTK,HGNC:1133,Bruton-type agammaglobulinemia,MONDO:0010421,Definitive,GO:0006412,translation,inferred,medium,Expression
BTK,HGNC:1133,Bruton-type agammaglobulinemia,MONDO:0010421,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
BUB1B,HGNC:1149,mosaic variegated aneuploidy syndrome 1,MONDO:0009759,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
BUB1B,HGNC:1149,mosaic variegated aneuploidy syndrome 1,MONDO:0009759,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
BUB1B,HGNC:1149,mosaic variegated aneuploidy syndrome 1,MONDO:0009759,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
BUB1B,HGNC:1149,mosaic variegated aneuploidy syndrome 1,MONDO:0009759,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
BUB1B,HGNC:1149,mosaic variegated aneuploidy syndrome 1,MONDO:0009759,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
C19orf12,HGNC:25443,neurodegeneration with brain iron accumulation 4,MONDO:0013674,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
C19orf12,HGNC:25443,neurodegeneration with brain iron accumulation 4,MONDO:0013674,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
C19orf12,HGNC:25443,neurodegeneration with brain iron accumulation 4,MONDO:0013674,Definitive,GO:0016301,kinase activity,keyword,high,keyword
C19orf12,HGNC:25443,neurodegeneration with brain iron accumulation 4,MONDO:0013674,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
C19orf12,HGNC:25443,neurodegeneration with brain iron accumulation 4,MONDO:0013674,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
C19orf12,HGNC:25443,neurodegeneration with brain iron accumulation 4,MONDO:0013674,Definitive,GO:0010467,gene expression,direct,high,Expression
C19orf12,HGNC:25443,neurodegeneration with brain iron accumulation 4,MONDO:0013674,Definitive,GO:0006412,translation,inferred,medium,Expression
C19orf12,HGNC:25443,neurodegeneration with brain iron accumulation 4,MONDO:0013674,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
C19orf12,HGNC:25443,neurodegeneration with brain iron accumulation 4,MONDO:0013674,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
C1QBP,HGNC:1243,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
C1QBP,HGNC:1243,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
C1QBP,HGNC:1243,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
C1QBP,HGNC:1243,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
C1QTNF5,HGNC:14344,inherited retinal dystrophy,MONDO:0019118,Definitive,GO:0010467,gene expression,direct,high,Expression
C1QTNF5,HGNC:14344,inherited retinal dystrophy,MONDO:0019118,Definitive,GO:0006412,translation,inferred,medium,Expression
C1QTNF5,HGNC:14344,inherited retinal dystrophy,MONDO:0019118,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
C1QTNF5,HGNC:14344,inherited retinal dystrophy,MONDO:0019118,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
C2CD3,HGNC:24564,orofaciodigital syndrome type 14,MONDO:0014413,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
C2CD3,HGNC:24564,orofaciodigital syndrome type 14,MONDO:0014413,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
C3,HGNC:1318,atypical hemolytic-uremic syndrome with C3 anomaly,MONDO:0013043,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
C3,HGNC:1318,atypical hemolytic-uremic syndrome with C3 anomaly,MONDO:0013043,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
C3,HGNC:1318,atypical hemolytic-uremic syndrome with C3 anomaly,MONDO:0013043,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
C9orf72,HGNC:28337,frontotemporal dementia and/or amyotrophic lateral sclerosis 1,MONDO:0007105,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
C9orf72,HGNC:28337,frontotemporal dementia and/or amyotrophic lateral sclerosis 1,MONDO:0007105,Definitive,GO:0016567,protein ubiquitination,keyword,high,keyword
C9orf72,HGNC:28337,frontotemporal dementia and/or amyotrophic lateral sclerosis 1,MONDO:0007105,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
C9orf72,HGNC:28337,frontotemporal dementia and/or amyotrophic lateral sclerosis 1,MONDO:0007105,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
C9orf72,HGNC:28337,frontotemporal dementia and/or amyotrophic lateral sclerosis 1,MONDO:0007105,Definitive,GO:0010467,gene expression,direct,high,Expression
C9orf72,HGNC:28337,frontotemporal dementia and/or amyotrophic lateral sclerosis 1,MONDO:0007105,Definitive,GO:0006412,translation,inferred,medium,Expression
CA2,HGNC:1373,autosomal recessive osteopetrosis 3,MONDO:0009818,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CA2,HGNC:1373,autosomal recessive osteopetrosis 3,MONDO:0009818,Definitive,GO:0010467,gene expression,direct,high,Expression
CA2,HGNC:1373,autosomal recessive osteopetrosis 3,MONDO:0009818,Definitive,GO:0006412,translation,inferred,medium,Expression
CA2,HGNC:1373,autosomal recessive osteopetrosis 3,MONDO:0009818,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CA2,HGNC:1373,autosomal recessive osteopetrosis 3,MONDO:0009818,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CA2,HGNC:1373,autosomal recessive osteopetrosis 3,MONDO:0009818,Definitive,GO:0006810,transport,keyword,medium,keyword
CABP2,HGNC:1385,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CABP2,HGNC:1385,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0005216,ion channel activity,keyword,medium,keyword
CABP2,HGNC:1385,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0005488,binding,keyword,medium,keyword
CABP2,HGNC:1385,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CABP2,HGNC:1385,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0010467,gene expression,direct,high,Expression
CABP2,HGNC:1385,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0006412,translation,inferred,medium,Expression
CABP2,HGNC:1385,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CACNA1C,HGNC:1390,Timothy syndrome,MONDO:0010979,Definitive,GO:0010467,gene expression,direct,high,Expression
CACNA1C,HGNC:1390,Timothy syndrome,MONDO:0010979,Definitive,GO:0006412,translation,inferred,medium,Expression
CACNA1C,HGNC:1390,Timothy syndrome,MONDO:0010979,Definitive,GO:0016020,membrane,keyword,medium,keyword
CACNA1C,HGNC:1390,Timothy syndrome,MONDO:0010979,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CAD,HGNC:1424,"developmental and epileptic encephalopathy, 50",MONDO:0014647,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CAD,HGNC:1424,"developmental and epileptic encephalopathy, 50",MONDO:0014647,Definitive,GO:0009058,biosynthetic process,keyword,medium,keyword
CAD,HGNC:1424,"developmental and epileptic encephalopathy, 50",MONDO:0014647,Definitive,GO:0006486,protein glycosylation,keyword,high,keyword
CAD,HGNC:1424,"developmental and epileptic encephalopathy, 50",MONDO:0014647,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CAD,HGNC:1424,"developmental and epileptic encephalopathy, 50",MONDO:0014647,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CALM1,HGNC:1442,long QT syndrome,MONDO:0002442,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CALM1,HGNC:1442,long QT syndrome,MONDO:0002442,Definitive,GO:0005488,binding,keyword,medium,keyword
CALM1,HGNC:1442,long QT syndrome,MONDO:0002442,Definitive,GO:0010467,gene expression,direct,high,Expression
CALM1,HGNC:1442,long QT syndrome,MONDO:0002442,Definitive,GO:0006412,translation,inferred,medium,Expression
CALM2,HGNC:1445,long QT syndrome,MONDO:0002442,Definitive,GO:0010467,gene expression,direct,high,Expression
CALM2,HGNC:1445,long QT syndrome,MONDO:0002442,Definitive,GO:0006412,translation,inferred,medium,Expression
CALM2,HGNC:1445,long QT syndrome,MONDO:0002442,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CALM2,HGNC:1445,long QT syndrome,MONDO:0002442,Definitive,GO:0005488,binding,keyword,medium,keyword
CALM3,HGNC:1449,long QT syndrome,MONDO:0002442,Definitive,GO:0010467,gene expression,direct,high,Expression
CALM3,HGNC:1449,long QT syndrome,MONDO:0002442,Definitive,GO:0006412,translation,inferred,medium,Expression
CAMTA1,HGNC:18806,cerebellar dysfunction with variable cognitive and behavioral abnormalities,MONDO:0013886,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CANT1,HGNC:19721,Desbuquois dysplasia 1,MONDO:0009629,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CANT1,HGNC:19721,Desbuquois dysplasia 1,MONDO:0009629,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CAPN5,HGNC:1482,CAPN5-related vitreoretinopathy,MONDO:0100450,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CAPN5,HGNC:1482,CAPN5-related vitreoretinopathy,MONDO:0100450,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CAPN5,HGNC:1482,CAPN5-related vitreoretinopathy,MONDO:0100450,Definitive,GO:0010467,gene expression,direct,high,Expression
CAPN5,HGNC:1482,CAPN5-related vitreoretinopathy,MONDO:0100450,Definitive,GO:0006412,translation,inferred,medium,Expression
CARD11,HGNC:16393,BENTA disease,MONDO:0014645,Definitive,GO:0010467,gene expression,direct,high,Expression
CARD11,HGNC:16393,BENTA disease,MONDO:0014645,Definitive,GO:0006412,translation,inferred,medium,Expression
CARD11,HGNC:16393,BENTA disease,MONDO:0014645,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CARD11,HGNC:16393,BENTA disease,MONDO:0014645,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CARD11,HGNC:16393,severe combined immunodeficiency due to CARD11 deficiency,MONDO:0014081,Definitive,GO:0010467,gene expression,direct,high,Expression
CARD11,HGNC:16393,severe combined immunodeficiency due to CARD11 deficiency,MONDO:0014081,Definitive,GO:0006412,translation,inferred,medium,Expression
CARD11,HGNC:16393,severe combined immunodeficiency due to CARD11 deficiency,MONDO:0014081,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CARD11,HGNC:16393,severe combined immunodeficiency due to CARD11 deficiency,MONDO:0014081,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CARD11,HGNC:16393,severe combined immunodeficiency due to CARD11 deficiency,MONDO:0014081,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CARD11,HGNC:16393,immunodeficiency 11b with atopic dermatitis,MONDO:0054697,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CARD11,HGNC:16393,immunodeficiency 11b with atopic dermatitis,MONDO:0054697,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CARD11,HGNC:16393,immunodeficiency 11b with atopic dermatitis,MONDO:0054697,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CARD11,HGNC:16393,immunodeficiency 11b with atopic dermatitis,MONDO:0054697,Definitive,GO:0010467,gene expression,direct,high,Expression
CARD11,HGNC:16393,immunodeficiency 11b with atopic dermatitis,MONDO:0054697,Definitive,GO:0006412,translation,inferred,medium,Expression
CARMIL2,HGNC:27089,severe combined immunodeficiency due to CARMIL2 deficiency,MONDO:0029134,Definitive,GO:0010467,gene expression,direct,high,Expression
CARMIL2,HGNC:27089,severe combined immunodeficiency due to CARMIL2 deficiency,MONDO:0029134,Definitive,GO:0006412,translation,inferred,medium,Expression
CARMIL2,HGNC:27089,severe combined immunodeficiency due to CARMIL2 deficiency,MONDO:0029134,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CARMIL2,HGNC:27089,severe combined immunodeficiency due to CARMIL2 deficiency,MONDO:0029134,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CARMIL2,HGNC:27089,severe combined immunodeficiency due to CARMIL2 deficiency,MONDO:0029134,Definitive,GO:0023052,signaling,keyword,medium,keyword
CARMIL2,HGNC:27089,severe combined immunodeficiency due to CARMIL2 deficiency,MONDO:0029134,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CASQ2,HGNC:1513,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CASQ2,HGNC:1513,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CASQ2,HGNC:1513,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,Definitive,GO:0010467,gene expression,direct,high,Expression
CASQ2,HGNC:1513,catecholaminergic polymorphic ventricular tachycardia,MONDO:0017990,Definitive,GO:0006412,translation,inferred,medium,Expression
CASR,HGNC:1514,neonatal severe primary hyperparathyroidism,MONDO:0009397,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CASR,HGNC:1514,neonatal severe primary hyperparathyroidism,MONDO:0009397,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CASR,HGNC:1514,neonatal severe primary hyperparathyroidism,MONDO:0009397,Definitive,GO:0010467,gene expression,direct,high,Expression
CASR,HGNC:1514,neonatal severe primary hyperparathyroidism,MONDO:0009397,Definitive,GO:0006412,translation,inferred,medium,Expression
CASR,HGNC:1514,neonatal severe primary hyperparathyroidism,MONDO:0009397,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CASR,HGNC:1514,familial hypocalciuric hypercalcemia 1,MONDO:0007791,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CASR,HGNC:1514,familial hypocalciuric hypercalcemia 1,MONDO:0007791,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CASR,HGNC:1514,familial hypocalciuric hypercalcemia 1,MONDO:0007791,Definitive,GO:0010467,gene expression,direct,high,Expression
CASR,HGNC:1514,familial hypocalciuric hypercalcemia 1,MONDO:0007791,Definitive,GO:0006412,translation,inferred,medium,Expression
CASR,HGNC:1514,familial hypocalciuric hypercalcemia 1,MONDO:0007791,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CASR,HGNC:1514,autosomal dominant hypocalcemia 1,MONDO:0011013,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CAV3,HGNC:1529,caveolinopathy,MONDO:0016146,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CAV3,HGNC:1529,caveolinopathy,MONDO:0016146,Definitive,GO:0010467,gene expression,direct,high,Expression
CAV3,HGNC:1529,caveolinopathy,MONDO:0016146,Definitive,GO:0006412,translation,inferred,medium,Expression
CBL,HGNC:1541,CBL-related disorder,MONDO:0013308,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CBL,HGNC:1541,CBL-related disorder,MONDO:0013308,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CC2D1A,HGNC:30237,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CC2D1A,HGNC:30237,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0010467,gene expression,direct,high,Expression
CC2D1A,HGNC:30237,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0006412,translation,inferred,medium,Expression
CC2D2A,HGNC:29253,ciliopathy,MONDO:0005308,Definitive,GO:0010467,gene expression,direct,high,Expression
CC2D2A,HGNC:29253,ciliopathy,MONDO:0005308,Definitive,GO:0006412,translation,inferred,medium,Expression
CC2D2A,HGNC:29253,ciliopathy,MONDO:0005308,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CC2D2A,HGNC:29253,ciliopathy,MONDO:0005308,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CC2D2A,HGNC:29253,ciliopathy,MONDO:0005308,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CC2D2A,HGNC:29253,ciliopathy,MONDO:0005308,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CCDC39,HGNC:25244,primary ciliary dyskinesia 14,MONDO:0013434,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CCDC39,HGNC:25244,primary ciliary dyskinesia 14,MONDO:0013434,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CCDC39,HGNC:25244,primary ciliary dyskinesia 14,MONDO:0013434,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
CCDC39,HGNC:25244,primary ciliary dyskinesia 14,MONDO:0013434,Definitive,GO:0010467,gene expression,direct,high,Expression
CCDC39,HGNC:25244,primary ciliary dyskinesia 14,MONDO:0013434,Definitive,GO:0006412,translation,inferred,medium,Expression
CCDC39,HGNC:25244,primary ciliary dyskinesia 14,MONDO:0013434,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CCDC40,HGNC:26090,primary ciliary dyskinesia 15,MONDO:0013435,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CCDC40,HGNC:26090,primary ciliary dyskinesia 15,MONDO:0013435,Definitive,GO:0010467,gene expression,direct,high,Expression
CCDC40,HGNC:26090,primary ciliary dyskinesia 15,MONDO:0013435,Definitive,GO:0006412,translation,inferred,medium,Expression
CCDC40,HGNC:26090,primary ciliary dyskinesia 15,MONDO:0013435,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CCDC40,HGNC:26090,primary ciliary dyskinesia 15,MONDO:0013435,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CCNO,HGNC:18576,primary ciliary dyskinesia 29,MONDO:0014378,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CCNO,HGNC:18576,primary ciliary dyskinesia 29,MONDO:0014378,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CCNO,HGNC:18576,primary ciliary dyskinesia 29,MONDO:0014378,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CCNO,HGNC:18576,primary ciliary dyskinesia 29,MONDO:0014378,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
CCNO,HGNC:18576,primary ciliary dyskinesia 29,MONDO:0014378,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
CCNO,HGNC:18576,primary ciliary dyskinesia 29,MONDO:0014378,Definitive,GO:0007049,cell cycle,keyword,high,keyword
CCNO,HGNC:18576,primary ciliary dyskinesia 29,MONDO:0014378,Definitive,GO:0010467,gene expression,direct,high,Expression
CCNO,HGNC:18576,primary ciliary dyskinesia 29,MONDO:0014378,Definitive,GO:0006412,translation,inferred,medium,Expression
CD19,HGNC:1633,"immunodeficiency, common variable, 3",MONDO:0013283,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CD19,HGNC:1633,"immunodeficiency, common variable, 3",MONDO:0013283,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CD19,HGNC:1633,"immunodeficiency, common variable, 3",MONDO:0013283,Definitive,GO:0023052,signaling,keyword,medium,keyword
CD19,HGNC:1633,"immunodeficiency, common variable, 3",MONDO:0013283,Definitive,GO:0010467,gene expression,direct,high,Expression
CD19,HGNC:1633,"immunodeficiency, common variable, 3",MONDO:0013283,Definitive,GO:0006412,translation,inferred,medium,Expression
CD19,HGNC:1633,"immunodeficiency, common variable, 3",MONDO:0013283,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CD19,HGNC:1633,"immunodeficiency, common variable, 3",MONDO:0013283,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CD247,HGNC:1677,immunodeficiency 25,MONDO:0012426,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CD247,HGNC:1677,immunodeficiency 25,MONDO:0012426,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CD247,HGNC:1677,immunodeficiency 25,MONDO:0012426,Definitive,GO:0016301,kinase activity,keyword,high,keyword
CD247,HGNC:1677,immunodeficiency 25,MONDO:0012426,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
CD247,HGNC:1677,immunodeficiency 25,MONDO:0012426,Definitive,GO:0023052,signaling,keyword,medium,keyword
CD247,HGNC:1677,immunodeficiency 25,MONDO:0012426,Definitive,GO:0016020,membrane,keyword,medium,keyword
CD247,HGNC:1677,immunodeficiency 25,MONDO:0012426,Definitive,GO:0010467,gene expression,direct,high,Expression
CD247,HGNC:1677,immunodeficiency 25,MONDO:0012426,Definitive,GO:0006412,translation,inferred,medium,Expression
CD2AP,HGNC:14258,"focal segmental glomerulosclerosis 3, susceptibility to",MONDO:0011917,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CD2AP,HGNC:14258,"focal segmental glomerulosclerosis 3, susceptibility to",MONDO:0011917,Definitive,GO:0010467,gene expression,direct,high,Expression
CD2AP,HGNC:14258,"focal segmental glomerulosclerosis 3, susceptibility to",MONDO:0011917,Definitive,GO:0006412,translation,inferred,medium,Expression
CD2AP,HGNC:14258,"focal segmental glomerulosclerosis 3, susceptibility to",MONDO:0011917,Definitive,GO:0016020,membrane,keyword,medium,keyword
CD2AP,HGNC:14258,"focal segmental glomerulosclerosis 3, susceptibility to",MONDO:0011917,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CD2AP,HGNC:14258,"focal segmental glomerulosclerosis 3, susceptibility to",MONDO:0011917,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CD320,HGNC:16692,methylmalonic acidemia due to transcobalamin receptor defect,MONDO:0013341,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CD320,HGNC:16692,methylmalonic acidemia due to transcobalamin receptor defect,MONDO:0013341,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CD320,HGNC:16692,methylmalonic acidemia due to transcobalamin receptor defect,MONDO:0013341,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CD320,HGNC:16692,methylmalonic acidemia due to transcobalamin receptor defect,MONDO:0013341,Definitive,GO:0005488,binding,keyword,medium,keyword
CD320,HGNC:16692,methylmalonic acidemia due to transcobalamin receptor defect,MONDO:0013341,Definitive,GO:0006810,transport,keyword,medium,keyword
CD320,HGNC:16692,methylmalonic acidemia due to transcobalamin receptor defect,MONDO:0013341,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CD320,HGNC:16692,methylmalonic acidemia due to transcobalamin receptor defect,MONDO:0013341,Definitive,GO:0016020,membrane,keyword,medium,keyword
CD320,HGNC:16692,methylmalonic acidemia due to transcobalamin receptor defect,MONDO:0013341,Definitive,GO:0005886,plasma membrane,keyword,high,keyword
CD320,HGNC:16692,methylmalonic acidemia due to transcobalamin receptor defect,MONDO:0013341,Definitive,GO:0005764,lysosome,keyword,high,keyword
CD3D,HGNC:1673,immunodeficiency 19,MONDO:0014280,Definitive,GO:0010467,gene expression,direct,high,Expression
CD3D,HGNC:1673,immunodeficiency 19,MONDO:0014280,Definitive,GO:0006412,translation,inferred,medium,Expression
CD3D,HGNC:1673,immunodeficiency 19,MONDO:0014280,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CD3D,HGNC:1673,immunodeficiency 19,MONDO:0014280,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CD3E,HGNC:1674,immunodeficiency 18,MONDO:0014278,Definitive,GO:0010467,gene expression,direct,high,Expression
CD3E,HGNC:1674,immunodeficiency 18,MONDO:0014278,Definitive,GO:0006412,translation,inferred,medium,Expression
CD3E,HGNC:1674,immunodeficiency 18,MONDO:0014278,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CD3E,HGNC:1674,immunodeficiency 18,MONDO:0014278,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
CD3G,HGNC:1675,combined immunodeficiency due to CD3gamma deficiency,MONDO:0014276,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CD3G,HGNC:1675,combined immunodeficiency due to CD3gamma deficiency,MONDO:0014276,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CD40,HGNC:11919,hyper-IgM syndrome type 3,MONDO:0011735,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CD40,HGNC:11919,hyper-IgM syndrome type 3,MONDO:0011735,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CD40,HGNC:11919,hyper-IgM syndrome type 3,MONDO:0011735,Definitive,GO:0005783,endoplasmic reticulum,keyword,high,keyword
CD40,HGNC:11919,hyper-IgM syndrome type 3,MONDO:0011735,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CD40,HGNC:11919,hyper-IgM syndrome type 3,MONDO:0011735,Definitive,GO:0023052,signaling,keyword,medium,keyword
CD40,HGNC:11919,hyper-IgM syndrome type 3,MONDO:0011735,Definitive,GO:0010467,gene expression,direct,high,Expression
CD40,HGNC:11919,hyper-IgM syndrome type 3,MONDO:0011735,Definitive,GO:0006412,translation,inferred,medium,Expression
CD40,HGNC:11919,hyper-IgM syndrome type 3,MONDO:0011735,Definitive,GO:0016020,membrane,keyword,medium,keyword
CD40LG,HGNC:11935,hyper-IgM syndrome type 1,MONDO:0010626,Definitive,GO:0010467,gene expression,direct,high,Expression
CD40LG,HGNC:11935,hyper-IgM syndrome type 1,MONDO:0010626,Definitive,GO:0006412,translation,inferred,medium,Expression
CD40LG,HGNC:11935,hyper-IgM syndrome type 1,MONDO:0010626,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CD40LG,HGNC:11935,hyper-IgM syndrome type 1,MONDO:0010626,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CD40LG,HGNC:11935,hyper-IgM syndrome type 1,MONDO:0010626,Definitive,GO:0005488,binding,keyword,medium,keyword
CD40LG,HGNC:11935,hyper-IgM syndrome type 1,MONDO:0010626,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CD40LG,HGNC:11935,hyper-IgM syndrome type 1,MONDO:0010626,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CD40LG,HGNC:11935,hyper-IgM syndrome type 1,MONDO:0010626,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
CD46,HGNC:6953,atypical hemolytic-uremic syndrome,MONDO:0016244,Definitive,GO:0010467,gene expression,direct,high,Expression
CD46,HGNC:6953,atypical hemolytic-uremic syndrome,MONDO:0016244,Definitive,GO:0006412,translation,inferred,medium,Expression
CD46,HGNC:6953,atypical hemolytic-uremic syndrome,MONDO:0016244,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CD46,HGNC:6953,atypical hemolytic-uremic syndrome,MONDO:0016244,Definitive,GO:0016020,membrane,keyword,medium,keyword
CD46,HGNC:6953,atypical hemolytic-uremic syndrome,MONDO:0016244,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CD79A,HGNC:1698,"agammaglobulinemia 3, autosomal recessive",MONDO:0013288,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CD79A,HGNC:1698,"agammaglobulinemia 3, autosomal recessive",MONDO:0013288,Definitive,GO:0010467,gene expression,direct,high,Expression
CD79A,HGNC:1698,"agammaglobulinemia 3, autosomal recessive",MONDO:0013288,Definitive,GO:0006412,translation,inferred,medium,Expression
CD79A,HGNC:1698,"agammaglobulinemia 3, autosomal recessive",MONDO:0013288,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CD79A,HGNC:1698,"agammaglobulinemia 3, autosomal recessive",MONDO:0013288,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CD79A,HGNC:1698,"agammaglobulinemia 3, autosomal recessive",MONDO:0013288,Definitive,GO:0007165,signal transduction,keyword,high,keyword
CD79A,HGNC:1698,"agammaglobulinemia 3, autosomal recessive",MONDO:0013288,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CD79A,HGNC:1698,"agammaglobulinemia 3, autosomal recessive",MONDO:0013288,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
CD79B,HGNC:1699,"agammaglobulinemia 6, autosomal recessive",MONDO:0012987,Definitive,GO:0010467,gene expression,direct,high,Expression
CD79B,HGNC:1699,"agammaglobulinemia 6, autosomal recessive",MONDO:0012987,Definitive,GO:0006412,translation,inferred,medium,Expression
CD79B,HGNC:1699,"agammaglobulinemia 6, autosomal recessive",MONDO:0012987,Definitive,GO:0006486,protein glycosylation,keyword,high,keyword
CD79B,HGNC:1699,"agammaglobulinemia 6, autosomal recessive",MONDO:0012987,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CD79B,HGNC:1699,"agammaglobulinemia 6, autosomal recessive",MONDO:0012987,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CD79B,HGNC:1699,"agammaglobulinemia 6, autosomal recessive",MONDO:0012987,Definitive,GO:0007165,signal transduction,keyword,high,keyword
CD79B,HGNC:1699,"agammaglobulinemia 6, autosomal recessive",MONDO:0012987,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CDC42,HGNC:1736,macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome,MONDO:0014757,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CDC45,HGNC:1739,Meier-Gorlin syndrome 7,MONDO:0014894,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CDC45,HGNC:1739,Meier-Gorlin syndrome 7,MONDO:0014894,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CDC45,HGNC:1739,Meier-Gorlin syndrome 7,MONDO:0014894,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CDC73,HGNC:16783,hyperparathyroidism 2 with jaw tumors,MONDO:0007768,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CDC73,HGNC:16783,hyperparathyroidism 2 with jaw tumors,MONDO:0007768,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CDC73,HGNC:16783,hyperparathyroidism 2 with jaw tumors,MONDO:0007768,Definitive,GO:0010467,gene expression,direct,high,Expression
CDC73,HGNC:16783,hyperparathyroidism 2 with jaw tumors,MONDO:0007768,Definitive,GO:0006412,translation,inferred,medium,Expression
CDH11,HGNC:1750,Elsahy-Waters syndrome,MONDO:0008885,Definitive,GO:0010467,gene expression,direct,high,Expression
CDH11,HGNC:1750,Elsahy-Waters syndrome,MONDO:0008885,Definitive,GO:0006412,translation,inferred,medium,Expression
CDH11,HGNC:1750,Elsahy-Waters syndrome,MONDO:0008885,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CDH11,HGNC:1750,Elsahy-Waters syndrome,MONDO:0008885,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CDH23,HGNC:13733,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CDH23,HGNC:13733,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
CDH23,HGNC:13733,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
CDH23,HGNC:13733,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CDH3,HGNC:1762,EEM syndrome,MONDO:0009155,Definitive,GO:0010467,gene expression,direct,high,Expression
CDH3,HGNC:1762,EEM syndrome,MONDO:0009155,Definitive,GO:0006412,translation,inferred,medium,Expression
CDK4,HGNC:1773,"melanoma, cutaneous malignant, susceptibility to, 3",MONDO:0012183,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CDK4,HGNC:1773,"melanoma, cutaneous malignant, susceptibility to, 3",MONDO:0012183,Definitive,GO:0016301,kinase activity,keyword,high,keyword
CDK4,HGNC:1773,"melanoma, cutaneous malignant, susceptibility to, 3",MONDO:0012183,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
CDK4,HGNC:1773,"melanoma, cutaneous malignant, susceptibility to, 3",MONDO:0012183,Definitive,GO:0005488,binding,keyword,medium,keyword
CDK4,HGNC:1773,"melanoma, cutaneous malignant, susceptibility to, 3",MONDO:0012183,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CDK5RAP2,HGNC:18672,autosomal recessive primary microcephaly,MONDO:0016660,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CDK5RAP2,HGNC:18672,autosomal recessive primary microcephaly,MONDO:0016660,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
CDK5RAP2,HGNC:18672,autosomal recessive primary microcephaly,MONDO:0016660,Definitive,GO:0007049,cell cycle,keyword,high,keyword
CDKL5,HGNC:11411,CDKL5 disorder,MONDO:0100039,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CDKN1B,HGNC:1785,multiple endocrine neoplasia type 4,MONDO:0012552,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CDKN1B,HGNC:1785,multiple endocrine neoplasia type 4,MONDO:0012552,Definitive,GO:0010467,gene expression,direct,high,Expression
CDKN1B,HGNC:1785,multiple endocrine neoplasia type 4,MONDO:0012552,Definitive,GO:0006412,translation,inferred,medium,Expression
CDKN1B,HGNC:1785,multiple endocrine neoplasia type 4,MONDO:0012552,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CDKN1B,HGNC:1785,multiple endocrine neoplasia type 4,MONDO:0012552,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CDKN1B,HGNC:1785,multiple endocrine neoplasia type 4,MONDO:0012552,Definitive,GO:0007049,cell cycle,keyword,high,keyword
CDKN1B,HGNC:1785,multiple endocrine neoplasia type 4,MONDO:0012552,Definitive,GO:0005634,nucleus,keyword,high,keyword
CDKN1B,HGNC:1785,multiple endocrine neoplasia type 4,MONDO:0012552,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
CDKN2A,HGNC:1787,melanoma-pancreatic cancer syndrome,MONDO:0011713,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CDKN2A,HGNC:1787,melanoma-pancreatic cancer syndrome,MONDO:0011713,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CDT1,HGNC:24576,Meier-Gorlin syndrome 4,MONDO:0013431,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CDT1,HGNC:24576,Meier-Gorlin syndrome 4,MONDO:0013431,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CDT1,HGNC:24576,Meier-Gorlin syndrome 4,MONDO:0013431,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CEACAM16,HGNC:31948,nonsyndromic genetic hearing loss,MONDO:0019497,Strong,GO:0008150,biological_process,inferred,low,Model Systems
CEACAM16,HGNC:31948,nonsyndromic genetic hearing loss,MONDO:0019497,Strong,GO:0010467,gene expression,direct,high,Expression
CEACAM16,HGNC:31948,nonsyndromic genetic hearing loss,MONDO:0019497,Strong,GO:0006412,translation,inferred,medium,Expression
CEBPA,HGNC:1833,acute myeloid leukemia,MONDO:0018874,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CEBPA,HGNC:1833,acute myeloid leukemia,MONDO:0018874,Definitive,GO:0006412,translation,keyword,high,keyword
CEBPA,HGNC:1833,acute myeloid leukemia,MONDO:0018874,Definitive,GO:0010467,gene expression,direct,high,Expression
CEBPA,HGNC:1833,acute myeloid leukemia,MONDO:0018874,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CEBPA,HGNC:1833,acute myeloid leukemia,MONDO:0018874,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CEBPA,HGNC:1833,acute myeloid leukemia,MONDO:0018874,Definitive,GO:0005488,binding,keyword,medium,keyword
CEBPA,HGNC:1833,acute myeloid leukemia,MONDO:0018874,Definitive,GO:0007049,cell cycle,keyword,high,keyword
CEBPA,HGNC:1833,acute myeloid leukemia,MONDO:0018874,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CENPJ,HGNC:17272,microcephaly 6 with or without short stature,MONDO:0700054,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CENPJ,HGNC:17272,microcephaly 6 with or without short stature,MONDO:0700054,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
CENPJ,HGNC:17272,microcephaly 6 with or without short stature,MONDO:0700054,Definitive,GO:0010467,gene expression,direct,high,Expression
CENPJ,HGNC:17272,microcephaly 6 with or without short stature,MONDO:0700054,Definitive,GO:0006412,translation,inferred,medium,Expression
CENPJ,HGNC:17272,microcephaly 6 with or without short stature,MONDO:0700054,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CENPJ,HGNC:17272,microcephaly 6 with or without short stature,MONDO:0700054,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CEP152,HGNC:29298,microcephaly with or without short stature,MONDO:0100346,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CEP152,HGNC:29298,microcephaly with or without short stature,MONDO:0100346,Definitive,GO:0010467,gene expression,direct,high,Expression
CEP152,HGNC:29298,microcephaly with or without short stature,MONDO:0100346,Definitive,GO:0006412,translation,inferred,medium,Expression
CEP290,HGNC:29021,CEP290-related ciliopathy,MONDO:0100451,Definitive,GO:0010467,gene expression,direct,high,Expression
CEP290,HGNC:29021,CEP290-related ciliopathy,MONDO:0100451,Definitive,GO:0006412,translation,inferred,medium,Expression
CEP290,HGNC:29021,CEP290-related ciliopathy,MONDO:0100451,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CEP290,HGNC:29021,CEP290-related ciliopathy,MONDO:0100451,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CEP57,HGNC:30794,mosaic variegated aneuploidy syndrome 2,MONDO:0013582,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CEP57,HGNC:30794,mosaic variegated aneuploidy syndrome 2,MONDO:0013582,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CEP57,HGNC:30794,mosaic variegated aneuploidy syndrome 2,MONDO:0013582,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CEP57,HGNC:30794,mosaic variegated aneuploidy syndrome 2,MONDO:0013582,Definitive,GO:0010467,gene expression,direct,high,Expression
CEP57,HGNC:30794,mosaic variegated aneuploidy syndrome 2,MONDO:0013582,Definitive,GO:0006412,translation,inferred,medium,Expression
CERKL,HGNC:21699,CERKL-related retinopathy,MONDO:0800401,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CERKL,HGNC:21699,CERKL-related retinopathy,MONDO:0800401,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
CERKL,HGNC:21699,CERKL-related retinopathy,MONDO:0800401,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CFAP300,HGNC:28188,"ciliary dyskinesia, primary, 38",MONDO:0054843,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CFAP300,HGNC:28188,"ciliary dyskinesia, primary, 38",MONDO:0054843,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CFAP300,HGNC:28188,"ciliary dyskinesia, primary, 38",MONDO:0054843,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CFAP300,HGNC:28188,"ciliary dyskinesia, primary, 38",MONDO:0054843,Definitive,GO:0010467,gene expression,direct,high,Expression
CFAP300,HGNC:28188,"ciliary dyskinesia, primary, 38",MONDO:0054843,Definitive,GO:0006412,translation,inferred,medium,Expression
CFAP418,HGNC:27232,ciliopathy,MONDO:0005308,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CFAP418,HGNC:27232,ciliopathy,MONDO:0005308,Definitive,GO:0010467,gene expression,direct,high,Expression
CFAP418,HGNC:27232,ciliopathy,MONDO:0005308,Definitive,GO:0006412,translation,inferred,medium,Expression
CFAP418,HGNC:27232,ciliopathy,MONDO:0005308,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CFAP43,HGNC:26684,spermatogenic failure 19,MONDO:0054723,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CFAP43,HGNC:26684,spermatogenic failure 19,MONDO:0054723,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CFAP43,HGNC:26684,spermatogenic failure 19,MONDO:0054723,Definitive,GO:0010467,gene expression,direct,high,Expression
CFAP43,HGNC:26684,spermatogenic failure 19,MONDO:0054723,Definitive,GO:0006412,translation,inferred,medium,Expression
CFAP43,HGNC:26684,spermatogenic failure 19,MONDO:0054723,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CFH,HGNC:4883,C3 glomerulonephritis,MONDO:0013892,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CFH,HGNC:4883,C3 glomerulonephritis,MONDO:0013892,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CFH,HGNC:4883,C3 glomerulonephritis,MONDO:0013892,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CFH,HGNC:4883,C3 glomerulonephritis,MONDO:0013892,Definitive,GO:0016020,membrane,keyword,medium,keyword
CFH,HGNC:4883,atypical hemolytic-uremic syndrome,MONDO:0016244,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CFH,HGNC:4883,atypical hemolytic-uremic syndrome,MONDO:0016244,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CFH,HGNC:4883,atypical hemolytic-uremic syndrome,MONDO:0016244,Definitive,GO:0005488,binding,keyword,medium,keyword
CFH,HGNC:4883,atypical hemolytic-uremic syndrome,MONDO:0016244,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CFI,HGNC:5394,atypical hemolytic-uremic syndrome,MONDO:0016244,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CFI,HGNC:5394,atypical hemolytic-uremic syndrome,MONDO:0016244,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CFL2,HGNC:1875,nemaline myopathy 7,MONDO:0012538,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CFL2,HGNC:1875,nemaline myopathy 7,MONDO:0012538,Definitive,GO:0010467,gene expression,direct,high,Expression
CFL2,HGNC:1875,nemaline myopathy 7,MONDO:0012538,Definitive,GO:0006412,translation,inferred,medium,Expression
CFL2,HGNC:1875,nemaline myopathy 7,MONDO:0012538,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
CFL2,HGNC:1875,nemaline myopathy 7,MONDO:0012538,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CFL2,HGNC:1875,nemaline myopathy 7,MONDO:0012538,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CFL2,HGNC:1875,nemaline myopathy 7,MONDO:0012538,Definitive,GO:0005488,binding,keyword,medium,keyword
CHAMP1,HGNC:20311,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CHCHD10,HGNC:15559,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CHCHD10,HGNC:15559,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
CHCHD10,HGNC:15559,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CHCHD10,HGNC:15559,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CHD7,HGNC:20626,CHARGE syndrome,MONDO:0008965,Definitive,GO:0010467,gene expression,direct,high,Expression
CHD7,HGNC:20626,CHARGE syndrome,MONDO:0008965,Definitive,GO:0006412,translation,inferred,medium,Expression
CHD7,HGNC:20626,CHARGE syndrome,MONDO:0008965,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CHD7,HGNC:20626,CHARGE syndrome,MONDO:0008965,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CHEK2,HGNC:16627,CHEK2-related cancer predisposition,MONDO:0700271,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CHEK2,HGNC:16627,CHEK2-related cancer predisposition,MONDO:0700271,Definitive,GO:0016301,kinase activity,keyword,high,keyword
CHEK2,HGNC:16627,CHEK2-related cancer predisposition,MONDO:0700271,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
CHEK2,HGNC:16627,CHEK2-related cancer predisposition,MONDO:0700271,Definitive,GO:0007049,cell cycle,keyword,high,keyword
CHEK2,HGNC:16627,CHEK2-related cancer predisposition,MONDO:0700271,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CHEK2,HGNC:16627,CHEK2-related cancer predisposition,MONDO:0700271,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CHEK2,HGNC:16627,CHEK2-related cancer predisposition,MONDO:0700271,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CHEK2,HGNC:16627,CHEK2-related cancer predisposition,MONDO:0700271,Definitive,GO:0006412,translation,keyword,high,keyword
CHEK2,HGNC:16627,CHEK2-related cancer predisposition,MONDO:0700271,Definitive,GO:0010467,gene expression,direct,high,Expression
CHM,HGNC:1940,choroideremia,MONDO:0010557,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CHM,HGNC:1940,choroideremia,MONDO:0010557,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CHM,HGNC:1940,choroideremia,MONDO:0010557,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CHM,HGNC:1940,choroideremia,MONDO:0010557,Definitive,GO:0010467,gene expression,direct,high,Expression
CHM,HGNC:1940,choroideremia,MONDO:0010557,Definitive,GO:0006412,translation,inferred,medium,Expression
CHM,HGNC:1940,choroideremia,MONDO:0010557,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CHM,HGNC:1940,choroideremia,MONDO:0010557,Definitive,GO:0005488,binding,keyword,medium,keyword
CHM,HGNC:1940,choroideremia,MONDO:0010557,Definitive,GO:0006810,transport,keyword,medium,keyword
CHM,HGNC:1940,choroideremia,MONDO:0010557,Definitive,GO:0016740,transferase activity,keyword,high,keyword
CHM,HGNC:1940,choroideremia,MONDO:0010557,Definitive,GO:0016020,membrane,keyword,medium,keyword
CHMP2B,HGNC:24537,frontotemporal dementia and/or amyotrophic lateral sclerosis 7,MONDO:0010936,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CHMP2B,HGNC:24537,frontotemporal dementia and/or amyotrophic lateral sclerosis 7,MONDO:0010936,Definitive,GO:0006914,autophagy,keyword,high,keyword
CHMP2B,HGNC:24537,frontotemporal dementia and/or amyotrophic lateral sclerosis 7,MONDO:0010936,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CHRNA4,HGNC:1958,sleep-related hypermotor epilepsy,MONDO:0000030,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CHRNA4,HGNC:1958,sleep-related hypermotor epilepsy,MONDO:0000030,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CHRNB2,HGNC:1962,sleep-related hypermotor epilepsy,MONDO:0000030,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CHRNB2,HGNC:1962,sleep-related hypermotor epilepsy,MONDO:0000030,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CHRNB2,HGNC:1962,sleep-related hypermotor epilepsy,MONDO:0000030,Definitive,GO:0005216,ion channel activity,keyword,medium,keyword
CHRNB2,HGNC:1962,sleep-related hypermotor epilepsy,MONDO:0000030,Definitive,GO:0010467,gene expression,direct,high,Expression
CHRNB2,HGNC:1962,sleep-related hypermotor epilepsy,MONDO:0000030,Definitive,GO:0006412,translation,inferred,medium,Expression
CHRNG,HGNC:1967,CHRNG-associated hypo-akinesia disorder of prenatal onset,MONDO:0100158,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CHRNG,HGNC:1967,CHRNG-associated hypo-akinesia disorder of prenatal onset,MONDO:0100158,Definitive,GO:0010467,gene expression,direct,high,Expression
CHRNG,HGNC:1967,CHRNG-associated hypo-akinesia disorder of prenatal onset,MONDO:0100158,Definitive,GO:0006412,translation,inferred,medium,Expression
CIB2,HGNC:24579,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CIB2,HGNC:24579,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0010467,gene expression,direct,high,Expression
CIB2,HGNC:24579,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0006412,translation,inferred,medium,Expression
CIB2,HGNC:24579,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
CIITA,HGNC:7067,MHC class II deficiency,MONDO:0008855,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CIITA,HGNC:7067,MHC class II deficiency,MONDO:0008855,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CIITA,HGNC:7067,MHC class II deficiency,MONDO:0008855,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CIITA,HGNC:7067,MHC class II deficiency,MONDO:0008855,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CIITA,HGNC:7067,MHC class II deficiency,MONDO:0008855,Definitive,GO:0010467,gene expression,direct,high,Expression
CIITA,HGNC:7067,MHC class II deficiency,MONDO:0008855,Definitive,GO:0006412,translation,inferred,medium,Expression
CIITA,HGNC:7067,MHC class II deficiency,MONDO:0008855,Definitive,GO:0016301,kinase activity,keyword,high,keyword
CIITA,HGNC:7067,MHC class II deficiency,MONDO:0008855,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
CLCN5,HGNC:2023,Dent disease type 1,MONDO:0010225,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CLCN5,HGNC:2023,Dent disease type 1,MONDO:0010225,Definitive,GO:0010467,gene expression,direct,high,Expression
CLCN5,HGNC:2023,Dent disease type 1,MONDO:0010225,Definitive,GO:0006412,translation,inferred,medium,Expression
CLCN7,HGNC:2025,autosomal dominant osteopetrosis 2,MONDO:0008156,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CLCN7,HGNC:2025,autosomal recessive osteopetrosis 4,MONDO:0012676,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CLDN14,HGNC:2035,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CLDN14,HGNC:2035,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CLDN14,HGNC:2035,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0010467,gene expression,direct,high,Expression
CLDN14,HGNC:2035,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0006412,translation,inferred,medium,Expression
CLN5,HGNC:2076,neuronal ceroid lipofuscinosis,MONDO:0016295,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CLN5,HGNC:2076,neuronal ceroid lipofuscinosis,MONDO:0016295,Definitive,GO:0005764,lysosome,keyword,high,keyword
CLN6,HGNC:2077,neuronal ceroid lipofuscinosis,MONDO:0016295,Definitive,GO:0010467,gene expression,direct,high,Expression
CLN6,HGNC:2077,neuronal ceroid lipofuscinosis,MONDO:0016295,Definitive,GO:0006412,translation,inferred,medium,Expression
CLN6,HGNC:2077,neuronal ceroid lipofuscinosis,MONDO:0016295,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CLN8,HGNC:2079,neuronal ceroid lipofuscinosis,MONDO:0016295,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CLN8,HGNC:2079,neuronal ceroid lipofuscinosis,MONDO:0016295,Definitive,GO:0005764,lysosome,keyword,high,keyword
CLPP,HGNC:2084,Perrault syndrome 3,MONDO:0013588,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CLPP,HGNC:2084,Perrault syndrome 3,MONDO:0013588,Definitive,GO:0010467,gene expression,direct,high,Expression
CLPP,HGNC:2084,Perrault syndrome 3,MONDO:0013588,Definitive,GO:0006412,translation,inferred,medium,Expression
CNGA1,HGNC:2148,CNGA1-related retinopathy,MONDO:0800405,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CNGA1,HGNC:2148,CNGA1-related retinopathy,MONDO:0800405,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CNGA3,HGNC:2150,CNGA3-related retinopathy,MONDO:0800102,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CNGA3,HGNC:2150,CNGA3-related retinopathy,MONDO:0800102,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CNGA3,HGNC:2150,CNGA3-related retinopathy,MONDO:0800102,Definitive,GO:0005216,ion channel activity,keyword,medium,keyword
CNGA3,HGNC:2150,CNGA3-related retinopathy,MONDO:0800102,Definitive,GO:0016020,membrane,keyword,medium,keyword
CNGB1,HGNC:2151,CNGB1-related retinopathy,MONDO:0800403,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CNGB1,HGNC:2151,CNGB1-related retinopathy,MONDO:0800403,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CNGB3,HGNC:2153,CNGB3-related retinopathy,MONDO:0100446,Definitive,GO:0010467,gene expression,direct,high,Expression
CNGB3,HGNC:2153,CNGB3-related retinopathy,MONDO:0100446,Definitive,GO:0006412,translation,inferred,medium,Expression
CNGB3,HGNC:2153,CNGB3-related retinopathy,MONDO:0100446,Definitive,GO:0005216,ion channel activity,keyword,medium,keyword
CNGB3,HGNC:2153,CNGB3-related retinopathy,MONDO:0100446,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CNGB3,HGNC:2153,CNGB3-related retinopathy,MONDO:0100446,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
CNGB3,HGNC:2153,CNGB3-related retinopathy,MONDO:0100446,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CNNM2,HGNC:103,"hypomagnesemia, seizures, and intellectual disability 1",MONDO:0020787,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CNNM2,HGNC:103,"hypomagnesemia, seizures, and intellectual disability 1",MONDO:0020787,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
CNNM2,HGNC:103,"hypomagnesemia, seizures, and intellectual disability 1",MONDO:0020787,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CNNM2,HGNC:103,"hypomagnesemia, seizures, and intellectual disability 1",MONDO:0020787,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CNNM2,HGNC:103,"hypomagnesemia, seizures, and intellectual disability 1",MONDO:0020787,Definitive,GO:0010467,gene expression,direct,high,Expression
CNNM2,HGNC:103,"hypomagnesemia, seizures, and intellectual disability 1",MONDO:0020787,Definitive,GO:0006412,translation,inferred,medium,Expression
CNNM2,HGNC:103,"hypomagnesemia, seizures, and intellectual disability 1",MONDO:0020787,Definitive,GO:0006810,transport,keyword,medium,keyword
CNNM2,HGNC:103,"hypomagnesemia, seizures, and intellectual disability 1",MONDO:0020787,Definitive,GO:0005215,transporter activity,keyword,high,keyword
CNNM4,HGNC:105,Jalili syndrome,MONDO:0009007,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CNNM4,HGNC:105,Jalili syndrome,MONDO:0009007,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CNNM4,HGNC:105,Jalili syndrome,MONDO:0009007,Definitive,GO:0010467,gene expression,direct,high,Expression
CNNM4,HGNC:105,Jalili syndrome,MONDO:0009007,Definitive,GO:0006412,translation,inferred,medium,Expression
CNNM4,HGNC:105,Jalili syndrome,MONDO:0009007,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CNTN2,HGNC:2172,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CNTNAP2,HGNC:13830,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COA8,HGNC:20492,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COA8,HGNC:20492,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
COA8,HGNC:20492,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COA8,HGNC:20492,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
COCH,HGNC:2180,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COCH,HGNC:2180,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0010467,gene expression,direct,high,Expression
COCH,HGNC:2180,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0006412,translation,inferred,medium,Expression
COG7,HGNC:18622,COG7-congenital disorder of glycosylation,MONDO:0012118,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
COG7,HGNC:18622,COG7-congenital disorder of glycosylation,MONDO:0012118,Definitive,GO:0008233,peptidase activity,keyword,high,keyword
COG7,HGNC:18622,COG7-congenital disorder of glycosylation,MONDO:0012118,Definitive,GO:0006508,proteolysis,keyword,high,keyword
COG7,HGNC:18622,COG7-congenital disorder of glycosylation,MONDO:0012118,Definitive,GO:0005794,Golgi apparatus,keyword,high,keyword
COG7,HGNC:18622,COG7-congenital disorder of glycosylation,MONDO:0012118,Definitive,GO:0005764,lysosome,keyword,high,keyword
COG7,HGNC:18622,COG7-congenital disorder of glycosylation,MONDO:0012118,Definitive,GO:0006810,transport,keyword,medium,keyword
COG7,HGNC:18622,COG7-congenital disorder of glycosylation,MONDO:0012118,Definitive,GO:0005215,transporter activity,keyword,high,keyword
COG7,HGNC:18622,COG7-congenital disorder of glycosylation,MONDO:0012118,Definitive,GO:0006486,protein glycosylation,keyword,high,keyword
COG7,HGNC:18622,COG7-congenital disorder of glycosylation,MONDO:0012118,Definitive,GO:0005488,binding,keyword,medium,keyword
COG7,HGNC:18622,COG7-congenital disorder of glycosylation,MONDO:0012118,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL10A1,HGNC:2185,Schmid metaphyseal chondrodysplasia,MONDO:0007983,Definitive,GO:0010467,gene expression,direct,high,Expression
COL10A1,HGNC:2185,Schmid metaphyseal chondrodysplasia,MONDO:0007983,Definitive,GO:0006412,translation,inferred,medium,Expression
COL10A1,HGNC:2185,Schmid metaphyseal chondrodysplasia,MONDO:0007983,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
COL10A1,HGNC:2185,Schmid metaphyseal chondrodysplasia,MONDO:0007983,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COL10A1,HGNC:2185,Schmid metaphyseal chondrodysplasia,MONDO:0007983,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL18A1,HGNC:2195,Knobloch syndrome 1,MONDO:0800167,Definitive,GO:0010467,gene expression,direct,high,Expression
COL18A1,HGNC:2195,Knobloch syndrome 1,MONDO:0800167,Definitive,GO:0006412,translation,inferred,medium,Expression
COL18A1,HGNC:2195,Knobloch syndrome 1,MONDO:0800167,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL3A1,HGNC:2201,"Ehlers-Danlos syndrome, vascular type",MONDO:0017314,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
COL3A1,HGNC:2201,"Ehlers-Danlos syndrome, vascular type",MONDO:0017314,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COL3A1,HGNC:2201,"Ehlers-Danlos syndrome, vascular type",MONDO:0017314,Definitive,GO:0010467,gene expression,direct,high,Expression
COL3A1,HGNC:2201,"Ehlers-Danlos syndrome, vascular type",MONDO:0017314,Definitive,GO:0006412,translation,inferred,medium,Expression
COL3A1,HGNC:2201,"Ehlers-Danlos syndrome, vascular type",MONDO:0017314,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL4A4,HGNC:2206,Alport syndrome,MONDO:0018965,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL4A4,HGNC:2206,Alport syndrome,MONDO:0018965,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
COL4A4,HGNC:2206,Alport syndrome,MONDO:0018965,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COL4A4,HGNC:2206,Alport syndrome,MONDO:0018965,Definitive,GO:0010467,gene expression,direct,high,Expression
COL4A4,HGNC:2206,Alport syndrome,MONDO:0018965,Definitive,GO:0006412,translation,inferred,medium,Expression
COL4A4,HGNC:2206,Alport syndrome,MONDO:0018965,Definitive,GO:0016020,membrane,keyword,medium,keyword
COL4A5,HGNC:2207,Alport syndrome,MONDO:0018965,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL4A5,HGNC:2207,Alport syndrome,MONDO:0018965,Definitive,GO:0010467,gene expression,direct,high,Expression
COL4A5,HGNC:2207,Alport syndrome,MONDO:0018965,Definitive,GO:0006412,translation,inferred,medium,Expression
COL5A1,HGNC:2209,"Ehlers-Danlos syndrome, classic type",MONDO:0007522,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
COL5A1,HGNC:2209,"Ehlers-Danlos syndrome, classic type",MONDO:0007522,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
COL5A1,HGNC:2209,"Ehlers-Danlos syndrome, classic type",MONDO:0007522,Definitive,GO:0016020,membrane,keyword,medium,keyword
COL5A1,HGNC:2209,"Ehlers-Danlos syndrome, classic type",MONDO:0007522,Definitive,GO:0005886,plasma membrane,keyword,high,keyword
COL5A1,HGNC:2209,"Ehlers-Danlos syndrome, classic type",MONDO:0007522,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL5A1,HGNC:2209,"Ehlers-Danlos syndrome, classic type",MONDO:0007522,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COL5A2,HGNC:2210,"Ehlers-Danlos syndrome, classic type",MONDO:0007522,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
COL5A2,HGNC:2210,"Ehlers-Danlos syndrome, classic type",MONDO:0007522,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL5A2,HGNC:2210,"Ehlers-Danlos syndrome, classic type",MONDO:0007522,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0010467,gene expression,direct,high,Expression
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0006412,translation,inferred,medium,Expression
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0016020,membrane,keyword,medium,keyword
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0016020,membrane,keyword,medium,keyword
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0010467,gene expression,direct,high,Expression
COL6A1,HGNC:2211,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0006412,translation,inferred,medium,Expression
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0016020,membrane,keyword,medium,keyword
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0010467,gene expression,direct,high,Expression
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0006412,translation,inferred,medium,Expression
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0010467,gene expression,direct,high,Expression
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0006412,translation,inferred,medium,Expression
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
COL6A2,HGNC:2212,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0016020,membrane,keyword,medium,keyword
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0016020,membrane,keyword,medium,keyword
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0010467,gene expression,direct,high,Expression
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0006412,translation,inferred,medium,Expression
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0016020,membrane,keyword,medium,keyword
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0010467,gene expression,direct,high,Expression
COL6A3,HGNC:2213,collagen 6-related myopathy,MONDO:0100225,Definitive,GO:0006412,translation,inferred,medium,Expression
COL7A1,HGNC:2214,recessive dystrophic epidermolysis bullosa,MONDO:0009179,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COL7A1,HGNC:2214,recessive dystrophic epidermolysis bullosa,MONDO:0009179,Definitive,GO:0016301,kinase activity,keyword,high,keyword
COL7A1,HGNC:2214,recessive dystrophic epidermolysis bullosa,MONDO:0009179,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
COL7A1,HGNC:2214,recessive dystrophic epidermolysis bullosa,MONDO:0009179,Definitive,GO:0016740,transferase activity,keyword,high,keyword
COL7A1,HGNC:2214,recessive dystrophic epidermolysis bullosa,MONDO:0009179,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
COL7A1,HGNC:2214,recessive dystrophic epidermolysis bullosa,MONDO:0009179,Definitive,GO:0010467,gene expression,direct,high,Expression
COL7A1,HGNC:2214,recessive dystrophic epidermolysis bullosa,MONDO:0009179,Definitive,GO:0006412,translation,inferred,medium,Expression
COQ2,HGNC:25223,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
COQ2,HGNC:25223,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
COQ2,HGNC:25223,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COQ2,HGNC:25223,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COQ2,HGNC:25223,mitochondrial disease,MONDO:0044970,Definitive,GO:0010467,gene expression,direct,high,Expression
COQ2,HGNC:25223,mitochondrial disease,MONDO:0044970,Definitive,GO:0006412,translation,inferred,medium,Expression
COQ2,HGNC:25223,mitochondrial disease,MONDO:0044970,Definitive,GO:0016020,membrane,keyword,medium,keyword
COQ4,HGNC:19693,mitochondrial disease,MONDO:0044970,Definitive,GO:0009058,biosynthetic process,keyword,medium,keyword
COQ4,HGNC:19693,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COQ4,HGNC:19693,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
COQ4,HGNC:19693,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COQ4,HGNC:19693,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
COQ8B,HGNC:19041,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COQ8B,HGNC:19041,mitochondrial disease,MONDO:0044970,Definitive,GO:0016020,membrane,keyword,medium,keyword
COQ8B,HGNC:19041,mitochondrial disease,MONDO:0044970,Definitive,GO:0010467,gene expression,direct,high,Expression
COQ8B,HGNC:19041,mitochondrial disease,MONDO:0044970,Definitive,GO:0006412,translation,inferred,medium,Expression
COQ8B,HGNC:19041,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
COQ9,HGNC:25302,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
COQ9,HGNC:25302,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
COQ9,HGNC:25302,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COQ9,HGNC:25302,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CORO1A,HGNC:2252,severe combined immunodeficiency due to CORO1A deficiency,MONDO:0014168,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CORO1A,HGNC:2252,severe combined immunodeficiency due to CORO1A deficiency,MONDO:0014168,Definitive,GO:0010467,gene expression,direct,high,Expression
CORO1A,HGNC:2252,severe combined immunodeficiency due to CORO1A deficiency,MONDO:0014168,Definitive,GO:0006412,translation,inferred,medium,Expression
CORO1A,HGNC:2252,severe combined immunodeficiency due to CORO1A deficiency,MONDO:0014168,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CORO1A,HGNC:2252,severe combined immunodeficiency due to CORO1A deficiency,MONDO:0014168,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
COX10,HGNC:2260,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
COX10,HGNC:2260,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COX10,HGNC:2260,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
COX10,HGNC:2260,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COX15,HGNC:2263,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
COX15,HGNC:2263,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COX15,HGNC:2263,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COX15,HGNC:2263,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
COX20,HGNC:26970,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COX20,HGNC:26970,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
COX20,HGNC:26970,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COX20,HGNC:26970,mitochondrial disease,MONDO:0044970,Definitive,GO:0006810,transport,keyword,medium,keyword
COX6B1,HGNC:2280,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
COX6B1,HGNC:2280,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
COX6B1,HGNC:2280,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
COX6B1,HGNC:2280,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
COX6B1,HGNC:2280,mitochondrial disease,MONDO:0044970,Definitive,GO:0016020,membrane,keyword,medium,keyword
CPAMD8,HGNC:23228,anterior segment dysgenesis 8,MONDO:0015017,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CPAMD8,HGNC:23228,anterior segment dysgenesis 8,MONDO:0015017,Definitive,GO:0010467,gene expression,direct,high,Expression
CPAMD8,HGNC:23228,anterior segment dysgenesis 8,MONDO:0015017,Definitive,GO:0006412,translation,inferred,medium,Expression
CPLANE1,HGNC:25801,Joubert syndrome 17,MONDO:0013824,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CPLANE1,HGNC:25801,Joubert syndrome 17,MONDO:0013824,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CPOX,HGNC:2321,CPOX-related hereditary coproporphyria,MONDO:0800180,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CPOX,HGNC:2321,CPOX-related hereditary coproporphyria,MONDO:0800180,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CPOX,HGNC:2321,CPOX-related hereditary coproporphyria,MONDO:0800180,Definitive,GO:0009058,biosynthetic process,keyword,medium,keyword
CPOX,HGNC:2321,CPOX-related hereditary coproporphyria,MONDO:0800180,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CPT1A,HGNC:2328,carnitine palmitoyl transferase 1A deficiency,MONDO:0009705,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CPT1A,HGNC:2328,carnitine palmitoyl transferase 1A deficiency,MONDO:0009705,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CPT1A,HGNC:2328,carnitine palmitoyl transferase 1A deficiency,MONDO:0009705,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
CPT1A,HGNC:2328,carnitine palmitoyl transferase 1A deficiency,MONDO:0009705,Definitive,GO:0010467,gene expression,direct,high,Expression
CPT1A,HGNC:2328,carnitine palmitoyl transferase 1A deficiency,MONDO:0009705,Definitive,GO:0006412,translation,inferred,medium,Expression
CPT1A,HGNC:2328,carnitine palmitoyl transferase 1A deficiency,MONDO:0009705,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CPT2,HGNC:2330,carnitine palmitoyltransferase II deficiency,MONDO:0015515,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CPT2,HGNC:2330,carnitine palmitoyltransferase II deficiency,MONDO:0015515,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
CPT2,HGNC:2330,carnitine palmitoyltransferase II deficiency,MONDO:0015515,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
CPT2,HGNC:2330,carnitine palmitoyltransferase II deficiency,MONDO:0015515,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CPT2,HGNC:2330,carnitine palmitoyltransferase II deficiency,MONDO:0015515,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CR2,HGNC:2336,"immunodeficiency, common variable, 7",MONDO:0013862,Definitive,GO:0010467,gene expression,direct,high,Expression
CR2,HGNC:2336,"immunodeficiency, common variable, 7",MONDO:0013862,Definitive,GO:0006412,translation,inferred,medium,Expression
CR2,HGNC:2336,"immunodeficiency, common variable, 7",MONDO:0013862,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CR2,HGNC:2336,"immunodeficiency, common variable, 7",MONDO:0013862,Definitive,GO:0005488,binding,keyword,medium,keyword
CR2,HGNC:2336,"immunodeficiency, common variable, 7",MONDO:0013862,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CRADD,HGNC:2340,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CRADD,HGNC:2340,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CRADD,HGNC:2340,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
CRB2,HGNC:18688,focal segmental glomerulosclerosis 9,MONDO:0014539,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CRB2,HGNC:18688,focal segmental glomerulosclerosis 9,MONDO:0014539,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CRB2,HGNC:18688,focal segmental glomerulosclerosis 9,MONDO:0014539,Definitive,GO:0010467,gene expression,direct,high,Expression
CRB2,HGNC:18688,focal segmental glomerulosclerosis 9,MONDO:0014539,Definitive,GO:0006412,translation,inferred,medium,Expression
CRX,HGNC:2383,cone-rod dystrophy 2,MONDO:0007362,Definitive,GO:0010467,gene expression,direct,high,Expression
CRX,HGNC:2383,cone-rod dystrophy 2,MONDO:0007362,Definitive,GO:0006412,translation,inferred,medium,Expression
CRX,HGNC:2383,cone-rod dystrophy 2,MONDO:0007362,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
CRX,HGNC:2383,cone-rod dystrophy 2,MONDO:0007362,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CRX,HGNC:2383,cone-rod dystrophy 2,MONDO:0007362,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CRX,HGNC:2383,cone-rod dystrophy 2,MONDO:0007362,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CRX,HGNC:2383,cone-rod dystrophy 2,MONDO:0007362,Definitive,GO:0005488,binding,keyword,medium,keyword
CRX,HGNC:2383,cone-rod dystrophy 2,MONDO:0007362,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
CRX,HGNC:2383,cone-rod dystrophy 2,MONDO:0007362,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CSF2RB,HGNC:2436,"surfactant metabolism dysfunction, pulmonary, 5",MONDO:0013712,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CSF2RB,HGNC:2436,"surfactant metabolism dysfunction, pulmonary, 5",MONDO:0013712,Definitive,GO:0010467,gene expression,direct,high,Expression
CSF2RB,HGNC:2436,"surfactant metabolism dysfunction, pulmonary, 5",MONDO:0013712,Definitive,GO:0006412,translation,inferred,medium,Expression
CSF2RB,HGNC:2436,"surfactant metabolism dysfunction, pulmonary, 5",MONDO:0013712,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CSF2RB,HGNC:2436,"surfactant metabolism dysfunction, pulmonary, 5",MONDO:0013712,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CSNK2A1,HGNC:2457,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CSNK2A1,HGNC:2457,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0016301,kinase activity,keyword,high,keyword
CSNK2A1,HGNC:2457,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
CSNK2A1,HGNC:2457,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0005634,nucleus,keyword,high,keyword
CSNK2A1,HGNC:2457,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CSNK2A1,HGNC:2457,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CSNK2B,HGNC:2460,Poirier-Bienvenu neurodevelopmental syndrome,MONDO:0032889,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CSNK2B,HGNC:2460,Poirier-Bienvenu neurodevelopmental syndrome,MONDO:0032889,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CSNK2B,HGNC:2460,Poirier-Bienvenu neurodevelopmental syndrome,MONDO:0032889,Definitive,GO:0010467,gene expression,direct,high,Expression
CSNK2B,HGNC:2460,Poirier-Bienvenu neurodevelopmental syndrome,MONDO:0032889,Definitive,GO:0006412,translation,inferred,medium,Expression
CSPP1,HGNC:26193,Joubert syndrome 21,MONDO:0014288,Definitive,GO:0010467,gene expression,direct,high,Expression
CSPP1,HGNC:26193,Joubert syndrome 21,MONDO:0014288,Definitive,GO:0006412,translation,inferred,medium,Expression
CSPP1,HGNC:26193,Joubert syndrome 21,MONDO:0014288,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CSPP1,HGNC:26193,Joubert syndrome 21,MONDO:0014288,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CSPP1,HGNC:26193,Joubert syndrome 21,MONDO:0014288,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CSRP3,HGNC:2472,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CSRP3,HGNC:2472,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
CSRP3,HGNC:2472,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0023052,signaling,keyword,medium,keyword
CSRP3,HGNC:2472,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0005488,binding,keyword,medium,keyword
CSRP3,HGNC:2472,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CSRP3,HGNC:2472,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0010467,gene expression,direct,high,Expression
CSRP3,HGNC:2472,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0006412,translation,inferred,medium,Expression
CSRP3,HGNC:2472,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CSTB,HGNC:2482,Unverricht-Lundborg syndrome,MONDO:0009698,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CSTB,HGNC:2482,Unverricht-Lundborg syndrome,MONDO:0009698,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CSTB,HGNC:2482,Unverricht-Lundborg syndrome,MONDO:0009698,Definitive,GO:0005634,nucleus,keyword,high,keyword
CSTB,HGNC:2482,Unverricht-Lundborg syndrome,MONDO:0009698,Definitive,GO:0005764,lysosome,keyword,high,keyword
CSTB,HGNC:2482,Unverricht-Lundborg syndrome,MONDO:0009698,Definitive,GO:0010467,gene expression,direct,high,Expression
CSTB,HGNC:2482,Unverricht-Lundborg syndrome,MONDO:0009698,Definitive,GO:0006412,translation,inferred,medium,Expression
CTCF,HGNC:13723,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CTH,HGNC:2501,cystathioninuria,MONDO:0009058,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CTH,HGNC:2501,cystathioninuria,MONDO:0009058,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CTH,HGNC:2501,cystathioninuria,MONDO:0009058,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CTNNA1,HGNC:2509,CTNNA1-related diffuse gastric and lobular breast cancer syndrome,MONDO:0100256,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CTNNA1,HGNC:2509,CTNNA1-related diffuse gastric and lobular breast cancer syndrome,MONDO:0100256,Definitive,GO:0010467,gene expression,direct,high,Expression
CTNNA1,HGNC:2509,CTNNA1-related diffuse gastric and lobular breast cancer syndrome,MONDO:0100256,Definitive,GO:0006412,translation,inferred,medium,Expression
CTNND1,HGNC:2515,blepharocheilodontic syndrome 2,MONDO:0040503,Definitive,GO:0010467,gene expression,direct,high,Expression
CTNND1,HGNC:2515,blepharocheilodontic syndrome 2,MONDO:0040503,Definitive,GO:0006412,translation,inferred,medium,Expression
CTNND1,HGNC:2515,blepharocheilodontic syndrome 2,MONDO:0040503,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CTNS,HGNC:2518,cystinosis,MONDO:0016239,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CTNS,HGNC:2518,cystinosis,MONDO:0016239,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CTNS,HGNC:2518,cystinosis,MONDO:0016239,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CTNS,HGNC:2518,cystinosis,MONDO:0016239,Definitive,GO:0006810,transport,keyword,medium,keyword
CTPS1,HGNC:2519,severe combined immunodeficiency due to CTPS1 deficiency,MONDO:0014391,Definitive,GO:0010467,gene expression,direct,high,Expression
CTPS1,HGNC:2519,severe combined immunodeficiency due to CTPS1 deficiency,MONDO:0014391,Definitive,GO:0006412,translation,inferred,medium,Expression
CTPS1,HGNC:2519,severe combined immunodeficiency due to CTPS1 deficiency,MONDO:0014391,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CTPS1,HGNC:2519,severe combined immunodeficiency due to CTPS1 deficiency,MONDO:0014391,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CTPS1,HGNC:2519,severe combined immunodeficiency due to CTPS1 deficiency,MONDO:0014391,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CTPS1,HGNC:2519,severe combined immunodeficiency due to CTPS1 deficiency,MONDO:0014391,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
CTSD,HGNC:2529,neuronal ceroid lipofuscinosis,MONDO:0016295,Definitive,GO:0006914,autophagy,keyword,high,keyword
CTSD,HGNC:2529,neuronal ceroid lipofuscinosis,MONDO:0016295,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CTSD,HGNC:2529,neuronal ceroid lipofuscinosis,MONDO:0016295,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CTSD,HGNC:2529,neuronal ceroid lipofuscinosis,MONDO:0016295,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CTSD,HGNC:2529,neuronal ceroid lipofuscinosis,MONDO:0016295,Definitive,GO:0010467,gene expression,direct,high,Expression
CTSD,HGNC:2529,neuronal ceroid lipofuscinosis,MONDO:0016295,Definitive,GO:0006412,translation,inferred,medium,Expression
CTSF,HGNC:2531,adult neuronal ceroid lipofuscinosis,MONDO:0019260,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CTSF,HGNC:2531,adult neuronal ceroid lipofuscinosis,MONDO:0019260,Definitive,GO:0005764,lysosome,keyword,high,keyword
CTSK,HGNC:2536,pycnodysostosis,MONDO:0009940,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CTSK,HGNC:2536,pycnodysostosis,MONDO:0009940,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
CTSK,HGNC:2536,pycnodysostosis,MONDO:0009940,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CTSK,HGNC:2536,pycnodysostosis,MONDO:0009940,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CTSK,HGNC:2536,pycnodysostosis,MONDO:0009940,Definitive,GO:0010467,gene expression,direct,high,Expression
CTSK,HGNC:2536,pycnodysostosis,MONDO:0009940,Definitive,GO:0006412,translation,inferred,medium,Expression
CTSK,HGNC:2536,pycnodysostosis,MONDO:0009940,Definitive,GO:0016020,membrane,keyword,medium,keyword
CUL3,HGNC:2553,pseudohypoaldosteronism type 2E,MONDO:0013782,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CUL3,HGNC:2553,pseudohypoaldosteronism type 2E,MONDO:0013782,Definitive,GO:0016874,ligase activity,keyword,high,keyword
CUL3,HGNC:2553,pseudohypoaldosteronism type 2E,MONDO:0013782,Definitive,GO:0016567,protein ubiquitination,keyword,high,keyword
CUL3,HGNC:2553,pseudohypoaldosteronism type 2E,MONDO:0013782,Definitive,GO:0010467,gene expression,direct,high,Expression
CUL3,HGNC:2553,pseudohypoaldosteronism type 2E,MONDO:0013782,Definitive,GO:0006412,translation,inferred,medium,Expression
CUL3,HGNC:2553,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CXCR4,HGNC:2561,WHIM syndrome,MONDO:0023880,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CXCR4,HGNC:2561,WHIM syndrome,MONDO:0023880,Definitive,GO:0023052,signaling,keyword,medium,keyword
CXCR4,HGNC:2561,WHIM syndrome,MONDO:0023880,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
CXCR4,HGNC:2561,WHIM syndrome,MONDO:0023880,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CXCR4,HGNC:2561,WHIM syndrome,MONDO:0023880,Definitive,GO:0010467,gene expression,direct,high,Expression
CXCR4,HGNC:2561,WHIM syndrome,MONDO:0023880,Definitive,GO:0006412,translation,inferred,medium,Expression
CXCR4,HGNC:2561,WHIM syndrome,MONDO:0023880,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CYLD,HGNC:2584,Brooke-Spiegler syndrome,MONDO:0011512,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CYLD,HGNC:2584,Brooke-Spiegler syndrome,MONDO:0011512,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CYLD,HGNC:2584,Brooke-Spiegler syndrome,MONDO:0011512,Definitive,GO:0023052,signaling,keyword,medium,keyword
CYLD,HGNC:2584,Brooke-Spiegler syndrome,MONDO:0011512,Definitive,GO:0010467,gene expression,direct,high,Expression
CYLD,HGNC:2584,Brooke-Spiegler syndrome,MONDO:0011512,Definitive,GO:0006412,translation,inferred,medium,Expression
CYLD,HGNC:2584,Brooke-Spiegler syndrome,MONDO:0011512,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CYLD,HGNC:2584,Brooke-Spiegler syndrome,MONDO:0011512,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
CYLD,HGNC:2584,Brooke-Spiegler syndrome,MONDO:0011512,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
CYLD,HGNC:2584,Brooke-Spiegler syndrome,MONDO:0011512,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
CYP11B2,HGNC:2592,familial hyperreninemic hypoaldosteronism type 2,MONDO:0011754,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CYP11B2,HGNC:2592,familial hyperreninemic hypoaldosteronism type 2,MONDO:0011754,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CYP11B2,HGNC:2592,familial hyperreninemic hypoaldosteronism type 2,MONDO:0011754,Definitive,GO:0009058,biosynthetic process,keyword,medium,keyword
CYP11B2,HGNC:2592,familial hyperreninemic hypoaldosteronism type 2,MONDO:0011754,Definitive,GO:0010467,gene expression,direct,high,Expression
CYP11B2,HGNC:2592,familial hyperreninemic hypoaldosteronism type 2,MONDO:0011754,Definitive,GO:0006412,translation,inferred,medium,Expression
CYP1B1,HGNC:2597,CYP1B1-related glaucoma with or without anterior segment dysgenesis,MONDO:0800472,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CYP27A1,HGNC:2605,cerebrotendinous xanthomatosis,MONDO:0008948,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
CYP27A1,HGNC:2605,cerebrotendinous xanthomatosis,MONDO:0008948,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
CYP27A1,HGNC:2605,cerebrotendinous xanthomatosis,MONDO:0008948,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
CYP27A1,HGNC:2605,cerebrotendinous xanthomatosis,MONDO:0008948,Definitive,GO:0009058,biosynthetic process,keyword,medium,keyword
CYP2U1,HGNC:20582,hereditary spastic paraplegia,MONDO:0019064,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CYP4V2,HGNC:23198,Bietti crystalline corneoretinal dystrophy,MONDO:0008865,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
CYP4V2,HGNC:23198,Bietti crystalline corneoretinal dystrophy,MONDO:0008865,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
CYP4V2,HGNC:23198,Bietti crystalline corneoretinal dystrophy,MONDO:0008865,Definitive,GO:0010467,gene expression,direct,high,Expression
CYP4V2,HGNC:23198,Bietti crystalline corneoretinal dystrophy,MONDO:0008865,Definitive,GO:0006412,translation,inferred,medium,Expression
DARS2,HGNC:25538,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DARS2,HGNC:25538,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DBT,HGNC:2698,maple syrup urine disease,MONDO:0009563,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DBT,HGNC:2698,maple syrup urine disease,MONDO:0009563,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DBT,HGNC:2698,maple syrup urine disease,MONDO:0009563,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DBT,HGNC:2698,maple syrup urine disease,MONDO:0009563,Definitive,GO:0009056,catabolic process,keyword,medium,keyword
DCAF17,HGNC:25784,Woodhouse-Sakati syndrome,MONDO:0009419,Definitive,GO:0010467,gene expression,direct,high,Expression
DCAF17,HGNC:25784,Woodhouse-Sakati syndrome,MONDO:0009419,Definitive,GO:0006412,translation,inferred,medium,Expression
DCAF17,HGNC:25784,Woodhouse-Sakati syndrome,MONDO:0009419,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DCC,HGNC:2701,mirror movements 1 and/or agenesis of the corpus callosum,MONDO:0100515,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DCC,HGNC:2701,mirror movements 1 and/or agenesis of the corpus callosum,MONDO:0100515,Definitive,GO:0010467,gene expression,direct,high,Expression
DCC,HGNC:2701,mirror movements 1 and/or agenesis of the corpus callosum,MONDO:0100515,Definitive,GO:0006412,translation,inferred,medium,Expression
DCC,HGNC:2701,mirror movements 1 and/or agenesis of the corpus callosum,MONDO:0100515,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
DCDC2,HGNC:18141,ciliopathy,MONDO:0005308,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DCDC2,HGNC:18141,ciliopathy,MONDO:0005308,Definitive,GO:0010467,gene expression,direct,high,Expression
DCDC2,HGNC:18141,ciliopathy,MONDO:0005308,Definitive,GO:0006412,translation,inferred,medium,Expression
DCLRE1C,HGNC:17642,severe combined immunodeficiency due to DCLRE1C deficiency,MONDO:0011225,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DCLRE1C,HGNC:17642,severe combined immunodeficiency due to DCLRE1C deficiency,MONDO:0011225,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DCLRE1C,HGNC:17642,severe combined immunodeficiency due to DCLRE1C deficiency,MONDO:0011225,Definitive,GO:0006281,DNA repair,keyword,high,keyword
DCLRE1C,HGNC:17642,severe combined immunodeficiency due to DCLRE1C deficiency,MONDO:0011225,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DCX,HGNC:2714,lissencephaly spectrum disorders,MONDO:0018838,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DDB2,HGNC:2718,xeroderma pigmentosum group E,MONDO:0010213,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DDB2,HGNC:2718,xeroderma pigmentosum group E,MONDO:0010213,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
DDB2,HGNC:2718,xeroderma pigmentosum group E,MONDO:0010213,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DDB2,HGNC:2718,xeroderma pigmentosum group E,MONDO:0010213,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DDC,HGNC:2719,aromatic L-amino acid decarboxylase deficiency,MONDO:0012084,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DDC,HGNC:2719,aromatic L-amino acid decarboxylase deficiency,MONDO:0012084,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DDC,HGNC:2719,aromatic L-amino acid decarboxylase deficiency,MONDO:0012084,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DDHD1,HGNC:19714,hereditary spastic paraplegia,MONDO:0019064,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DDR2,HGNC:2731,spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,MONDO:0010077,Definitive,GO:0010467,gene expression,direct,high,Expression
DDR2,HGNC:2731,spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,MONDO:0010077,Definitive,GO:0006412,translation,inferred,medium,Expression
DDR2,HGNC:2731,spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,MONDO:0010077,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DDX3X,HGNC:2745,X-linked syndromic intellectual disability,MONDO:0020119,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DDX3X,HGNC:2745,X-linked syndromic intellectual disability,MONDO:0020119,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DDX3X,HGNC:2745,X-linked syndromic intellectual disability,MONDO:0020119,Definitive,GO:0010467,gene expression,direct,high,Expression
DDX3X,HGNC:2745,X-linked syndromic intellectual disability,MONDO:0020119,Definitive,GO:0006412,translation,inferred,medium,Expression
DDX41,HGNC:18674,DDX41-related hematologic malignancy predisposition syndrome,MONDO:0014809,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DDX41,HGNC:18674,DDX41-related hematologic malignancy predisposition syndrome,MONDO:0014809,Definitive,GO:0005634,nucleus,keyword,high,keyword
DDX41,HGNC:18674,DDX41-related hematologic malignancy predisposition syndrome,MONDO:0014809,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
DGUOK,HGNC:2858,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DGUOK,HGNC:2858,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DGUOK,HGNC:2858,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DGUOK,HGNC:2858,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
DHTKD1,HGNC:23537,2-aminoadipic 2-oxoadipic aciduria,MONDO:0008774,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DHTKD1,HGNC:23537,2-aminoadipic 2-oxoadipic aciduria,MONDO:0008774,Definitive,GO:0023052,signaling,keyword,medium,keyword
DHTKD1,HGNC:23537,2-aminoadipic 2-oxoadipic aciduria,MONDO:0008774,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DHTKD1,HGNC:23537,2-aminoadipic 2-oxoadipic aciduria,MONDO:0008774,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
DHTKD1,HGNC:23537,2-aminoadipic 2-oxoadipic aciduria,MONDO:0008774,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DIAPH1,HGNC:2876,DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome,MONDO:0044635,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DIAPH1,HGNC:2876,DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome,MONDO:0044635,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DIAPH1,HGNC:2876,DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome,MONDO:0044635,Definitive,GO:0010467,gene expression,direct,high,Expression
DIAPH1,HGNC:2876,DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome,MONDO:0044635,Definitive,GO:0006412,translation,inferred,medium,Expression
DICER1,HGNC:17098,DICER1-related tumor predisposition,MONDO:0100216,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DICER1,HGNC:17098,DICER1-related tumor predisposition,MONDO:0100216,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DIS3L2,HGNC:28648,Perlman syndrome,MONDO:0009965,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DIS3L2,HGNC:28648,Perlman syndrome,MONDO:0009965,Definitive,GO:0010467,gene expression,direct,high,Expression
DIS3L2,HGNC:28648,Perlman syndrome,MONDO:0009965,Definitive,GO:0006412,translation,inferred,medium,Expression
DIS3L2,HGNC:28648,Perlman syndrome,MONDO:0009965,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
DIS3L2,HGNC:28648,Perlman syndrome,MONDO:0009965,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DLD,HGNC:2898,Leigh syndrome,MONDO:0009723,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DLD,HGNC:2898,Leigh syndrome,MONDO:0009723,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DLD,HGNC:2898,Leigh syndrome,MONDO:0009723,Definitive,GO:0010467,gene expression,direct,high,Expression
DLD,HGNC:2898,Leigh syndrome,MONDO:0009723,Definitive,GO:0006412,translation,inferred,medium,Expression
DLD,HGNC:2898,Leigh syndrome,MONDO:0009723,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
DLD,HGNC:2898,pyruvate dehydrogenase E3 deficiency,MONDO:0009529,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DLD,HGNC:2898,pyruvate dehydrogenase E3 deficiency,MONDO:0009529,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DLD,HGNC:2898,pyruvate dehydrogenase E3 deficiency,MONDO:0009529,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
DLD,HGNC:2898,pyruvate dehydrogenase E3 deficiency,MONDO:0009529,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DLL1,HGNC:2908,neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures,MONDO:0032877,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAAF1,HGNC:30539,primary ciliary dyskinesia 13,MONDO:0013174,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAAF1,HGNC:30539,primary ciliary dyskinesia 13,MONDO:0013174,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DNAAF1,HGNC:30539,primary ciliary dyskinesia 13,MONDO:0013174,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
DNAAF1,HGNC:30539,primary ciliary dyskinesia 13,MONDO:0013174,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAAF1,HGNC:30539,primary ciliary dyskinesia 13,MONDO:0013174,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAAF11,HGNC:16725,primary ciliary dyskinesia 19,MONDO:0013979,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DNAAF11,HGNC:16725,primary ciliary dyskinesia 19,MONDO:0013979,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DNAAF11,HGNC:16725,primary ciliary dyskinesia 19,MONDO:0013979,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAAF11,HGNC:16725,primary ciliary dyskinesia 19,MONDO:0013979,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAAF11,HGNC:16725,primary ciliary dyskinesia 19,MONDO:0013979,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAAF2,HGNC:20188,primary ciliary dyskinesia 10,MONDO:0012918,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DNAAF2,HGNC:20188,primary ciliary dyskinesia 10,MONDO:0012918,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DNAAF2,HGNC:20188,primary ciliary dyskinesia 10,MONDO:0012918,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAAF2,HGNC:20188,primary ciliary dyskinesia 10,MONDO:0012918,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAAF2,HGNC:20188,primary ciliary dyskinesia 10,MONDO:0012918,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAAF3,HGNC:30492,primary ciliary dyskinesia 2,MONDO:0011718,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DNAAF3,HGNC:30492,primary ciliary dyskinesia 2,MONDO:0011718,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
DNAAF3,HGNC:30492,primary ciliary dyskinesia 2,MONDO:0011718,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAAF3,HGNC:30492,primary ciliary dyskinesia 2,MONDO:0011718,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAAF3,HGNC:30492,primary ciliary dyskinesia 2,MONDO:0011718,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAAF4,HGNC:21493,primary ciliary dyskinesia 25,MONDO:0014203,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAAF4,HGNC:21493,primary ciliary dyskinesia 25,MONDO:0014203,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAAF4,HGNC:21493,primary ciliary dyskinesia 25,MONDO:0014203,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAAF4,HGNC:21493,primary ciliary dyskinesia 25,MONDO:0014203,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DNAAF4,HGNC:21493,primary ciliary dyskinesia 25,MONDO:0014203,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DNAAF5,HGNC:26013,primary ciliary dyskinesia 18,MONDO:0013940,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAAF5,HGNC:26013,primary ciliary dyskinesia 18,MONDO:0013940,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAAF5,HGNC:26013,primary ciliary dyskinesia 18,MONDO:0013940,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAAF5,HGNC:26013,primary ciliary dyskinesia 18,MONDO:0013940,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
DNAAF6,HGNC:28570,"ciliary dyskinesia, primary, 36, X-linked",MONDO:0010517,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAAF6,HGNC:28570,"ciliary dyskinesia, primary, 36, X-linked",MONDO:0010517,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DNAAF6,HGNC:28570,"ciliary dyskinesia, primary, 36, X-linked",MONDO:0010517,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAAF6,HGNC:28570,"ciliary dyskinesia, primary, 36, X-linked",MONDO:0010517,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAH1,HGNC:2940,spermatogenic failure 18,MONDO:0054615,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAH1,HGNC:2940,spermatogenic failure 18,MONDO:0054615,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DNAH1,HGNC:2940,spermatogenic failure 18,MONDO:0054615,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAH1,HGNC:2940,spermatogenic failure 18,MONDO:0054615,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAH11,HGNC:2942,primary ciliary dyskinesia 7,MONDO:0012748,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAH11,HGNC:2942,primary ciliary dyskinesia 7,MONDO:0012748,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAH11,HGNC:2942,primary ciliary dyskinesia 7,MONDO:0012748,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DNAH11,HGNC:2942,primary ciliary dyskinesia 7,MONDO:0012748,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DNAH11,HGNC:2942,primary ciliary dyskinesia 7,MONDO:0012748,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAH17,HGNC:2946,spermatogenic failure 39,MONDO:0032845,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DNAH17,HGNC:2946,spermatogenic failure 39,MONDO:0032845,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAH17,HGNC:2946,spermatogenic failure 39,MONDO:0032845,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAH17,HGNC:2946,spermatogenic failure 39,MONDO:0032845,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAH5,HGNC:2950,primary ciliary dyskinesia 3,MONDO:0012085,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAH5,HGNC:2950,primary ciliary dyskinesia 3,MONDO:0012085,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAH5,HGNC:2950,primary ciliary dyskinesia 3,MONDO:0012085,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAH5,HGNC:2950,primary ciliary dyskinesia 3,MONDO:0012085,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
DNAH8,HGNC:2952,spermatogenic failure 46,MONDO:0033673,Strong,GO:0008150,biological_process,inferred,low,Model Systems
DNAH8,HGNC:2952,spermatogenic failure 46,MONDO:0033673,Strong,GO:0003674,molecular_function,inferred,low,Functional Alteration
DNAH8,HGNC:2952,spermatogenic failure 46,MONDO:0033673,Strong,GO:0010467,gene expression,direct,high,Expression
DNAH8,HGNC:2952,spermatogenic failure 46,MONDO:0033673,Strong,GO:0006412,translation,inferred,medium,Expression
DNAH9,HGNC:2953,"ciliary dyskinesia, primary, 40",MONDO:0032664,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAH9,HGNC:2953,"ciliary dyskinesia, primary, 40",MONDO:0032664,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAH9,HGNC:2953,"ciliary dyskinesia, primary, 40",MONDO:0032664,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAI1,HGNC:2954,primary ciliary dyskinesia 1,MONDO:0009484,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAI1,HGNC:2954,primary ciliary dyskinesia 1,MONDO:0009484,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DNAI1,HGNC:2954,primary ciliary dyskinesia 1,MONDO:0009484,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DNAI1,HGNC:2954,primary ciliary dyskinesia 1,MONDO:0009484,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAI1,HGNC:2954,primary ciliary dyskinesia 1,MONDO:0009484,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAI2,HGNC:18744,primary ciliary dyskinesia 9,MONDO:0012906,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAI2,HGNC:18744,primary ciliary dyskinesia 9,MONDO:0012906,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAI2,HGNC:18744,primary ciliary dyskinesia 9,MONDO:0012906,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAI2,HGNC:18744,primary ciliary dyskinesia 9,MONDO:0012906,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DNAI2,HGNC:18744,primary ciliary dyskinesia 9,MONDO:0012906,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DNAJB2,HGNC:5228,Charcot-Marie-Tooth disease axonal type 2T,MONDO:0014866,Definitive,GO:0010467,gene expression,direct,high,Expression
DNAJB2,HGNC:5228,Charcot-Marie-Tooth disease axonal type 2T,MONDO:0014866,Definitive,GO:0006412,translation,inferred,medium,Expression
DNAJB2,HGNC:5228,Charcot-Marie-Tooth disease axonal type 2T,MONDO:0014866,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DNAJB2,HGNC:5228,Charcot-Marie-Tooth disease axonal type 2T,MONDO:0014866,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DNAJC12,HGNC:28908,hyperphenylalaninemia due to DNAJC12 deficiency,MONDO:0044304,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DNAJC19,HGNC:30528,3-methylglutaconic aciduria type 5,MONDO:0012435,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DNAJC19,HGNC:30528,3-methylglutaconic aciduria type 5,MONDO:0012435,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
DNAJC19,HGNC:30528,3-methylglutaconic aciduria type 5,MONDO:0012435,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNAJC19,HGNC:30528,3-methylglutaconic aciduria type 5,MONDO:0012435,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DNAJC19,HGNC:30528,3-methylglutaconic aciduria type 5,MONDO:0012435,Definitive,GO:0030150,(explicit mention),direct,high,explicit
DNAJC19,HGNC:30528,3-methylglutaconic aciduria type 5,MONDO:0012435,Definitive,GO:1900208,(explicit mention),direct,high,explicit
DNAJC19,HGNC:30528,3-methylglutaconic aciduria type 5,MONDO:0012435,Definitive,GO:0001405,(explicit mention),direct,high,explicit
DNASE1L3,HGNC:2959,autosomal systemic lupus erythematosus type 16,MONDO:0013743,Definitive,GO:0010467,gene expression,direct,high,Expression
DNASE1L3,HGNC:2959,autosomal systemic lupus erythematosus type 16,MONDO:0013743,Definitive,GO:0006412,translation,inferred,medium,Expression
DNASE1L3,HGNC:2959,autosomal systemic lupus erythematosus type 16,MONDO:0013743,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNASE1L3,HGNC:2959,autosomal systemic lupus erythematosus type 16,MONDO:0013743,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DNM1L,HGNC:2973,encephalopathy due to mitochondrial and peroxisomal fission defect,MONDO:0054865,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DNM1L,HGNC:2973,encephalopathy due to mitochondrial and peroxisomal fission defect,MONDO:0054865,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DNM1L,HGNC:2973,encephalopathy due to mitochondrial and peroxisomal fission defect,MONDO:0054865,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNM1L,HGNC:2973,encephalopathy due to mitochondrial and peroxisomal fission defect,MONDO:0054865,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
DNM2,HGNC:2974,Charcot-Marie-Tooth disease,MONDO:0015626,Definitive,GO:0010467,gene expression,direct,high,Expression
DNM2,HGNC:2974,Charcot-Marie-Tooth disease,MONDO:0015626,Definitive,GO:0006412,translation,inferred,medium,Expression
DNM2,HGNC:2974,Charcot-Marie-Tooth disease,MONDO:0015626,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNM2,HGNC:2974,Charcot-Marie-Tooth disease,MONDO:0015626,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DNM2,HGNC:2974,Charcot-Marie-Tooth disease,MONDO:0015626,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
DNM2,HGNC:2974,autosomal dominant centronuclear myopathy,MONDO:0008048,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DNM2,HGNC:2974,autosomal dominant centronuclear myopathy,MONDO:0008048,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DNM2,HGNC:2974,autosomal dominant centronuclear myopathy,MONDO:0008048,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DNMT3B,HGNC:2979,immunodeficiency-centromeric instability-facial anomalies syndrome 1,MONDO:0009454,Strong,GO:0032259,methylation,keyword,medium,keyword
DNMT3B,HGNC:2979,immunodeficiency-centromeric instability-facial anomalies syndrome 1,MONDO:0009454,Strong,GO:0008150,biological_process,inferred,low,Model Systems
DNMT3B,HGNC:2979,immunodeficiency-centromeric instability-facial anomalies syndrome 1,MONDO:0009454,Strong,GO:0010467,gene expression,direct,high,Expression
DNMT3B,HGNC:2979,immunodeficiency-centromeric instability-facial anomalies syndrome 1,MONDO:0009454,Strong,GO:0006412,translation,inferred,medium,Expression
DNMT3B,HGNC:2979,immunodeficiency-centromeric instability-facial anomalies syndrome 1,MONDO:0009454,Strong,GO:0003674,molecular_function,direct,high,Biochemical Function
DNMT3B,HGNC:2979,immunodeficiency-centromeric instability-facial anomalies syndrome 1,MONDO:0009454,Strong,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DNMT3B,HGNC:2979,immunodeficiency-centromeric instability-facial anomalies syndrome 1,MONDO:0009454,Strong,GO:0005488,binding,keyword,medium,keyword
DOCK2,HGNC:2988,DOCK2 deficiency,MONDO:0014637,Definitive,GO:0010467,gene expression,direct,high,Expression
DOCK2,HGNC:2988,DOCK2 deficiency,MONDO:0014637,Definitive,GO:0006412,translation,inferred,medium,Expression
DOCK2,HGNC:2988,DOCK2 deficiency,MONDO:0014637,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DOCK2,HGNC:2988,DOCK2 deficiency,MONDO:0014637,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DOCK2,HGNC:2988,DOCK2 deficiency,MONDO:0014637,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DOCK2,HGNC:2988,DOCK2 deficiency,MONDO:0014637,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
DOCK6,HGNC:19189,Adams-Oliver syndrome,MONDO:0007034,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DOCK6,HGNC:19189,Adams-Oliver syndrome,MONDO:0007034,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DOCK7,HGNC:19190,developmental and epileptic encephalopathy,MONDO:0100062,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DOCK8,HGNC:19191,combined immunodeficiency due to DOCK8 deficiency,MONDO:0009478,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DOCK8,HGNC:19191,combined immunodeficiency due to DOCK8 deficiency,MONDO:0009478,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DOCK8,HGNC:19191,combined immunodeficiency due to DOCK8 deficiency,MONDO:0009478,Definitive,GO:0010467,gene expression,direct,high,Expression
DOCK8,HGNC:19191,combined immunodeficiency due to DOCK8 deficiency,MONDO:0009478,Definitive,GO:0006412,translation,inferred,medium,Expression
DOLK,HGNC:23406,DK1-congenital disorder of glycosylation,MONDO:0012556,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DOLK,HGNC:23406,DK1-congenital disorder of glycosylation,MONDO:0012556,Definitive,GO:0006486,protein glycosylation,keyword,high,keyword
DOLK,HGNC:23406,DK1-congenital disorder of glycosylation,MONDO:0012556,Definitive,GO:0010467,gene expression,direct,high,Expression
DOLK,HGNC:23406,DK1-congenital disorder of glycosylation,MONDO:0012556,Definitive,GO:0006412,translation,inferred,medium,Expression
DOLK,HGNC:23406,DK1-congenital disorder of glycosylation,MONDO:0012556,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DOLK,HGNC:23406,DK1-congenital disorder of glycosylation,MONDO:0012556,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DPAGT1,HGNC:2995,DPAGT1-congenital disorder of glycosylation,MONDO:0011964,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DPAGT1,HGNC:2995,DPAGT1-congenital disorder of glycosylation,MONDO:0011964,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DPAGT1,HGNC:2995,DPAGT1-congenital disorder of glycosylation,MONDO:0011964,Definitive,GO:0006486,protein glycosylation,keyword,high,keyword
DPAGT1,HGNC:2995,DPAGT1-congenital disorder of glycosylation,MONDO:0011964,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DPH1,HGNC:3003,"developmental delay with short stature, dysmorphic facial features, and sparse hair",MONDO:0031632,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DPH1,HGNC:3003,"developmental delay with short stature, dysmorphic facial features, and sparse hair",MONDO:0031632,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DPH1,HGNC:3003,"developmental delay with short stature, dysmorphic facial features, and sparse hair",MONDO:0031632,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DPH1,HGNC:3003,"developmental delay with short stature, dysmorphic facial features, and sparse hair",MONDO:0031632,Definitive,GO:0006412,translation,keyword,high,keyword
DPM1,HGNC:3005,congenital disorder of glycosylation type 1E,MONDO:0012123,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DPM1,HGNC:3005,congenital disorder of glycosylation type 1E,MONDO:0012123,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DPM1,HGNC:3005,congenital disorder of glycosylation type 1E,MONDO:0012123,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DPM1,HGNC:3005,congenital disorder of glycosylation type 1E,MONDO:0012123,Definitive,GO:0006486,protein glycosylation,keyword,high,keyword
DSC2,HGNC:3036,familial isolated arrhythmogenic right ventricular dysplasia,MONDO:0016342,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DSC2,HGNC:3036,familial isolated arrhythmogenic right ventricular dysplasia,MONDO:0016342,Definitive,GO:0010467,gene expression,direct,high,Expression
DSC2,HGNC:3036,familial isolated arrhythmogenic right ventricular dysplasia,MONDO:0016342,Definitive,GO:0006412,translation,inferred,medium,Expression
DSG2,HGNC:3049,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DSG2,HGNC:3049,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,Definitive,GO:0010467,gene expression,direct,high,Expression
DSG2,HGNC:3049,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,Definitive,GO:0006412,translation,inferred,medium,Expression
DSG2,HGNC:3049,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DSG2,HGNC:3049,arrhythmogenic right ventricular cardiomyopathy,MONDO:0016587,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DSPP,HGNC:3054,dentinogenesis imperfecta,MONDO:0018849,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DSPP,HGNC:3054,dentinogenesis imperfecta,MONDO:0018849,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DSPP,HGNC:3054,dentinogenesis imperfecta,MONDO:0018849,Definitive,GO:0010467,gene expression,direct,high,Expression
DSPP,HGNC:3054,dentinogenesis imperfecta,MONDO:0018849,Definitive,GO:0006412,translation,inferred,medium,Expression
DST,HGNC:1090,hereditary sensory and autonomic neuropathy type 6,MONDO:0013839,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DST,HGNC:1090,hereditary sensory and autonomic neuropathy type 6,MONDO:0013839,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DST,HGNC:1090,hereditary sensory and autonomic neuropathy type 6,MONDO:0013839,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DST,HGNC:1090,hereditary sensory and autonomic neuropathy type 6,MONDO:0013839,Definitive,GO:0006810,transport,keyword,medium,keyword
DST,HGNC:1090,hereditary sensory and autonomic neuropathy type 6,MONDO:0013839,Definitive,GO:0010467,gene expression,direct,high,Expression
DST,HGNC:1090,hereditary sensory and autonomic neuropathy type 6,MONDO:0013839,Definitive,GO:0006412,translation,inferred,medium,Expression
DST,HGNC:1090,hereditary sensory and autonomic neuropathy type 6,MONDO:0013839,Definitive,GO:0005488,binding,keyword,medium,keyword
DTNBP1,HGNC:17328,Hermansky-Pudlak syndrome 7,MONDO:0013559,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
DTNBP1,HGNC:17328,Hermansky-Pudlak syndrome 7,MONDO:0013559,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
DTNBP1,HGNC:17328,Hermansky-Pudlak syndrome 7,MONDO:0013559,Definitive,GO:0005764,lysosome,keyword,high,keyword
DTNBP1,HGNC:17328,Hermansky-Pudlak syndrome 7,MONDO:0013559,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DYNC1H1,HGNC:2961,"obsolete neuronopathy, distal hereditary motor",MONDO:0000075,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DYNC1H1,HGNC:2961,"obsolete neuronopathy, distal hereditary motor",MONDO:0000075,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DYNC1H1,HGNC:2961,"obsolete neuronopathy, distal hereditary motor",MONDO:0000075,Definitive,GO:0005794,Golgi apparatus,keyword,high,keyword
DYNC2I1,HGNC:21862,short-rib thoracic dysplasia 8 with or without polydactyly,MONDO:0014214,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
DYNC2I1,HGNC:21862,short-rib thoracic dysplasia 8 with or without polydactyly,MONDO:0014214,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DYRK1A,HGNC:3091,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
DYRK1A,HGNC:3091,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0010467,gene expression,direct,high,Expression
DYRK1A,HGNC:3091,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0006412,translation,inferred,medium,Expression
DYRK1A,HGNC:3091,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0007049,cell cycle,keyword,high,keyword
EARS2,HGNC:29419,Leigh syndrome,MONDO:0009723,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
EARS2,HGNC:29419,Leigh syndrome,MONDO:0009723,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
EARS2,HGNC:29419,Leigh syndrome,MONDO:0009723,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
EBF3,HGNC:19087,"hypotonia, ataxia, and delayed development syndrome",MONDO:0015021,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
EBP,HGNC:3133,MEND syndrome,MONDO:0010498,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EBP,HGNC:3133,MEND syndrome,MONDO:0010498,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
EBP,HGNC:3133,MEND syndrome,MONDO:0010498,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ECHS1,HGNC:3151,Leigh syndrome,MONDO:0009723,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ECHS1,HGNC:3151,Leigh syndrome,MONDO:0009723,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ECHS1,HGNC:3151,Leigh syndrome,MONDO:0009723,Definitive,GO:0010467,gene expression,direct,high,Expression
ECHS1,HGNC:3151,Leigh syndrome,MONDO:0009723,Definitive,GO:0006412,translation,inferred,medium,Expression
ECHS1,HGNC:3151,Leigh syndrome,MONDO:0009723,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
ECHS1,HGNC:3151,mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency,MONDO:0014563,Definitive,GO:0010467,gene expression,direct,high,Expression
ECHS1,HGNC:3151,mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency,MONDO:0014563,Definitive,GO:0006412,translation,inferred,medium,Expression
ECHS1,HGNC:3151,mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency,MONDO:0014563,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ECHS1,HGNC:3151,mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency,MONDO:0014563,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
EDEM3,HGNC:16787,"congenital disorder of glycosylation, type 2v",MONDO:0030423,Strong,GO:0008150,biological_process,inferred,low,Model Systems
EDEM3,HGNC:16787,"congenital disorder of glycosylation, type 2v",MONDO:0030423,Strong,GO:0010467,gene expression,direct,high,Expression
EDEM3,HGNC:16787,"congenital disorder of glycosylation, type 2v",MONDO:0030423,Strong,GO:0006412,translation,inferred,medium,Expression
EDEM3,HGNC:16787,"congenital disorder of glycosylation, type 2v",MONDO:0030423,Strong,GO:0006810,transport,keyword,medium,keyword
EDEM3,HGNC:16787,"congenital disorder of glycosylation, type 2v",MONDO:0030423,Strong,GO:0005783,endoplasmic reticulum,keyword,high,keyword
EEF1A2,HGNC:3192,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EEF1A2,HGNC:3192,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0010467,gene expression,direct,high,Expression
EEF1A2,HGNC:3192,complex neurodevelopmental disorder,MONDO:0100038,Definitive,GO:0006412,translation,inferred,medium,Expression
EFEMP1,HGNC:3218,Doyne honeycomb retinal dystrophy,MONDO:0007471,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EFEMP1,HGNC:3218,Doyne honeycomb retinal dystrophy,MONDO:0007471,Definitive,GO:0016020,membrane,keyword,medium,keyword
EFEMP1,HGNC:3218,Doyne honeycomb retinal dystrophy,MONDO:0007471,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
EFEMP1,HGNC:3218,Doyne honeycomb retinal dystrophy,MONDO:0007471,Definitive,GO:0010467,gene expression,direct,high,Expression
EFEMP1,HGNC:3218,Doyne honeycomb retinal dystrophy,MONDO:0007471,Definitive,GO:0006412,translation,inferred,medium,Expression
EFNB1,HGNC:3226,craniofrontonasal syndrome,MONDO:0010570,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EFNB1,HGNC:3226,craniofrontonasal syndrome,MONDO:0010570,Definitive,GO:0010467,gene expression,direct,high,Expression
EFNB1,HGNC:3226,craniofrontonasal syndrome,MONDO:0010570,Definitive,GO:0006412,translation,inferred,medium,Expression
EFTUD2,HGNC:30858,mandibulofacial dysostosis-microcephaly syndrome,MONDO:0012516,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EFTUD2,HGNC:30858,mandibulofacial dysostosis-microcephaly syndrome,MONDO:0012516,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
EGFR,HGNC:3236,non-small cell lung carcinoma,MONDO:0005233,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EGFR,HGNC:3236,non-small cell lung carcinoma,MONDO:0005233,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
EGFR,HGNC:3236,non-small cell lung carcinoma,MONDO:0005233,Definitive,GO:0016301,kinase activity,keyword,high,keyword
EGFR,HGNC:3236,non-small cell lung carcinoma,MONDO:0005233,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
EIF2AK4,HGNC:19687,pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosis,MONDO:0018554,Definitive,GO:0010467,gene expression,direct,high,Expression
EIF2AK4,HGNC:19687,pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosis,MONDO:0018554,Definitive,GO:0006412,translation,inferred,medium,Expression
EIF2B2,HGNC:3258,leukoencephalopathy with vanishing white matter 2,MONDO:0957870,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EIF2B3,HGNC:3259,leukoencephalopathy with vanishing white matter 3,MONDO:0957871,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EIF2B4,HGNC:3260,leukoencephalopathy with vanishing white matter 4,MONDO:0957872,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EIF2S3,HGNC:3267,MEHMO syndrome,MONDO:0010258,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EIF2S3,HGNC:3267,MEHMO syndrome,MONDO:0010258,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
EIF2S3,HGNC:3267,MEHMO syndrome,MONDO:0010258,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
EIF3F,HGNC:3275,syndromic intellectual disability,MONDO:0000508,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ELAC2,HGNC:14198,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ELAC2,HGNC:14198,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
ELAC2,HGNC:14198,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ELAC2,HGNC:14198,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ELANE,HGNC:3309,neutropenia,MONDO:0001475,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ELANE,HGNC:3309,neutropenia,MONDO:0001475,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ELANE,HGNC:3309,neutropenia,MONDO:0001475,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
ELANE,HGNC:3309,neutropenia,MONDO:0001475,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
ELANE,HGNC:3309,neutropenia,MONDO:0001475,Definitive,GO:0016020,membrane,keyword,medium,keyword
ELANE,HGNC:3309,neutropenia,MONDO:0001475,Definitive,GO:0005886,plasma membrane,keyword,high,keyword
ELANE,HGNC:3309,neutropenia,MONDO:0001475,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ELN,HGNC:3327,"cutis laxa, autosomal dominant 1",MONDO:0007411,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ELN,HGNC:3327,"cutis laxa, autosomal dominant 1",MONDO:0007411,Definitive,GO:0010467,gene expression,direct,high,Expression
ELN,HGNC:3327,"cutis laxa, autosomal dominant 1",MONDO:0007411,Definitive,GO:0006412,translation,inferred,medium,Expression
ELN,HGNC:3327,"cutis laxa, autosomal dominant 1",MONDO:0007411,Definitive,GO:0023052,signaling,keyword,medium,keyword
ENTPD1,HGNC:3363,complex hereditary spastic paraplegia,MONDO:0015150,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ENTPD1,HGNC:3363,complex hereditary spastic paraplegia,MONDO:0015150,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
EP300,HGNC:3373,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,MONDO:0013364,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EP300,HGNC:3373,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,MONDO:0013364,Definitive,GO:0010467,gene expression,direct,high,Expression
EP300,HGNC:3373,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,MONDO:0013364,Definitive,GO:0006412,translation,inferred,medium,Expression
EPCAM,HGNC:11529,Lynch syndrome,MONDO:0005835,Definitive,GO:0010467,gene expression,direct,high,Expression
EPCAM,HGNC:11529,Lynch syndrome,MONDO:0005835,Definitive,GO:0006412,translation,inferred,medium,Expression
EPCAM,HGNC:11529,Lynch syndrome,MONDO:0005835,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
EPCAM,HGNC:11529,Lynch syndrome,MONDO:0005835,Definitive,GO:0032259,methylation,keyword,medium,keyword
EPG5,HGNC:29331,Vici syndrome,MONDO:0009452,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EPG5,HGNC:29331,Vici syndrome,MONDO:0009452,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
EPG5,HGNC:29331,Vici syndrome,MONDO:0009452,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
EPG5,HGNC:29331,Vici syndrome,MONDO:0009452,Definitive,GO:0006914,autophagy,keyword,high,keyword
EPG5,HGNC:29331,Vici syndrome,MONDO:0009452,Definitive,GO:0005764,lysosome,keyword,high,keyword
EPHB4,HGNC:3395,EPHB4-associated vascular malformation spectrum,MONDO:0700080,Definitive,GO:0010467,gene expression,direct,high,Expression
EPHB4,HGNC:3395,EPHB4-associated vascular malformation spectrum,MONDO:0700080,Definitive,GO:0006412,translation,inferred,medium,Expression
EPHB4,HGNC:3395,EPHB4-associated vascular malformation spectrum,MONDO:0700080,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EPM2A,HGNC:3413,Lafora disease,MONDO:0009697,Definitive,GO:0010467,gene expression,direct,high,Expression
EPM2A,HGNC:3413,Lafora disease,MONDO:0009697,Definitive,GO:0006412,translation,inferred,medium,Expression
EPM2A,HGNC:3413,Lafora disease,MONDO:0009697,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
EPM2A,HGNC:3413,Lafora disease,MONDO:0009697,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
EPM2A,HGNC:3413,Lafora disease,MONDO:0009697,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EPM2A,HGNC:3413,Lafora disease,MONDO:0009697,Definitive,GO:0016791,phosphatase activity,keyword,high,keyword
EPM2A,HGNC:3413,Lafora disease,MONDO:0009697,Definitive,GO:0016311,dephosphorylation,keyword,high,keyword
ERCC2,HGNC:3434,xeroderma pigmentosum group D,MONDO:0010212,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ERCC2,HGNC:3434,xeroderma pigmentosum group D,MONDO:0010212,Definitive,GO:0016301,kinase activity,keyword,high,keyword
ERCC2,HGNC:3434,xeroderma pigmentosum group D,MONDO:0010212,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
ERCC2,HGNC:3434,xeroderma pigmentosum group D,MONDO:0010212,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
ERCC2,HGNC:3434,xeroderma pigmentosum group D,MONDO:0010212,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ERCC2,HGNC:3434,xeroderma pigmentosum group D,MONDO:0010212,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ERCC3,HGNC:3435,xeroderma pigmentosum group B,MONDO:0012531,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ERCC3,HGNC:3435,xeroderma pigmentosum group B,MONDO:0012531,Definitive,GO:0006281,DNA repair,keyword,high,keyword
ERCC3,HGNC:3435,xeroderma pigmentosum group B,MONDO:0012531,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ERCC3,HGNC:3435,xeroderma pigmentosum group B,MONDO:0012531,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ERCC4,HGNC:3436,xeroderma pigmentosum group F,MONDO:0010215,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ERCC4,HGNC:3436,xeroderma pigmentosum group F,MONDO:0010215,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ERCC4,HGNC:3436,xeroderma pigmentosum group F,MONDO:0010215,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ERCC5,HGNC:3437,xeroderma pigmentosum group G,MONDO:0010216,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ERCC5,HGNC:3437,xeroderma pigmentosum group G,MONDO:0010216,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ERCC5,HGNC:3437,xeroderma pigmentosum group G,MONDO:0010216,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ERCC6,HGNC:3438,Cockayne spectrum with or without cerebrooculofacioskeletal syndrome,MONDO:0100506,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
ERCC6,HGNC:3438,Cockayne spectrum with or without cerebrooculofacioskeletal syndrome,MONDO:0100506,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ERCC6,HGNC:3438,Cockayne spectrum with or without cerebrooculofacioskeletal syndrome,MONDO:0100506,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
ERCC6,HGNC:3438,Cockayne spectrum with or without cerebrooculofacioskeletal syndrome,MONDO:0100506,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ERCC8,HGNC:3439,Cockayne syndrome type 1,MONDO:0019569,Definitive,GO:0016567,protein ubiquitination,keyword,high,keyword
ERCC8,HGNC:3439,Cockayne syndrome type 1,MONDO:0019569,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ERCC8,HGNC:3439,Cockayne syndrome type 1,MONDO:0019569,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
ERCC8,HGNC:3439,Cockayne syndrome type 1,MONDO:0019569,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
ERF,HGNC:3444,craniosynostosis 4,MONDO:0010929,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ERF,HGNC:3444,craniosynostosis 4,MONDO:0010929,Definitive,GO:0010467,gene expression,direct,high,Expression
ERF,HGNC:3444,craniosynostosis 4,MONDO:0010929,Definitive,GO:0006412,translation,inferred,medium,Expression
ESPN,HGNC:13281,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0010467,gene expression,direct,high,Expression
ESPN,HGNC:13281,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0006412,translation,inferred,medium,Expression
ESPN,HGNC:13281,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ESRRB,HGNC:3473,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0010467,gene expression,direct,high,Expression
ESRRB,HGNC:3473,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0006412,translation,inferred,medium,Expression
ESRRB,HGNC:3473,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ETHE1,HGNC:23287,Leigh syndrome,MONDO:0009723,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ETHE1,HGNC:23287,Leigh syndrome,MONDO:0009723,Definitive,GO:0010467,gene expression,direct,high,Expression
ETHE1,HGNC:23287,Leigh syndrome,MONDO:0009723,Definitive,GO:0006412,translation,inferred,medium,Expression
ETV6,HGNC:3495,thrombocytopenia 5,MONDO:0014536,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
ETV6,HGNC:3495,thrombocytopenia 5,MONDO:0014536,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
ETV6,HGNC:3495,thrombocytopenia 5,MONDO:0014536,Definitive,GO:0005488,binding,keyword,medium,keyword
ETV6,HGNC:3495,thrombocytopenia 5,MONDO:0014536,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
ETV6,HGNC:3495,thrombocytopenia 5,MONDO:0014536,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
EXT1,HGNC:3512,"exostoses, multiple, type 1",MONDO:0007585,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EXT1,HGNC:3512,"exostoses, multiple, type 1",MONDO:0007585,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
EXT1,HGNC:3512,"exostoses, multiple, type 1",MONDO:0007585,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
EXT1,HGNC:3512,"exostoses, multiple, type 1",MONDO:0007585,Definitive,GO:0023052,signaling,keyword,medium,keyword
EXT1,HGNC:3512,"exostoses, multiple, type 1",MONDO:0007585,Definitive,GO:0009058,biosynthetic process,keyword,medium,keyword
EXT1,HGNC:3512,"exostoses, multiple, type 1",MONDO:0007585,Definitive,GO:0016740,transferase activity,keyword,high,keyword
EXT2,HGNC:3513,"exostoses, multiple, type 2",MONDO:0007586,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EXT2,HGNC:3513,"exostoses, multiple, type 2",MONDO:0007586,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
EXT2,HGNC:3513,"exostoses, multiple, type 2",MONDO:0007586,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
EXT2,HGNC:3513,"exostoses, multiple, type 2",MONDO:0007586,Definitive,GO:0023052,signaling,keyword,medium,keyword
EXT2,HGNC:3513,"exostoses, multiple, type 2",MONDO:0007586,Definitive,GO:0009058,biosynthetic process,keyword,medium,keyword
EXT2,HGNC:3513,"exostoses, multiple, type 2",MONDO:0007586,Definitive,GO:0016740,transferase activity,keyword,high,keyword
EXT2,HGNC:3513,"exostoses, multiple, type 2",MONDO:0007586,Definitive,GO:0010467,gene expression,direct,high,Expression
EXT2,HGNC:3513,"exostoses, multiple, type 2",MONDO:0007586,Definitive,GO:0006412,translation,inferred,medium,Expression
EYA1,HGNC:3519,branchio-oto-renal syndrome,MONDO:0007029,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EYA1,HGNC:3519,branchio-oto-renal syndrome,MONDO:0007029,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
EYA1,HGNC:3519,branchio-oto-renal syndrome,MONDO:0007029,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
EYA1,HGNC:3519,branchio-oto-renal syndrome,MONDO:0007029,Definitive,GO:0016791,phosphatase activity,keyword,high,keyword
EYA1,HGNC:3519,branchio-oto-renal syndrome,MONDO:0007029,Definitive,GO:0016311,dephosphorylation,keyword,high,keyword
EYA1,HGNC:3519,branchio-oto-renal syndrome,MONDO:0007029,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
EYA4,HGNC:3522,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EYA4,HGNC:3522,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0010467,gene expression,direct,high,Expression
EYA4,HGNC:3522,nonsyndromic genetic hearing loss,MONDO:0019497,Definitive,GO:0006412,translation,inferred,medium,Expression
EYS,HGNC:21555,EYS-related retinopathy,MONDO:0800391,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
EYS,HGNC:21555,EYS-related retinopathy,MONDO:0800391,Definitive,GO:0006915,apoptotic process,keyword,high,keyword
EYS,HGNC:21555,EYS-related retinopathy,MONDO:0800391,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
EYS,HGNC:21555,EYS-related retinopathy,MONDO:0800391,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
EYS,HGNC:21555,EYS-related retinopathy,MONDO:0800391,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
EYS,HGNC:21555,EYS-related retinopathy,MONDO:0800391,Definitive,GO:0010467,gene expression,direct,high,Expression
EYS,HGNC:21555,EYS-related retinopathy,MONDO:0800391,Definitive,GO:0006412,translation,inferred,medium,Expression
EZH2,HGNC:3527,Weaver syndrome,MONDO:0010193,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
EZH2,HGNC:3527,Weaver syndrome,MONDO:0010193,Definitive,GO:0016740,transferase activity,keyword,high,keyword
EZH2,HGNC:3527,Weaver syndrome,MONDO:0010193,Definitive,GO:0032259,methylation,keyword,medium,keyword
EZH2,HGNC:3527,Weaver syndrome,MONDO:0010193,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
F10,HGNC:3528,congenital factor X deficiency,MONDO:0009212,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
F10,HGNC:3528,congenital factor X deficiency,MONDO:0009212,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
F10,HGNC:3528,congenital factor X deficiency,MONDO:0009212,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
F11,HGNC:3529,congenital factor XI deficiency,MONDO:0012897,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
F11,HGNC:3529,congenital factor XI deficiency,MONDO:0012897,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
F11,HGNC:3529,congenital factor XI deficiency,MONDO:0012897,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
F12,HGNC:3530,congenital factor XII deficiency,MONDO:0009315,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
F12,HGNC:3530,congenital factor XII deficiency,MONDO:0009315,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
F12,HGNC:3530,congenital factor XII deficiency,MONDO:0009315,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
F13A1,HGNC:3531,"factor XIII, A subunit, deficiency of",MONDO:0013187,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
F13B,HGNC:3534,"factor XIII, b subunit, deficiency of",MONDO:0013190,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
F2,HGNC:3535,thrombophilia due to thrombin defect,MONDO:0008559,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
F2,HGNC:3535,congenital prothrombin deficiency,MONDO:0013361,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
F2,HGNC:3535,congenital prothrombin deficiency,MONDO:0013361,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
F2,HGNC:3535,congenital prothrombin deficiency,MONDO:0013361,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
F5,HGNC:3542,thrombophilia due to activated protein C resistance,MONDO:0008560,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
F5,HGNC:3542,thrombophilia due to activated protein C resistance,MONDO:0008560,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
F5,HGNC:3542,thrombophilia due to activated protein C resistance,MONDO:0008560,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
F5,HGNC:3542,congenital factor V deficiency,MONDO:0009210,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
F5,HGNC:3542,congenital factor V deficiency,MONDO:0009210,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
F5,HGNC:3542,congenital factor V deficiency,MONDO:0009210,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
F7,HGNC:3544,factor VII deficiency,MONDO:0002244,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
F7,HGNC:3544,factor VII deficiency,MONDO:0002244,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
F7,HGNC:3544,factor VII deficiency,MONDO:0002244,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
F8,HGNC:3546,hemophilia A,MONDO:0010602,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
F8,HGNC:3546,hemophilia A,MONDO:0010602,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
F8,HGNC:3546,hemophilia A,MONDO:0010602,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
F9,HGNC:3551,hemophilia B,MONDO:0010604,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
F9,HGNC:3551,hemophilia B,MONDO:0010604,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
F9,HGNC:3551,hemophilia B,MONDO:0010604,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FANCA,HGNC:3582,Fanconi anemia complementation group A,MONDO:0009215,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FANCA,HGNC:3582,Fanconi anemia complementation group A,MONDO:0009215,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FANCA,HGNC:3582,Fanconi anemia complementation group A,MONDO:0009215,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FANCB,HGNC:3583,Fanconi anemia complementation group B,MONDO:0010351,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FANCB,HGNC:3583,Fanconi anemia complementation group B,MONDO:0010351,Definitive,GO:0032259,methylation,keyword,medium,keyword
FANCB,HGNC:3583,Fanconi anemia complementation group B,MONDO:0010351,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FANCB,HGNC:3583,Fanconi anemia complementation group B,MONDO:0010351,Definitive,GO:0016567,protein ubiquitination,keyword,high,keyword
FANCC,HGNC:3584,Fanconi anemia complementation group C,MONDO:0009213,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FANCC,HGNC:3584,Fanconi anemia complementation group C,MONDO:0009213,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FANCC,HGNC:3584,Fanconi anemia complementation group C,MONDO:0009213,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FANCD2,HGNC:3585,Fanconi anemia complementation group D2,MONDO:0009214,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FANCE,HGNC:3586,Fanconi anemia complementation group E,MONDO:0010953,Definitive,GO:0016567,protein ubiquitination,keyword,high,keyword
FANCE,HGNC:3586,Fanconi anemia complementation group E,MONDO:0010953,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FANCF,HGNC:3587,Fanconi anemia complementation group F,MONDO:0011325,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FANCF,HGNC:3587,Fanconi anemia complementation group F,MONDO:0011325,Definitive,GO:0016567,protein ubiquitination,keyword,high,keyword
FANCF,HGNC:3587,Fanconi anemia complementation group F,MONDO:0011325,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FANCF,HGNC:3587,Fanconi anemia complementation group F,MONDO:0011325,Definitive,GO:0010467,gene expression,direct,high,Expression
FANCF,HGNC:3587,Fanconi anemia complementation group F,MONDO:0011325,Definitive,GO:0006412,translation,inferred,medium,Expression
FANCG,HGNC:3588,Fanconi anemia complementation group G,MONDO:0013565,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FANCG,HGNC:3588,Fanconi anemia complementation group G,MONDO:0013565,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FANCG,HGNC:3588,Fanconi anemia complementation group G,MONDO:0013565,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FANCI,HGNC:25568,Fanconi anemia complementation group I,MONDO:0012186,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FANCI,HGNC:25568,Fanconi anemia complementation group I,MONDO:0012186,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FANCI,HGNC:25568,Fanconi anemia complementation group I,MONDO:0012186,Definitive,GO:0016567,protein ubiquitination,keyword,high,keyword
FANCI,HGNC:25568,Fanconi anemia complementation group I,MONDO:0012186,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FANCI,HGNC:25568,Fanconi anemia complementation group I,MONDO:0012186,Definitive,GO:0010467,gene expression,direct,high,Expression
FANCI,HGNC:25568,Fanconi anemia complementation group I,MONDO:0012186,Definitive,GO:0006412,translation,inferred,medium,Expression
FANCL,HGNC:20748,Fanconi anemia complementation group L,MONDO:0013566,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FANCL,HGNC:20748,Fanconi anemia complementation group L,MONDO:0013566,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FANCL,HGNC:20748,Fanconi anemia complementation group L,MONDO:0013566,Definitive,GO:0016567,protein ubiquitination,keyword,high,keyword
FANCL,HGNC:20748,Fanconi anemia complementation group L,MONDO:0013566,Definitive,GO:0006281,DNA repair,keyword,high,keyword
FASTKD2,HGNC:29160,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FASTKD2,HGNC:29160,mitochondrial disease,MONDO:0044970,Definitive,GO:0006412,translation,keyword,high,keyword
FASTKD2,HGNC:29160,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
FASTKD2,HGNC:29160,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FBN1,HGNC:3603,Marfan syndrome,MONDO:0007947,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FBN1,HGNC:3603,Marfan syndrome,MONDO:0007947,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FBN1,HGNC:3603,Marfan syndrome,MONDO:0007947,Definitive,GO:0023052,signaling,keyword,medium,keyword
FBN1,HGNC:3603,Marfan syndrome,MONDO:0007947,Definitive,GO:0010467,gene expression,direct,high,Expression
FBN1,HGNC:3603,Marfan syndrome,MONDO:0007947,Definitive,GO:0006412,translation,inferred,medium,Expression
FBN1,HGNC:3603,Marfan syndrome,MONDO:0007947,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FBXL4,HGNC:13601,Leigh syndrome,MONDO:0009723,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
FBXL4,HGNC:13601,Leigh syndrome,MONDO:0009723,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FBXL4,HGNC:13601,Leigh syndrome,MONDO:0009723,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FBXL4,HGNC:13601,Leigh syndrome,MONDO:0009723,Definitive,GO:0010467,gene expression,direct,high,Expression
FBXL4,HGNC:13601,Leigh syndrome,MONDO:0009723,Definitive,GO:0006412,translation,inferred,medium,Expression
FCHO1,HGNC:29002,immunodeficiency 76,MONDO:0030898,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FCHO1,HGNC:29002,immunodeficiency 76,MONDO:0030898,Definitive,GO:0023052,signaling,keyword,medium,keyword
FCHO1,HGNC:29002,immunodeficiency 76,MONDO:0030898,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
FCHO1,HGNC:29002,immunodeficiency 76,MONDO:0030898,Definitive,GO:0010467,gene expression,direct,high,Expression
FCHO1,HGNC:29002,immunodeficiency 76,MONDO:0030898,Definitive,GO:0006412,translation,inferred,medium,Expression
FCHO1,HGNC:29002,immunodeficiency 76,MONDO:0030898,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FCHO1,HGNC:29002,immunodeficiency 76,MONDO:0030898,Definitive,GO:0016020,membrane,keyword,medium,keyword
FCHO1,HGNC:29002,immunodeficiency 76,MONDO:0030898,Definitive,GO:0005886,plasma membrane,keyword,high,keyword
FECH,HGNC:3647,"protoporphyria, erythropoietic, 1",MONDO:0008319,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FECH,HGNC:3647,"protoporphyria, erythropoietic, 1",MONDO:0008319,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FECH,HGNC:3647,"protoporphyria, erythropoietic, 1",MONDO:0008319,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FERMT3,HGNC:23151,leukocyte adhesion deficiency 3,MONDO:0013016,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FERMT3,HGNC:23151,leukocyte adhesion deficiency 3,MONDO:0013016,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FERMT3,HGNC:23151,leukocyte adhesion deficiency 3,MONDO:0013016,Definitive,GO:0023052,signaling,keyword,medium,keyword
FERMT3,HGNC:23151,leukocyte adhesion deficiency 3,MONDO:0013016,Definitive,GO:0010467,gene expression,direct,high,Expression
FERMT3,HGNC:23151,leukocyte adhesion deficiency 3,MONDO:0013016,Definitive,GO:0006412,translation,inferred,medium,Expression
FERMT3,HGNC:23151,leukocyte adhesion deficiency 3,MONDO:0013016,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FERMT3,HGNC:23151,leukocyte adhesion deficiency 3,MONDO:0013016,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
FGA,HGNC:3661,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FGA,HGNC:3661,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FGA,HGNC:3661,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0010467,gene expression,direct,high,Expression
FGA,HGNC:3661,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0006412,translation,inferred,medium,Expression
FGA,HGNC:3661,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FGB,HGNC:3662,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FGB,HGNC:3662,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FGB,HGNC:3662,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FGB,HGNC:3662,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0010467,gene expression,direct,high,Expression
FGB,HGNC:3662,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0006412,translation,inferred,medium,Expression
FGD4,HGNC:19125,Charcot-Marie-Tooth disease,MONDO:0015626,Definitive,GO:0010467,gene expression,direct,high,Expression
FGD4,HGNC:19125,Charcot-Marie-Tooth disease,MONDO:0015626,Definitive,GO:0006412,translation,inferred,medium,Expression
FGD4,HGNC:19125,Charcot-Marie-Tooth disease,MONDO:0015626,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FGD4,HGNC:19125,Charcot-Marie-Tooth disease,MONDO:0015626,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FGF12,HGNC:3668,developmental and epileptic encephalopathy,MONDO:0100062,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FGF12,HGNC:3668,developmental and epileptic encephalopathy,MONDO:0100062,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FGF12,HGNC:3668,developmental and epileptic encephalopathy,MONDO:0100062,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FGF3,HGNC:3681,"deafness with labyrinthine aplasia, microtia, and microdontia",MONDO:0012541,Definitive,GO:0010467,gene expression,direct,high,Expression
FGF3,HGNC:3681,"deafness with labyrinthine aplasia, microtia, and microdontia",MONDO:0012541,Definitive,GO:0006412,translation,inferred,medium,Expression
FGF3,HGNC:3681,"deafness with labyrinthine aplasia, microtia, and microdontia",MONDO:0012541,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FGF3,HGNC:3681,"deafness with labyrinthine aplasia, microtia, and microdontia",MONDO:0012541,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FGF3,HGNC:3681,"deafness with labyrinthine aplasia, microtia, and microdontia",MONDO:0012541,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FGFR1,HGNC:3688,Pfeiffer syndrome type 1,MONDO:0019659,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FGFR1,HGNC:3688,Pfeiffer syndrome type 1,MONDO:0019659,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FGFR1,HGNC:3688,Pfeiffer syndrome type 1,MONDO:0019659,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FGFR1,HGNC:3688,Pfeiffer syndrome type 1,MONDO:0019659,Definitive,GO:0005488,binding,keyword,medium,keyword
FGFR2,HGNC:3689,Apert syndrome,MONDO:0007041,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FGFR2,HGNC:3689,Apert syndrome,MONDO:0007041,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FGFR2,HGNC:3689,Apert syndrome,MONDO:0007041,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FGFR2,HGNC:3689,Beare-Stevenson cutis gyrata syndrome,MONDO:0007412,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FGFR2,HGNC:3689,Crouzon syndrome,MONDO:0007405,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FGFR2,HGNC:3689,Crouzon syndrome,MONDO:0007405,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FGFR2,HGNC:3689,Crouzon syndrome,MONDO:0007405,Definitive,GO:0016301,kinase activity,keyword,high,keyword
FGFR2,HGNC:3689,Crouzon syndrome,MONDO:0007405,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
FGFR2,HGNC:3689,Crouzon syndrome,MONDO:0007405,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
FGFR2,HGNC:3689,Pfeiffer syndrome,MONDO:0007043,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FGFR3,HGNC:3690,Crouzon syndrome-acanthosis nigricans syndrome,MONDO:0012833,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FGFR3,HGNC:3690,Muenke syndrome,MONDO:0011274,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FGG,HGNC:3694,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FGG,HGNC:3694,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0005488,binding,keyword,medium,keyword
FGG,HGNC:3694,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0010467,gene expression,direct,high,Expression
FGG,HGNC:3694,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0006412,translation,inferred,medium,Expression
FGG,HGNC:3694,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FGG,HGNC:3694,congenital fibrinogen deficiency,MONDO:0018060,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FHOD3,HGNC:26178,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FHOD3,HGNC:26178,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FHOD3,HGNC:26178,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0005488,binding,keyword,medium,keyword
FHOD3,HGNC:26178,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0010467,gene expression,direct,high,Expression
FHOD3,HGNC:26178,hypertrophic cardiomyopathy,MONDO:0005045,Definitive,GO:0006412,translation,inferred,medium,Expression
FITM2,HGNC:16135,Siddiqi syndrome,MONDO:0032842,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FITM2,HGNC:16135,Siddiqi syndrome,MONDO:0032842,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
FLCN,HGNC:27310,obsolete Birt-Hogg-Dube syndrome,MONDO:0007607,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FLCN,HGNC:27310,obsolete Birt-Hogg-Dube syndrome,MONDO:0007607,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FLCN,HGNC:27310,obsolete Birt-Hogg-Dube syndrome,MONDO:0007607,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FLCN,HGNC:27310,obsolete Birt-Hogg-Dube syndrome,MONDO:0007607,Definitive,GO:0010467,gene expression,direct,high,Expression
FLCN,HGNC:27310,obsolete Birt-Hogg-Dube syndrome,MONDO:0007607,Definitive,GO:0006412,translation,inferred,medium,Expression
FLNA,HGNC:3754,periventricular nodular heterotopia,MONDO:0020341,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FLNA,HGNC:3754,periventricular nodular heterotopia,MONDO:0020341,Definitive,GO:0038023,signaling receptor activity,keyword,medium,keyword
FLNC,HGNC:3756,myofibrillar myopathy,MONDO:0018943,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FLNC,HGNC:3756,myofibrillar myopathy,MONDO:0018943,Definitive,GO:0006914,autophagy,keyword,high,keyword
FLNC,HGNC:3756,myofibrillar myopathy,MONDO:0018943,Definitive,GO:0005488,binding,keyword,medium,keyword
FLNC,HGNC:3756,myofibrillar myopathy,MONDO:0018943,Definitive,GO:0005764,lysosome,keyword,high,keyword
FLNC,HGNC:3756,myofibrillar myopathy,MONDO:0018943,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FLNC,HGNC:3756,myofibrillar myopathy,MONDO:0018943,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FLNC,HGNC:3756,myofibrillar myopathy,MONDO:0018943,Definitive,GO:0010467,gene expression,direct,high,Expression
FLNC,HGNC:3756,myofibrillar myopathy,MONDO:0018943,Definitive,GO:0006412,translation,inferred,medium,Expression
FLT4,HGNC:3767,lymphatic malformation 1,MONDO:0007919,Definitive,GO:0010467,gene expression,direct,high,Expression
FLT4,HGNC:3767,lymphatic malformation 1,MONDO:0007919,Definitive,GO:0006412,translation,inferred,medium,Expression
FLT4,HGNC:3767,lymphatic malformation 1,MONDO:0007919,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FLT4,HGNC:3767,lymphatic malformation 1,MONDO:0007919,Definitive,GO:0016301,kinase activity,keyword,high,keyword
FLT4,HGNC:3767,lymphatic malformation 1,MONDO:0007919,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
FLT4,HGNC:3767,lymphatic malformation 1,MONDO:0007919,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FLVCR1,HGNC:24682,FLVCR1-related retinopathy with or without ataxia,MONDO:0100449,Definitive,GO:0010467,gene expression,direct,high,Expression
FLVCR1,HGNC:24682,FLVCR1-related retinopathy with or without ataxia,MONDO:0100449,Definitive,GO:0006412,translation,inferred,medium,Expression
FLVCR1,HGNC:24682,FLVCR1-related retinopathy with or without ataxia,MONDO:0100449,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FLVCR1,HGNC:24682,FLVCR1-related retinopathy with or without ataxia,MONDO:0100449,Definitive,GO:0005216,ion channel activity,keyword,medium,keyword
FMO3,HGNC:3771,trimethylaminuria,MONDO:0011182,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FMO3,HGNC:3771,trimethylaminuria,MONDO:0011182,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FMO3,HGNC:3771,trimethylaminuria,MONDO:0011182,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FMO3,HGNC:3771,trimethylaminuria,MONDO:0011182,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
FMR1,HGNC:3775,fragile X syndrome,MONDO:0010383,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FMR1,HGNC:3775,fragile X syndrome,MONDO:0010383,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FMR1,HGNC:3775,fragile X syndrome,MONDO:0010383,Definitive,GO:0010467,gene expression,direct,high,Expression
FMR1,HGNC:3775,fragile X syndrome,MONDO:0010383,Definitive,GO:0006412,translation,inferred,medium,Expression
FMR1,HGNC:3775,fragile X syndrome,MONDO:0010383,Definitive,GO:0005634,nucleus,keyword,high,keyword
FN1,HGNC:3778,"spondylometaphyseal dysplasia, 'corner fracture' type",MONDO:0008479,Definitive,GO:0010467,gene expression,direct,high,Expression
FN1,HGNC:3778,"spondylometaphyseal dysplasia, 'corner fracture' type",MONDO:0008479,Definitive,GO:0006412,translation,inferred,medium,Expression
FOXC2,HGNC:3801,lymphedema-distichiasis syndrome,MONDO:0007922,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FOXC2,HGNC:3801,lymphedema-distichiasis syndrome,MONDO:0007922,Definitive,GO:0010467,gene expression,direct,high,Expression
FOXC2,HGNC:3801,lymphedema-distichiasis syndrome,MONDO:0007922,Definitive,GO:0006412,translation,inferred,medium,Expression
FOXC2,HGNC:3801,lymphedema-distichiasis syndrome,MONDO:0007922,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FOXC2,HGNC:3801,lymphedema-distichiasis syndrome,MONDO:0007922,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FOXE1,HGNC:3806,Bamforth-Lazarus syndrome,MONDO:0009437,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FOXE1,HGNC:3806,Bamforth-Lazarus syndrome,MONDO:0009437,Definitive,GO:0010467,gene expression,direct,high,Expression
FOXE1,HGNC:3806,Bamforth-Lazarus syndrome,MONDO:0009437,Definitive,GO:0006412,translation,inferred,medium,Expression
FOXE1,HGNC:3806,Bamforth-Lazarus syndrome,MONDO:0009437,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FOXE1,HGNC:3806,Bamforth-Lazarus syndrome,MONDO:0009437,Definitive,GO:0005488,binding,keyword,medium,keyword
FOXG1,HGNC:3811,FOXG1 disorder,MONDO:0100040,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FOXG1,HGNC:3811,FOXG1 disorder,MONDO:0100040,Definitive,GO:0010467,gene expression,direct,high,Expression
FOXG1,HGNC:3811,FOXG1 disorder,MONDO:0100040,Definitive,GO:0006412,translation,inferred,medium,Expression
FOXN1,HGNC:12765,"T-cell immunodeficiency, congenital alopecia, and nail dystrophy",MONDO:0011132,Definitive,GO:0010467,gene expression,direct,high,Expression
FOXN1,HGNC:12765,"T-cell immunodeficiency, congenital alopecia, and nail dystrophy",MONDO:0011132,Definitive,GO:0006412,translation,inferred,medium,Expression
FOXN1,HGNC:12765,"T-cell immunodeficiency, congenital alopecia, and nail dystrophy",MONDO:0011132,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FOXN1,HGNC:12765,"T-cell immunodeficiency, congenital alopecia, and nail dystrophy",MONDO:0011132,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FOXP1,HGNC:3823,intellectual disability-severe speech delay-mild dysmorphism syndrome,MONDO:0013352,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FOXP1,HGNC:3823,intellectual disability-severe speech delay-mild dysmorphism syndrome,MONDO:0013352,Definitive,GO:0010467,gene expression,direct,high,Expression
FOXP1,HGNC:3823,intellectual disability-severe speech delay-mild dysmorphism syndrome,MONDO:0013352,Definitive,GO:0006412,translation,inferred,medium,Expression
FOXP1,HGNC:3823,intellectual disability-severe speech delay-mild dysmorphism syndrome,MONDO:0013352,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FOXP1,HGNC:3823,intellectual disability-severe speech delay-mild dysmorphism syndrome,MONDO:0013352,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
FOXP2,HGNC:13875,specific language disorder,MONDO:0016226,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FOXP2,HGNC:13875,specific language disorder,MONDO:0016226,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FOXP2,HGNC:13875,specific language disorder,MONDO:0016226,Definitive,GO:0006351,DNA-templated transcription,keyword,high,keyword
FOXP2,HGNC:13875,specific language disorder,MONDO:0016226,Definitive,GO:0010467,gene expression,direct,high,Expression
FOXP2,HGNC:13875,specific language disorder,MONDO:0016226,Definitive,GO:0006412,translation,inferred,medium,Expression
FOXP3,HGNC:6106,immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome,MONDO:0010580,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FOXP3,HGNC:6106,immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome,MONDO:0010580,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FOXP3,HGNC:6106,immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome,MONDO:0010580,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FOXRED1,HGNC:26927,mitochondrial disease,MONDO:0044970,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FOXRED1,HGNC:26927,mitochondrial disease,MONDO:0044970,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FOXRED1,HGNC:26927,mitochondrial disease,MONDO:0044970,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FOXRED1,HGNC:26927,mitochondrial disease,MONDO:0044970,Definitive,GO:0005739,mitochondrion,keyword,medium,keyword
FRAS1,HGNC:19185,Fraser syndrome,MONDO:0009046,Definitive,GO:0010467,gene expression,direct,high,Expression
FRAS1,HGNC:19185,Fraser syndrome,MONDO:0009046,Definitive,GO:0006412,translation,inferred,medium,Expression
FRAS1,HGNC:19185,Fraser syndrome,MONDO:0009046,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FRMPD4,HGNC:29007,X-linked complex neurodevelopmental disorder,MONDO:0100148,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FRMPD4,HGNC:29007,X-linked complex neurodevelopmental disorder,MONDO:0100148,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FRRS1L,HGNC:1362,developmental and epileptic encephalopathy,MONDO:0100062,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FTSJ1,HGNC:13254,X-linked complex neurodevelopmental disorder,MONDO:0100148,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FTSJ1,HGNC:13254,X-linked complex neurodevelopmental disorder,MONDO:0100148,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FTSJ1,HGNC:13254,X-linked complex neurodevelopmental disorder,MONDO:0100148,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
FTSJ1,HGNC:13254,X-linked complex neurodevelopmental disorder,MONDO:0100148,Definitive,GO:0016740,transferase activity,keyword,high,keyword
FTSJ1,HGNC:13254,X-linked complex neurodevelopmental disorder,MONDO:0100148,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FTSJ1,HGNC:13254,X-linked complex neurodevelopmental disorder,MONDO:0100148,Definitive,GO:0006412,translation,keyword,high,keyword
FTSJ1,HGNC:13254,X-linked complex neurodevelopmental disorder,MONDO:0100148,Definitive,GO:0032259,methylation,keyword,medium,keyword
FUCA1,HGNC:4006,fucosidosis,MONDO:0009254,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FUCA1,HGNC:4006,fucosidosis,MONDO:0009254,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
FUCA1,HGNC:4006,fucosidosis,MONDO:0009254,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FUCA1,HGNC:4006,fucosidosis,MONDO:0009254,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FUS,HGNC:4010,amyotrophic lateral sclerosis type 6,MONDO:0011951,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FUS,HGNC:4010,amyotrophic lateral sclerosis type 6,MONDO:0011951,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
FUS,HGNC:4010,amyotrophic lateral sclerosis type 6,MONDO:0011951,Definitive,GO:0006281,DNA repair,keyword,high,keyword
FUS,HGNC:4010,amyotrophic lateral sclerosis type 6,MONDO:0011951,Definitive,GO:0005737,cytoplasm,keyword,high,keyword
FUT8,HGNC:4019,congenital disorder of glycosylation with defective fucosylation 1,MONDO:0020775,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
FUT8,HGNC:4019,congenital disorder of glycosylation with defective fucosylation 1,MONDO:0020775,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FUT8,HGNC:4019,congenital disorder of glycosylation with defective fucosylation 1,MONDO:0020775,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FXN,HGNC:3951,Friedreich ataxia,MONDO:0100339,Definitive,GO:0010467,gene expression,direct,high,Expression
FXN,HGNC:3951,Friedreich ataxia,MONDO:0100339,Definitive,GO:0006412,translation,inferred,medium,Expression
FXN,HGNC:3951,Friedreich ataxia,MONDO:0100339,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
FXN,HGNC:3951,Friedreich ataxia,MONDO:0100339,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
FXN,HGNC:3951,Friedreich ataxia,MONDO:0100339,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
G6PC1,HGNC:4056,glycogen storage disease I,MONDO:0002413,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
G6PC1,HGNC:4056,glycogen storage disease I,MONDO:0002413,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
G6PC1,HGNC:4056,glycogen storage disease I,MONDO:0002413,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
G6PC1,HGNC:4056,glycogen storage disease I,MONDO:0002413,Definitive,GO:0016020,membrane,keyword,medium,keyword
G6PC3,HGNC:24861,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,MONDO:0012930,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
G6PC3,HGNC:24861,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,MONDO:0012930,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
G6PC3,HGNC:24861,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,MONDO:0012930,Definitive,GO:0016787,hydrolase activity,keyword,high,keyword
G6PC3,HGNC:24861,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,MONDO:0012930,Definitive,GO:0006486,protein glycosylation,keyword,high,keyword
G6PD,HGNC:4057,G6PD deficiency,MONDO:0005775,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
G6PD,HGNC:4057,G6PD deficiency,MONDO:0005775,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
G6PD,HGNC:4057,G6PD deficiency,MONDO:0005775,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
G6PD,HGNC:4057,"anemia, nonspherocytic hemolytic, due to G6PD deficiency",MONDO:0010480,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
G6PD,HGNC:4057,"anemia, nonspherocytic hemolytic, due to G6PD deficiency",MONDO:0010480,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
G6PD,HGNC:4057,"anemia, nonspherocytic hemolytic, due to G6PD deficiency",MONDO:0010480,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
GAA,HGNC:4065,glycogen storage disease II,MONDO:0009290,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
GAA,HGNC:4065,glycogen storage disease II,MONDO:0009290,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
GAA,HGNC:4065,glycogen storage disease II,MONDO:0009290,Definitive,GO:0006412,translation,keyword,high,keyword
GAA,HGNC:4065,glycogen storage disease II,MONDO:0009290,Definitive,GO:0006810,transport,keyword,medium,keyword
GAA,HGNC:4065,glycogen storage disease II,MONDO:0009290,Definitive,GO:0010467,gene expression,direct,high,Expression
GAA,HGNC:4065,glycogen storage disease II,MONDO:0009290,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
GAA,HGNC:4065,glycogen storage disease II,MONDO:0009290,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
GAA,HGNC:4065,glycogen storage disease II,MONDO:0009290,Definitive,GO:0005764,lysosome,keyword,high,keyword
GABRB3,HGNC:4083,developmental and epileptic encephalopathy,MONDO:0100062,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
GABRB3,HGNC:4083,developmental and epileptic encephalopathy,MONDO:0100062,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
GABRG2,HGNC:4087,epilepsy,MONDO:0005027,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
GAD1,HGNC:4092,obsolete early infantile epileptic encephalopathy,MONDO:0016021,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
GAD1,HGNC:4092,obsolete early infantile epileptic encephalopathy,MONDO:0016021,Definitive,GO:0010467,gene expression,direct,high,Expression
GAD1,HGNC:4092,obsolete early infantile epileptic encephalopathy,MONDO:0016021,Definitive,GO:0006412,translation,inferred,medium,Expression
GAD1,HGNC:4092,obsolete early infantile epileptic encephalopathy,MONDO:0016021,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
GAD1,HGNC:4092,obsolete early infantile epileptic encephalopathy,MONDO:0016021,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
GALC,HGNC:4115,Krabbe disease,MONDO:0009499,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
GALC,HGNC:4115,Krabbe disease,MONDO:0009499,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
GALC,HGNC:4115,Krabbe disease,MONDO:0009499,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
GALE,HGNC:4116,galactose epimerase deficiency,MONDO:0009257,Definitive,GO:0003674,molecular_function,inferred,low,Functional Alteration
GALE,HGNC:4116,galactose epimerase deficiency,MONDO:0009257,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
GALE,HGNC:4116,galactose epimerase deficiency,MONDO:0009257,Definitive,GO:0008152,metabolic process,keyword,medium,keyword
GALE,HGNC:4116,galactose epimerase deficiency,MONDO:0009257,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
GALK1,HGNC:4118,galactokinase deficiency,MONDO:0009255,Definitive,GO:0008150,biological_process,inferred,low,Model Systems
GALK1,HGNC:4118,galactokinase deficiency,MONDO:0009255,Definitive,GO:0016301,kinase activity,keyword,high,keyword
GALK1,HGNC:4118,galactokinase deficiency,MONDO:0009255,Definitive,GO:0016310,phosphorylation,keyword,high,keyword
GALK1,HGNC:4118,galactokinase deficiency,MONDO:0009255,Definitive,GO:0003674,molecular_function,direct,high,Biochemical Function
GALK1,HGNC:4118,galactokinase deficiency,MONDO:0009255,Definitive,GO:0003824,catalytic activity,inferred,medium,Biochemical Function
